# ::snt Regulation of Muscle Fiber Type and Running Endurance by PPAR .
# ::tok Regulation of Muscle Fiber Type and Running Endurance by PPAR .
# ::alignments 9-10|0.0.2.0.0+0.0.2.0+0.0.2 6-8|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 5-6|0.0 2-5|0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:51:57.701
(r2 / regulation 
      :op1-of (a / and 
            :op2 (o2 / organization 
                  :name (n3 / name 
                        :op1 "Muscle" 
                        :op2 "Fiber" 
                        :op3 "Type")) 
            :op3 (t / thing 
                  :name (n2 / name 
                        :op1 (r / Running) 
                        :op2 (e / Endurance))) 
            :op4 (o / organization 
                  :name (n / name 
                        :op1 "PPAR"))))

# ::snt Endurance exercise training can promote an adaptive muscle fiber transformation and an increase of mitochondrial biogenesis by triggering scripted changes in gene expression .
# ::tok Endurance exercise training can promote an adaptive muscle fiber transformation and an increase of mitochondrial biogenesis by triggering scripted changes in gene expression .
# ::alignments 22-23|0.0.0.0.0.0 21-22|0.0.0.0.0.0.0 19-20|0.0.0.0.0 18-19|0.0.0.0.0.1 17-18|0.0.0.0 15-16|0.0.2.0.0 12-13|0.0.2.0 10-11|0.0.2 9-10|0.0.1 8-9|0.0.1.1 7-8|0.0.1.0 6-7|0.0.1.0.0 4-5|0.0 3-4|0 2-3|0.0.0 1-2|0.0.0.1 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:51:59.901
(p2 / possible-01 
      :ARG1 (p / promote-02 
            :ARG0 (t3 / train-01 
                  :ARG0-of (t / trigger-01 
                        :ARG1 (c / change-01 
                              :ARG1 (e / express-01 
                                    :mod (g / gene)) 
                              :ARG1-of (s / script-01))) 
                  :ARG1 (e2 / exercise-02) 
                  :manner (e3 / endurance)) 
            :ARG1 (t2 / transform-01 
                  :ARG1 (m / muscle-01 
                        :ARG1 (a2 / adaptive)) 
                  :mod (f / fib)) 
            :op1-of (a / and 
                  :op2 (i / increase-01 
                        :ARG1 (b / biogenesi)))))

# ::snt However , no transcription factor has yet been identified that can direct this process .
# ::tok However , no transcription factor has yet been identified that can direct this process .
# ::alignments 13-14|0.1.0.1 12-13|0.1.0.1.0 11-12|0.1.0 10-11|0.1 9-10|0.1.0.0 8-9|0 6-7|0.3 4-5|0.0 3-4|0.0.0 2-3|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:00.806
(i / identify-01 
      :ARG1 (f / factor 
            :mod (t3 / transcription)) 
      :ARG2 (p2 / possible-01 
            :ARG1 (d / direct-02 
                  :ARG0 (t2 / that) 
                  :ARG1 (p / process-02 
                        :mod (t / this)))) 
      :polarity - 
      :time (y / yet))

# ::snt We describe the engineering of a mouse capable of continuous running of up to twice the distance of a wild-type littermate .
# ::tok We describe the engineering of a mouse capable of continuous running of up to twice the distance of a wild-type littermate .
# ::alignments 20-21|0 16-17|0.0 10-11|0.0.0.0 9-10|0.0.0 7-8|0.0.0.1 6-7|0.0.0.1.0 3-4|0.0.0.1.0.0 1-2|0.0.0.1.0.0.0 0-1|0.0.0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:01.143
(l / littermate 
      :ARG1-of (d / distance-01 
            :ARG2-of (c / continue-01 
                  :ARG1 (r / run-01) 
                  :ARG2-of (c2 / capable-01 
                        :ARG1 (m / mouse 
                              :ARG1-of (e / engineer-01 
                                    :ARG1-of (d2 / describe-01 
                                          :ARG0 (w / we))))))))

# ::snt This was achieved by targeted expression of an activated form of peroxisome proliferator-activated receptor  ( PPAR ) in skeletal muscle , which induces a switch to form increased numbers of type I muscle fibers .
# ::tok This was achieved by targeted expression of an activated form of peroxisome proliferator-activated receptor  ( PPAR ) in skeletal muscle , which induces a switch to form increased numbers of type I muscle fibers .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:01.147
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Treatment of wild-type mice with PPAR agonist elicits a similar type I fiber gene expression profile in muscle .
# ::tok Treatment of wild-type mice with PPAR agonist elicits a similar type I fiber gene expression profile in muscle .
# ::alignments 17-18|0.1.0 15-16|0.1.0.0 14-15|0.1.0.0.0.0 13-14|0.1.0.0.0 11-12|0.1.0.0.1 10-11|0.1 9-10|0.1.1 7-8|0 6-7|0.1.0.0.1.0 5-6|0.1.0.0.1.0.0.0.0+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0 3-4|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:02.157
(e2 / elicit-01 
      :ARG0 (t2 / treatment 
            :mod (m2 / mouse)) 
      :ARG1 (t / type 
            :ARG1-of (m / muscle-01 
                  :ARG0 (p / profile 
                        :mod (g / gene 
                              :ARG1-of (e / express-01)) 
                        :poss (i / i 
                              :poss-of (a / agonist 
                                    :mod (o / organization 
                                          :name (n / name 
                                                :op1 "PPAR")))))) 
            :ARG1-of (r / resemble-01)))

# ::snt Moreover , these genetically generated fibers confer resistance to obesity with improved metabolic profiles , even in the absence of exercise .
# ::tok Moreover , these genetically generated fibers confer resistance to obesity with improved metabolic profiles , even in the absence of exercise .
# ::alignments 20-21|0.1.0.0.0.0 18-19|0.1.0.0.0.0.1 15-16|0.1.0.0.0.0.1.0 13-14|0.1.0.0 12-13|0.1.0.0.1 11-12|0.1.0.0.0 9-10|0.1.0 7-8|0.1 6-7|0 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0.1 0-1|0.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:02.494
(c / confer-01 
      :ARG0 (f / fiber 
            :ARG1-of (g / generate-01 
                  :degree (g2 / genetics)) 
            :mod (t / this)) 
      :ARG1 (r / resist-01 
            :ARG1 (o / obesity 
                  :topic (p / profile-01 
                        :ARG1-of (i / improve-01 
                              :purpose-of (e / exercise-02 
                                    :ARG1 (m2 / moreover) 
                                    :ARG1-of (a / absent-01 
                                          :mod (e2 / even)))) 
                        :mod (m / metabolic)))))

# ::snt These results demonstrate that complex physiologic properties such as fatigue , endurance , and running capacity can be molecularly analyzed and manipulated .
# ::tok These results demonstrate that complex physiologic properties such as fatigue , endurance , and running capacity can be molecularly analyzed and manipulated .
# ::alignments 21-22|0.0.0.0.1.2 20-21|0.0.0.0.1 19-20|0.0.0.0.1.1 16-17|0.0.0.0.1.0 15-16|0.0 14-15|0 13-14|0.0.0 11-12|0.0.0.2 9-10|0.0.0.1 7-8|0.0.0.3 6-7|0.0.0.0.1.2.0 5-6|0.0.0.0.1.2.0.0 4-5|0.0.0.0.1.2.0.1 2-3|0.0.0.0 1-2|0.0.0.0.0.0+0.0.0.0.0 0-1|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:02.682
(r / run-02 
      :mod-of (c / capacity 
            :op3-of (a3 / and 
                  :ARG2-of (d / demonstrate-01 
                        :ARG0 (t / thing 
                              :ARG2-of (r2 / result-01) 
                              :mod (t2 / this)) 
                        :ARG1 (a / and 
                              :ARG1-of (p / possible-01) 
                              :op1 (a2 / analyze-01) 
                              :op2 (m / manipulate-02 
                                    :ARG1 (p2 / property 
                                          :mod (p3 / physiologic) 
                                          :mod (c2 / complex))))) 
                  :op1 (f / fatigue) 
                  :op2 (e / endurance) 
                  :purpose-of (s / such))))

# ::snt Skeletal muscle fibers are generally classified as type I ( oxidative/slow ) or type II ( glycolytic/fast ) fibers .
# ::tok Skeletal muscle fibers are generally classified as type I ( oxidative/slow ) or type II ( glycolytic/fast ) fibers .
# ::alignments 18-19|0.3.2 14-15|0.3.1.0.1+0.3.1.0.0.2+0.3.1.0.0.1+0.3.1.0.0.0+0.3.1.0.0+0.3.1.0 13-14|0.3.1 12-13|0.3 8-9|0.3.0 7-8|0.0 5-6|0 4-5|0.2 2-3|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:02.837
(c / classify-01 
      :ARG0 (t2 / type) 
      :ARG1 (f2 / fiber 
            :ARG1-of (m / muscle-01 
                  :ARG0 (s / skeletal))) 
      :ARG1-of (g / general-02) 
      :ARG2 (o / or 
            :op1 (i / i) 
            :op2 (t / type 
                  :mod (w / war 
                        :name (n / name 
                              :op1 "World" 
                              :op2 "War" 
                              :op3 "II") 
                        :wiki "World_War_II")) 
            :op3 (f / fiber)))

# ::snt They display marked differences in respect to contraction , metabolism , and susceptibility to fatigue .
# ::tok They display marked differences in respect to contraction , metabolism , and susceptibility to fatigue .
# ::alignments 14-15|0 12-13|0.0.1.1.1 11-12|0.0.1.1 9-10|0.0.1.1.0 7-8|0.0.1.0 5-6|0.0.1 3-4|0.0.0.0 2-3|0.0.0.0.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:02.910
(f / fatigue 
      :ARG1-of (d2 / display-01 
            :ARG0 (t / they 
                  :ARG0-of (d / differ-01 
                        :ARG1-of (m2 / mark-01))) 
            :topic (r / respect-01 
                  :ARG1 (c / contraction) 
                  :op1-of (a / and 
                        :op2 (m / metabolism) 
                        :op3 (s / susceptibility)))))

# ::snt Type I fibers are mitochondria-rich and mainly use oxidative metabolism for energy production , which provides a stable and long-lasting supply of ATP , and thus are fatigue-resistant .
# ::tok Type I fibers are mitochondria-rich and mainly use oxidative metabolism for energy production , which provides a stable and long-lasting supply of ATP , and thus are fatigue-resistant .
# ::alignments 25-26|0.1.0 24-25|0.0.0.1.0.1.3.0 22-23|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 20-21|0.0.0 19-20|0.1 18-19|0 17-18|0.0 15-16|0.0.0.1 12-13|0.0.0.1.0 11-12|0.0.0.1.0.0 9-10|0.0.0.1.0.1.1 8-9|0.0.0.1.0.1.1.0 7-8|0.0.0.1.0.1 6-7|0.0.0.1.0.1.2 5-6|0.0.0.1.0.1.3 2-3|0.0.0.1.0.1.0 1-2|0.0.0.1.0.1.0.1 0-1|0.0.0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:03.770
(a2 / and 
      :op1 (s2 / stable-03 
            :ARG1 (s / supply-01 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "ATP")) 
                  :ARG1-of (p / provide-01 
                        :ARG0 (p2 / produce-01 
                              :ARG1 (e / energy) 
                              :ARG2-of (u / use-01 
                                    :ARG0 (f / fiber 
                                          :ARG1-of (t2 / type-01) 
                                          :mod (i / i)) 
                                    :ARG1 (m / metabolism 
                                          :mod (o2 / oxidative)) 
                                    :mod (m2 / main) 
                                    :op1-of (a3 / and 
                                          :op2 (a / and))))))) 
      :op2 (l / long-last 
            :location-of (t / thus-far)))

# ::snt Type II fibers comprise three subtypes , IIa , IIx , and IIb .
# ::tok Type II fibers comprise three subtypes , IIa , IIx , and IIb .
# ::alignments 12-13|0.1.2.0.0+0.1.2.0+0.1.2 11-12|0.1 9-10|0.1.1.0.0+0.1.1.0+0.1.1 5-6|0.1.0 4-5|0.1.0.0 3-4|0 2-3|0.0 0-2|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:04.577
(c / comprise-01 
      :ARG0 (f / fiber 
            :mod (t / thing 
                  :name (n3 / name 
                        :op1 (t2 / Type) 
                        :op2 (i / II)))) 
      :ARG1 (a / and 
            :op1 (s / subtyp 
                  :quant 3) 
            :op2 (p2 / person 
                  :name (n2 / name 
                        :op1 "IIx")) 
            :op3 (p / person 
                  :name (n / name 
                        :op1 "IIb"))))

# ::snt Type IIb fibers have the lowest levels of mitochondrial content and oxidative enzymes , rely on glycolytic metabolism as a major energy source , and are susceptible to fatigue , while the oxidative and contraction functions of type IIa and IIx lie between type I and IIb ( Booth and Thomason 1991 ; Berchtold et al. 2000 ; Olson and Williams 2000 ) .
# ::tok Type IIb fibers have the lowest levels of mitochondrial content and oxidative enzymes , rely on glycolytic metabolism as a major energy source , and are susceptible to fatigue , while the oxidative and contraction functions of type IIa and IIx lie between type I and IIb ( Booth and Thomason 1991 ; Berchtold et al. 2000 ; Olson and Williams 2000 ) .
# ::alignments 61-62|0.3.1.0+0.3.1 60-61|0.0.1.2.0 59-60|0.0.1.2 56-57|0.3.0.0+0.3.0 53-56|0.0.1.1.1.0.2+0.0.1.1.1.0.1+0.0.1.1.1.0.0+0.0.1.1.1.0+0.0.1.1.1 52-53|0.0.1.1 51-52|0.0.1.1.1.1.0+0.0.1.1.1.1 50-51|0.0.1.1.2.1.0.0+0.0.1.1.2.1.0+0.0.1.1.2.1 49-50|0.0.1.1.2 48-49|0.0.1.1.2.0.0.0+0.0.1.1.2.0.0+0.0.1.1.2.0 45-46|0.0.1 44-45|0.0.1.0 43-44|0.0.1.1.0 41-42|0.0 40-41|0.3.2.1.0.0+0.3.2.1.0+0.3.2.1 39-40|0.3.2 38-39|0.3.2.0.1.0+0.3.2.0.1+0.3.2.0 37-38|0.3.2.0.0 35-36|0.3 34-35|0.2 33-34|0 32-33|0.1 28-29|0.0.0.3.0 26-27|0.0.0.3 24-25|0.0.0 22-23|0.0.0.2 21-22|0.0.0.2.1 20-21|0.0.0.2.0 17-18|0.0.0.1.1 14-15|0.0.0.1 12-13|0.0.0.1.2.2 11-12|0.0.0.1.2.1 10-11|0.0.0.1.2 9-10|0.0.0.1.2.0 6-7|0.0.0.0 5-6|0.0.0.0.0.0+0.0.0.0.0 2-3|0.0.0.1.0 0-2|0.0.0.1.0.0.0.1+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:12.833
(a6 / and 
      :ARG0-of (l / lie-08 
            :ARG1 (a7 / and 
                  :op1 (l2 / level 
                        :ARG1-of (l3 / low-04 
                              :degree (m3 / most))) 
                  :op2 (r / rely-01 
                        :ARG0 (f3 / fiber 
                              :mod (t4 / thing 
                                    :name (n6 / name 
                                          :op1 (t5 / Type) 
                                          :op2 (i2 / IIb)))) 
                        :ARG1 (m2 / metabolism) 
                        :op4-of (a8 / and 
                              :op1 (c2 / content) 
                              :op2 (o2 / oxidative) 
                              :op3 (e2 / enzym))) 
                  :op3 (s2 / source 
                        :ARG1-of (m / major-02) 
                        :mod (e / energy)) 
                  :op4 (s / susceptible 
                        :domain (f2 / fatigue))) 
            :op1-of (a4 / and 
                  :op2 (i / i) 
                  :op3 (a2 / and 
                        :op1 (t2 / type) 
                        :op2 (t / thing 
                              :name (n / name 
                                    :op1 "Berchtold" 
                                    :op2 "et" 
                                    :op3 "al.") 
                              :quant (d3 / date-entity 
                                    :year 1991)) 
                        :op3-of (a3 / and 
                              :op1 (p2 / person 
                                    :name (n3 / name 
                                          :op1 "Booth")) 
                              :op2 (p / person 
                                    :name (n2 / name 
                                          :op1 "Thomason")))) 
                  :op4 (a / and 
                        :op1 (w / william)))) 
      :op1 (o / oxidative) 
      :op2 (c / contraction) 
      :op3 (f / function-01 
            :ARG1 (d2 / date-entity 
                  :year 2000) 
            :op1-of (d / date-entity 
                  :year 2000) 
            :op1-of (a5 / and 
                  :op2 (p4 / person 
                        :mod (t3 / type) 
                        :name (n5 / name 
                              :op1 "IIa")) 
                  :op3 (p3 / person 
                        :name (n4 / name 
                              :op1 "IIx")))))

# ::snt Adult skeletal muscle shows plasticity and can undergo conversion between different fiber types in response to exercise training or modulation of motoneuron activity ( Booth and Thomason 1991 , Jarvis et al. 1996 ; Pette 1998 ; Olson and Williams 2000 ; Hood 2001 ) .
# ::tok Adult skeletal muscle shows plasticity and can undergo conversion between different fiber types in response to exercise training or modulation of motoneuron activity ( Booth and Thomason 1991 , Jarvis et al. 1996 ; Pette 1998 ; Olson and Williams 2000 ; Hood 2001 ) .
# ::alignments 43-44|0.0.0.0.3.1.1.1.0.1+0.0.0.0.3.1.1.1.0 42-43|0.0.0.0.3.1.1.1.0.0 40-41|0.0.0.0.3.1.0.0+0.0.0.0.3.1.0 39-40|0.0.0.1.0.0 38-39|0.0.0.1.0 35-36|0.0.0.0.3.0.0+0.0.0.0.3.0 33-34|0.0.0.1 32-33|0.0.0.0.2.0.0+0.0.0.0.2.0 29-32|0.0.0.0.3.1.1.2.1.0.2+0.0.0.0.3.1.1.2.1.0.1+0.0.0.0.3.1.1.2.1.0.0+0.0.0.0.3.1.1.2.1.0+0.0.0.0.3.1.1.2.1 27-28|0.0.0.0.0.0.0+0.0.0.0.0.0 26-27|0.0.0.0.3.1.1.0.1.0.0.0+0.0.0.0.3.1.1.0.1.0.0+0.0.0.0.3.1.1.0.1.0 25-26|0.0.0.0.3.1.1.0.1 24-25|0.0.0.0.3.1.1.0.0.0+0.0.0.0.3.1.1.0.0+0.0.0.0.3.1.1.0 22-23|0.0.0.0.3.1.1.1 21-22|0.0.0.0.3.1.1.1.1 19-20|0.0.0.0.3.1.1.2.0 18-19|0.0.0.0.3.1.1.2 17-18|0.0.0.0.3.1.1 16-17|0.0.0.0.3.1 14-15|0.0.0.0.3 12-13|0.0.0.0.2.1 11-12|0.0.0.0.2.1.0 10-11|0.0.0.0.2.1.0.0 8-9|0.0.0.0.2 7-8|0.0.0.0 6-7|0.0.0 5-6|0.0 4-5|0.0.0.0.1 3-4|0 2-3|0.0.0.0.0 1-2|0.0.0.0.0.1 0-1|0.0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:17.271
(s / show-01 
      :ARG1 (a5 / and 
            :op1 (p3 / possible-01 
                  :ARG1 (u / undergo-28 
                        :ARG0 (m3 / muscle-01 
                              :ARG1 (d5 / date-entity 
                                    :year 1991) 
                              :mod (s2 / skeletal) 
                              :mod (a6 / adult)) 
                        :ARG1 (p4 / plasticity) 
                        :ARG2 (c / convert-01 
                              :ARG0 (d4 / date-entity 
                                    :year 1996) 
                              :ARG1 (t3 / type 
                                    :mod (f / fib 
                                          :ARG1-of (d6 / differ-02)))) 
                        :ARG2-of (r / respond-01 
                              :ARG0 (d3 / date-entity 
                                    :year 1998) 
                              :ARG1 (e / exercise-01 
                                    :ARG0 (d2 / date-entity 
                                          :year 2000) 
                                    :ARG1 (t2 / train-01 
                                          :ARG0 (p2 / person 
                                                :name (n3 / name 
                                                      :op1 "Booth") 
                                                :op1-of (a3 / and 
                                                      :op2 (p / person 
                                                            :name (n2 / name 
                                                                  :op1 "Thomason")))) 
                                          :ARG1 (a4 / activity-06 
                                                :ARG0 (d / date-entity 
                                                      :time-of (h / hood) 
                                                      :year 2001) 
                                                :ARG1 (m / motoneuron)) 
                                          :op1-of (o / or 
                                                :op2 (m2 / modulation) 
                                                :op3 (t / thing 
                                                      :name (n / name 
                                                            :op1 "Jarvis" 
                                                            :op2 "et" 
                                                            :op3 "al."))))))) 
                  :op1-of (a2 / and 
                        :op2 (a / and 
                              :op1 (w / william))))))

# ::snt This conversion of muscle fiber from type IIb to type IIa and type I is likely to be mediated by a calcium signaling pathway that involves calcineurin , calmodulin-dependent kinase , and the transcriptional cofactor Peroxisome proliferator-activated receptor-gamma coactivator 1 ( PGC-1 ) ( Naya et al. 2000 ; Olson and Williams 2000 ; Lin et al. 2002 ; Wu et al. 2002 ) .
# ::tok This conversion of muscle fiber from type IIb to type IIa and type I is likely to be mediated by a calcium signaling pathway that involves calcineurin , calmodulin-dependent kinase , and the transcriptional cofactor Peroxisome proliferator-activated receptor-gamma coactivator 1 ( PGC-1 ) ( Naya et al. 2000 ; Olson and Williams 2000 ; Lin et al. 2002 ; Wu et al. 2002 ) .
# ::alignments 62-63|0.0.1.0.3.0+0.0.1.0.3 59-60|0.0.1.6.1+0.0.1.6.0.0+0.0.1.6.0+0.0.1.6 57-58|0.0.1.0.4.0+0.0.1.0.4 54-55|0.0.1.5.2+0.0.1.5.0.0+0.0.1.5.0+0.0.1.5 52-53|0.0.1.5.1.0+0.0.1.5.1 51-52|0.1 50-51|0 48-49|0.2 47-48|0.2.0.0+0.2.0 44-47|0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 39-40|0.0.1.0.0.0.1.0 38-39|0.0.1.4 36-37|0.0.1.4.0 34-35|0.0.1.0.1.0.0.0 31-32|0.0.1 29-30|0.0.1.3 26-27|0.0.1.2 25-26|0.0 23-24|0.0.1.0.2 22-23|0.0.1.0 21-22|0.0.1.0.0 18-19|0.0.1.0.0.0 15-16|0.0.1.0.0.0.1 13-14|0.0.1.0.0.0.0 12-13|0.0.1.1.2.0 11-12|0.0.1.1.2 10-11|0.0.1.1.1.0+0.0.1.1.1+0.0.1.1 9-10|0.0.1.1.0 6-7|0.0.1.0.1.0.1 4-5|0.0.1.0.1.0 3-4|0.0.1.0.1.0.0 1-2|0.0.1.0.1 0-1|0.0.1.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:23.709
(a / and 
      :ARG2-of (i / involve-01 
            :ARG0 (t / thing 
                  :name (n3 / name 
                        :op1 "Naya" 
                        :op2 "et" 
                        :op3 "al.")) 
            :ARG1 (a3 / and 
                  :ARG0-of (s / signal-01 
                        :ARG1 (c4 / calcium 
                              :ARG1-of (m / mediate-01 
                                    :ARG0 (i2 / i) 
                                    :ARG1-of (l / likely-01 
                                          :ARG0 1))) 
                        :ARG2-of (c5 / convert-01 
                              :ARG1 (f / fib 
                                    :ARG1-of (m2 / muscle-01 
                                          :ARG0 (c2 / cofactor)) 
                                    :source (t4 / type)) 
                              :mod (t5 / this)) 
                        :manner (p4 / pathway) 
                        :op1-of (d / date-entity 
                              :year 2002) 
                        :op1-of (d2 / date-entity 
                              :year 2002)) 
                  :op1 (p5 / person 
                        :mod (t3 / type) 
                        :name (n4 / name 
                              :op1 "IIa") 
                        :op1-of (a4 / and 
                              :op2 (t2 / type))) 
                  :op2 (c3 / calcineurin) 
                  :op3 (k / kinase) 
                  :op4 (c / coactivator 
                        :mod (p3 / proliferator-activat)) 
                  :op5 (p2 / person 
                        :name (n2 / name 
                              :op1 "Lin") 
                        :quant (d3 / date-entity 
                              :year 2000) 
                        :wiki -) 
                  :op6 (p / person 
                        :name (n / name 
                              :op1 "Wu") 
                        :wiki -))) 
      :op1 (w / william) 
      :op2-of (a2 / and 
            :op1 (d4 / date-entity 
                  :year 2000)))

# ::snt However , the targeted transcriptional factors directly responsible for reprogramming the fiber-specific contractile and metabolic genes remain to be identified .
# ::tok However , the targeted transcriptional factors directly responsible for reprogramming the fiber-specific contractile and metabolic genes remain to be identified .
# ::alignments 19-20|0.2.0 16-17|0.2.0.1 15-16|0.2 14-15|0.1 13-14|0 12-13|0.0 7-8|0.2.0.0.1 6-7|0.2.0.0.1.0 5-6|0.2.0.0 3-4|0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:23.953
(a / and 
      :op1 (c / contractile) 
      :op2 (m / metabolic) 
      :op3 (g / gene 
            :ARG1-of (i / identify-01 
                  :ARG0 (f / factor 
                        :ARG1-of (t / target-01) 
                        :ARG1-of (r2 / responsible-01 
                              :ARG1-of (d / direct-02))) 
                  :ARG1-of (r / remain-01))))

# ::snt Muscle fiber specification appears to be associated with obesity and diabetes .
# ::tok Muscle fiber specification appears to be associated with obesity and diabetes .
# ::alignments 10-11|0.0.1.1 9-10|0.0.1 8-9|0.0.1.0 6-7|0.0 3-4|0 2-3|0.0.0 1-2|0.0.0.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:24.053
(a3 / appear-02 
      :ARG1 (a2 / associate-01 
            :ARG1 (s / specification 
                  :ARG1-of (m / muscle-01) 
                  :mod (f / fib)) 
            :ARG2 (a / and 
                  :op1 (o / obesity) 
                  :op2 (d / diabetes))))

# ::snt For instance , rodents that gain the most weight on high-fat diets possess fewer type I fibers ( Abou et al. 1992 ) .
# ::tok For instance , rodents that gain the most weight on high-fat diets possess fewer type I fibers ( Abou et al. 1992 ) .
# ::alignments 21-22|0.0.0.0.1.0+0.0.0.0.1 18-21|0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 16-17|0.2 15-16|0.2.1 14-15|0.2.0 13-14|0.2.2 12-13|0 11-12|0.0 8-9|0.0.0 7-8|0.0.0.1 5-6|0.0.0.0 3-4|0.0.0.0.0 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:25.134
(p / possess-01 
      :ARG0 (d2 / diet 
            :topic-of (w / weight 
                  :ARG1-of (g / gain-02 
                        :ARG0 (r / rodent) 
                        :ARG2 (d / date-entity 
                              :year 1992)) 
                  :quant (m / most))) 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 "Abou" 
                  :op2 "et" 
                  :op3 "al.")) 
      :ARG2 (f / fiber 
            :mod (t2 / type) 
            :mod (i / i) 
            :quant (f2 / few)) 
      :purpose (i2 / instance))

# ::snt In obese patients , skeletal muscle has been observed to have reduced oxidative capacity , increased glycolytic capacity , and a decreased percentage of type I fibers ( Hickey et al. 1995 ; Tanner et al. 2002 ) .
# ::tok In obese patients , skeletal muscle has been observed to have reduced oxidative capacity , increased glycolytic capacity , and a decreased percentage of type I fibers ( Hickey et al. 1995 ; Tanner et al. 2002 ) .
# ::alignments 36-37|0.0.0.0.0.1.1.1.0.0.0+0.0.0.0.0.1.1.1.0.0 33-35|0.1.0.1+0.1.0.0+0.1.0+0.1 32-33|0 31-32|0.0.0.0.0.1.1.0.0.0.1.0.0+0.0.0.0.0.1.1.0.0.0.1.0 28-31|0.0.0.0.0.1.1.0.0.0.0.0.2+0.0.0.0.0.1.1.0.0.0.0.0.1+0.0.0.0.0.1.1.0.0.0.0.0.0+0.0.0.0.0.1.1.0.0.0.0.0+0.0.0.0.0.1.1.0.0.0.0 26-27|0.0.0.0.0 25-26|0.0.0.0 24-25|0.0.0.0.0.0 22-23|0.0.0.0.0.1 21-22|0.0.0.0.0.1.0 19-20|0.0.0.0.0.1.1 17-18|0.0.0.0.0.1.1.1 15-16|0.0.0.0.0.1.1.1.0 13-14|0.0.0.0.0.1.1.0 12-13|0.0.0.0.0.1.1.0.1 11-12|0.0.0.0.0.1.1.0.0 8-9|0.0.0.0.0.1.1.0.0.0.1 5-6|0.0.0.0.0.1.1.0.0.0 4-5|0.0.0.0.0.1.1.0.0.0.2 2-3|0.0.0.1+0.0.0+0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:27.135
(a / and 
      :op1 (p2 / person 
            :ARG0-of (h / have-rel-role-91 
                  :ARG1 (i / i 
                        :mod-of (f / fiber 
                              :mod (t4 / type) 
                              :part (p / percentage 
                                    :ARG1-of (d3 / decrease-01) 
                                    :op3-of (a2 / and 
                                          :op1 (c2 / capacity 
                                                :ARG1-of (r / reduce-01 
                                                      :ARG0 (m / muscle-01 
                                                            :ARG1 (t3 / thing 
                                                                  :name (n2 / name 
                                                                        :op1 "Hickey" 
                                                                        :op2 "et" 
                                                                        :op3 "al.")) 
                                                            :ARG1-of (o2 / observe-01 
                                                                  :ARG0 (d2 / date-entity 
                                                                        :year 1995)) 
                                                            :mod (s / skeletal))) 
                                                :mod (o / oxidative)) 
                                          :op2 (c / capacity 
                                                :ARG1-of (i2 / increase-01 
                                                      :ARG2 (d / date-entity 
                                                            :year 2002))))))) 
                  :ARG2 (p3 / patient)) 
            :mod (o3 / obese)) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 (t2 / Tanner) 
                  :op2 (e / et))))

# ::snt Similar observations have been made in type 2 diabetic patients ( Lillioja et al. 1987 ; Hickey et al. 1995 ) .
# ::tok Similar observations have been made in type 2 diabetic patients ( Lillioja et al. 1987 ; Hickey et al. 1995 ) .
# ::alignments 19-20|0.0.0.2.1+0.0.0.2 16-17|0.1 15-16|0 14-15|0.0.0.3.0+0.0.0.3 11-14|0.0.0.1.0.2+0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 9-10|0.0.1.0.0+0.0.1.0+0.0.1 8-9|0.0 7-8|0.0.0.2.0 6-7|0.0.0.4 1-2|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:27.422
(a / and 
      :op1 (d3 / diabetic 
            :ARG0-of (r / resemble-01 
                  :ARG1 (o / observation) 
                  :ARG2 (t / thing 
                        :name (n / name 
                              :op1 "Lillioja" 
                              :op2 "et" 
                              :op3 "al.")) 
                  :op1-of (d / date-entity 
                        :poss 2 
                        :year 1995) 
                  :op1-of (d2 / date-entity 
                        :year 1987) 
                  :topic-of (t2 / type)) 
            :mod-of (p / person 
                  :ARG0-of (h2 / have-rel-role-91 
                        :ARG2 (p2 / patient)))) 
      :op2 (h / hickey))

# ::snt Recently , it has been shown that increasing oxidative fibers can lead to improved insulin action and reduced adipocyte size ( Luquet et al. 2003 ; Ryder et al. 2003 ) .
# ::tok Recently , it has been shown that increasing oxidative fibers can lead to improved insulin action and reduced adipocyte size ( Luquet et al. 2003 ; Ryder et al. 2003 ) .
# ::alignments 29-30|0.1.0.2.0.0.0.0+0.1.0.2.0.0.0 26-28|0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 25-26|0.1.1 24-25|0.1.0.1.0+0.1.0.1 21-24|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 19-20|0.1.0.2.1 17-18|0.1.0.2.1.0 16-17|0.1.0.2 15-16|0.1.0.2.0 14-15|0.1.0.2.0.1 13-14|0.1.0.2.0.0 11-12|0.1.0 10-11|0.1 9-10|0.1.0.0 8-9|0.1.0.0.1 7-8|0.1.0.0.0 5-6|0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:28.149
(s2 / show-01 
      :ARG0 (t2 / thing 
            :name (n2 / name 
                  :op1 "Luquet" 
                  :op2 "et" 
                  :op3 "al.")) 
      :ARG1 (p / possible-01 
            :ARG1 (l / lead-03 
                  :ARG0 (f / fiber 
                        :ARG1-of (i3 / increase-01) 
                        :mod (o / oxidative)) 
                  :ARG1 (d2 / date-entity 
                        :year 2003) 
                  :ARG2 (a2 / and 
                        :op1 (a3 / action 
                              :ARG1-of (i2 / improve-01 
                                    :ARG0 (d / date-entity 
                                          :year 2003)) 
                              :poss (i / insulin)) 
                        :op2 (s / size 
                              :ARG1-of (r2 / reduce-01)))) 
            :op1-of (a / and 
                  :op2 (t / thing 
                        :name (n / name 
                              :op1 (r / Ryder) 
                              :op2 (e / et))))) 
      :time (r3 / recent))

# ::snt We have previously established that peroxisome proliferator-activated receptor ( PPAR )  is a major transcriptional regulator of fat burning in adipose tissue through activation of enzymes associated with long-chain fatty-acid -oxidation ( Wang et al. 2003 ) .
# ::tok We have previously established that peroxisome proliferator-activated receptor ( PPAR )  is a major transcriptional regulator of fat burning in adipose tissue through activation of enzymes associated with long-chain fatty-acid -oxidation ( Wang et al. 2003 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:28.151
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Although PPAR is the predominant PPAR isoform present in skeletal muscle , its in vivo function has not been determined .
# ::tok Although PPAR is the predominant PPAR isoform present in skeletal muscle , its in vivo function has not been determined .
# ::alignments 19-20|0 17-18|0.1 15-16|0.0.0.0 10-11|0.0.0 9-10|0.0.0.1 7-8|0.0.1.0 6-7|0.0.1 4-5|0.0.0.0.0 1-2|0.0.2.0+0.0.2+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:28.244
(d / determined-02 
      :ARG1 (o / organization 
            :ARG0-of (m / muscle-01 
                  :ARG1 (f / function-01 
                        :ARG1 (p2 / predominant)) 
                  :mod (s / skeletal)) 
            :domain-of (i / isoform 
                  :location (p / present)) 
            :name (n / name 
                  :op1 "PPAR")) 
      :polarity -)

# ::snt Our current study uncovers PPAR as the first transcription factor able to drive the formation of functional type I muscle fibers , whose activation entrains complex pathways both enhancing physical performance and creating a state of obesity resistance .
# ::tok Our current study uncovers PPAR as the first transcription factor able to drive the formation of functional type I muscle fibers , whose activation entrains complex pathways both enhancing physical performance and creating a state of obesity resistance .
# ::alignments 37-38|0.1.1.0.0.0.0 36-37|0.1.1.0.0.0.0.1 34-35|0.1.1.0.0.0 32-33|0.1.1.0.0 31-32|0 30-31|0.1.1 29-30|0.1.1.2 28-29|0.1 27-28|0.1.0 26-27|0.1.1.0 25-26|0.1.1.0.1 23-24|0.1.1.1 20-21|0.0.0.1.0 19-20|0.0.0.1.0.0 18-19|0.0.0.1.0.0.0 17-18|0.0.0.1.1 16-17|0.1.1.0.0.0.0.0 14-15|0.0.0.1 12-13|0.0.0 10-11|0.0 9-10|0.0.0.0 8-9|0.0.0.0.1 4-5|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 3-4|0.0.0.0.0 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0.0.1 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:30.283
(a / and 
      :op1 (p4 / possible-01 
            :ARG1 (d / drive-01 
                  :ARG0 (f4 / factor 
                        :ARG2-of (u / uncover-01 
                              :ARG0 (s2 / study-01 
                                    :ARG1 (w / we) 
                                    :time (c3 / current)) 
                              :ARG1 (o2 / organization 
                                    :name (n / name 
                                          :op1 "PPAR"))) 
                        :mod (t2 / transcription)) 
                  :ARG1 (f3 / form-01 
                        :ARG1 (f / fiber 
                              :ARG0-of (m / muscle-01 
                                    :ARG1 (i / i))) 
                        :ARG2 (t / type)))) 
      :op2 (e / enhance-01 
            :ARG0 (b / both) 
            :ARG1 (p / perform-02 
                  :ARG0 (p3 / pathway 
                        :ARG0-of (c / create-01 
                              :ARG1 (s / state 
                                    :mod (r / resist-01 
                                          :ARG1 (f2 / functional) 
                                          :mod (o / obesity)))) 
                        :mod (c2 / complex)) 
                  :ARG1 (a2 / activation) 
                  :ARG2 (p2 / physical))))

# ::snt Activation of PPAR Leads to Muscle Fiber Transformation .
# ::tok Activation of PPAR Leads to Muscle Fiber Transformation .
# ::alignments 5-8|0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 2-4|0.0.1.1+0.0.1.0+0.0.1+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:30.325
(a / activation 
      :poss (o2 / organization 
            :beneficiary (o / organization 
                  :name (n / name 
                        :op1 "Muscle" 
                        :op2 "Fiber" 
                        :op3 "Transformation")) 
            :name (n2 / name 
                  :op1 "PPAR" 
                  :op2 "Leads")))

# ::snt A role of PPAR in muscle fiber was suggested by its enhanced expression -- at levels 10-fold and 50-fold greater than PPAR and  isoforms , respectively ( unpublished data ) .
# ::tok A role of PPAR in muscle fiber was suggested by its enhanced expression -- at levels 10-fold and 50-fold greater than PPAR and  isoforms , respectively ( unpublished data ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:30.332
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt An examination of PPAR in different muscle fibers reveals a significantly higher level in type I muscle ( soleus ) relative to type II -- rich muscle ( extensor digitorum longus ) or type I and type II mixed muscle ( gastrocnemius ) ( Figure 1A ) ; this expression pattern closely resembles that of PGC-1 ( Lin et al. 2002 ) .
# ::tok An examination of PPAR in different muscle fibers reveals a significantly higher level in type I muscle ( soleus ) relative to type II -- rich muscle ( extensor digitorum longus ) or type I and type II mixed muscle ( gastrocnemius ) ( Figure 1A ) ; this expression pattern closely resembles that of PGC-1 ( Lin et al. 2002 ) .
# ::alignments 60-61|0.2.0.0.1.0.0+0.2.0.0.1.0 57-58|0.2.0.0.1.1.2.0.1.2+0.2.0.0.1.1.2.0.1.1.0+0.2.0.0.1.1.2.0.1.1+0.2.0.0.1.1.2.0.1 53-54|0.2.0.0.1.1.2.0.1.0.0.0.1 52-53|0.2.0.0.1.1.2.0.1.0.0.0 51-52|0.2.0.0.1.1.2.0.1.0.0.0.2 50-51|0.2.0.0.1.1.2.0.1.0.0 49-50|0.2.0.0.1.1.2.0.1.0 48-49|0.2.0.0.1.1.2.0.1.0.0.1 47-48|0.2.0.0.1.1.2.0.1.0.0.0.3 44-45|0.2.0.0.1.1.0.0 41-42|0.2.0.0.0 39-40|0.2.0.0.1 38-39|0.2.0.0 36-37|0.2.0.0.1.1.2.0.0 35-36|0.2.0.0.1.1.2.0 34-35|0.2.0.0.1.1.2 33-34|0.2.0.0.1.1.1 32-33|0.2.0.0.1.1 30-31|0.2.0.0.1.1.2.0.1.0.0.0.0 29-30|0.2.0.0.1.1.2.0.1.0.0.0.0.0 28-29|0.2.0.0.1.1.2.0.1.0.0.0.0.0.0 26-27|0.2.0.0.1.1.0 25-26|0.2.0.0.1.1.0.1 23-24|0.0.0.0.1+0.0.0.0.0.2+0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 22-23|0.0.0 20-21|0.0.2.0.0 18-19|0.1.0.0.0 16-17|0.2 15-16|0.2.0 14-15|0.2.1 12-13|0.1 11-12|0.1.0 10-11|0.1.0.0 8-9|0 7-8|0.0.2 6-7|0.0.2.0 5-6|0.0.2.1 3-4|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:33.217
(r4 / reveal-01 
      :ARG0 (e3 / examine-01 
            :ARG0 (t5 / type 
                  :mod-of (w / war 
                        :name (n2 / name 
                              :op1 "World" 
                              :op2 "War" 
                              :op3 "II") 
                        :wiki "World_War_II")) 
            :ARG1 (o2 / organization 
                  :name (n3 / name 
                        :op1 "PPAR")) 
            :location (f2 / fiber 
                  :ARG1-of (m5 / muscle-01 
                        :ARG0 (r3 / relative)) 
                  :ARG1-of (d3 / differ-02))) 
      :ARG1 (l2 / level 
            :ARG1-of (h / high-02 
                  :ARG1-of (s2 / significant-02 
                        :ARG0 (s / soleu)))) 
      :ARG1-of (m4 / muscle-01 
            :ARG0 (i2 / i 
                  :ARG0-of (m2 / mix-01 
                        :ARG1 (g / gastrocnemiu) 
                        :ARG3 (m / muscle-01 
                              :ARG0 (d / date-entity 
                                    :year 2002) 
                              :ARG1 (o / or 
                                    :op1 (m3 / muscle-01 
                                          :ARG1 (f / figure) 
                                          :mod (r2 / rich)) 
                                    :op2 (t4 / type) 
                                    :op3 (i / i 
                                          :op1-of (a2 / and 
                                                :op2 (t3 / type) 
                                                :op3 (p / person 
                                                      :ARG0-of (e / express-01 
                                                            :ARG1 (p2 / pattern 
                                                                  :ARG1-of (r / resemble-01 
                                                                        :ARG0 (l / longu 
                                                                              :mod (d2 / digitorum 
                                                                                    :mod (e2 / extensor))) 
                                                                        :ARG2 (t / that) 
                                                                        :manner (c / close) 
                                                                        :op1-of (a / and)) 
                                                                  :mod (t2 / this))) 
                                                      :name (n / name 
                                                            :op1 "Lin") 
                                                      :wiki -))))))) 
            :mod (t6 / type)))

# ::snt A similar pattern but with more pronounced differences was found at the protein level ( Figure 1B ) .
# ::tok A similar pattern but with more pronounced differences was found at the protein level ( Figure 1B ) .
# ::alignments 15-16|0.0.1.0 13-14|0.0.0.0 12-13|0.0.0.0.0 9-10|0.0.0 7-8|0.0.2 6-7|0.0.2.0 5-6|0.0.2.0.0 3-4|0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:33.342
(c / contrast-01 
      :ARG1 (p3 / pattern 
            :ARG1-of (f2 / find-01 
                  :location (l / level 
                        :mod (p / protein))) 
            :ARG1-of (r / resemble-01 
                  :ARG0 (f / figure)) 
            :prep-with (d / differ-01 
                  :ARG1-of (p2 / pronounce-01 
                        :degree (m / more)))))

# ::snt To directly assess the role of activation of PPAR in control of muscle fiber plasticity and mitochondrial biogenesis , we generated mice expressing a transgene in which the 78-amino-acid VP16 activation domain was fused to the N-terminus of full-length PPAR , under control of the 2.2-kb human -skeletal actin promoter .
# ::tok To directly assess the role of activation of PPAR in control of muscle fiber plasticity and mitochondrial biogenesis , we generated mice expressing a transgene in which the 78-amino-acid VP16 activation domain was fused to the N-terminus of full-length PPAR , under control of the 2.2-kb human -skeletal actin promoter .
# ::alignments 49-50|0.0.0.0.0.0.1 48-49|0.0.0.0.0.0.1.0 46-47|0.0.0.0.0.0.0 42-43|0.0.0.0.0.0 38-39|0.0.0.0.0.1.1.2.0.0.0 36-37|0 33-34|0.0 31-32|0.0.1 30-31|0.0.1.0 29-30|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 24-25|0.0.0 22-23|0.0.0.0 21-22|0.0.0.0.0 20-21|0.0.0.0.0.1 19-20|0.0.0.0.0.1.0 17-18|0.0.0.0.0.1.1.2.1.0 15-16|0.0.0.0.0.1.1.2.1 14-15|0.0.0.0.0.1.1.2.0 13-14|0.0.0.0.0.1.1.2.0.1 12-13|0.0.0.0.0.1.1.2.0.0 10-11|0.0.0.0.0.1.1.2 8-9|0.0.0.0.0.1.1.0.0.0.0+0.0.0.0.0.1.1.0.0.0+0.0.0.0.0.1.1.0.0 6-7|0.0.0.0.0.1.1.0.1 4-5|0.0.0.0.0.1.1.0 2-3|0.0.0.0.0.1.1 1-2|0.0.0.0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:34.867
(n / n-terminu 
      :ARG2-of (f2 / fuse-01 
            :ARG0 (t2 / transgene 
                  :ARG1-of (e / express-01 
                        :ARG0 (m / mouse 
                              :ARG1-of (c / control-01 
                                    :ARG0 (h / human) 
                                    :ARG2 (p / promote-01 
                                          :ARG1 (a / actin))) 
                              :ARG1-of (g / generate-01 
                                    :ARG0 (w / we) 
                                    :purpose (a5 / assess-01 
                                          :ARG1 (r / role 
                                                :poss (o / organization 
                                                      :name (n3 / name 
                                                            :op1 "PPAR")) 
                                                :poss (a4 / activation)) 
                                          :ARG1-of (d2 / direct-02) 
                                          :ARG2 (c2 / control-01 
                                                :ARG0 (p2 / plasticity 
                                                      :ARG1-of (m2 / muscle-01 
                                                            :ARG0 (f / full-length)) 
                                                      :mod (f3 / fib)) 
                                                :ARG1 (a3 / and 
                                                      :op1 (b / biogenesi)))))))) 
            :ARG1 (d / domain 
                  :mod (a2 / activation) 
                  :mod (t / thing 
                        :name (n2 / name 
                              :op1 "VP16")))))

# ::snt In agreement with the previous characterization of this promoter ( Brennan and Hardeman 1993 ; Clapham et al. 2000 ) , the VP16-PPAR transgene was selectively expressed in skeletal muscle , with 10-fold less in the heart ( Figure 1C ) .
# ::tok In agreement with the previous characterization of this promoter ( Brennan and Hardeman 1993 ; Clapham et al. 2000 ) , the VP16-PPAR transgene was selectively expressed in skeletal muscle , with 10-fold less in the heart ( Figure 1C ) .
# ::alignments 38-39|0.0.1.0.1.0 36-37|0.3.0 33-34|0.3 29-30|0.2 28-29|0.2.1 26-27|0 25-26|0.4 23-24|0.1 18-19|0.2.0.0+0.2.0 15-18|0.0.1.0.2.0.2+0.0.1.0.2.0.1+0.0.1.0.2.0.0+0.0.1.0.2.0+0.0.1.0.2 14-15|0.0.1.0 13-14|0.5.0+0.5 11-12|0.0.1 10-11|0.0.0.0+0.0.0+0.0 8-9|0.0.1.0.1 7-8|0.0.1.0.1.1 5-6|0.0.1.0.0.0 4-5|0.0.1.0.0.0.0 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:35.299
(e / express-01 
      :ARG0 (p / person 
            :name (n2 / name 
                  :op1 "Brennan") 
            :op1-of (a2 / and 
                  :op2 (a / and 
                        :ARG1-of (a3 / agree-01 
                              :ARG2 (c / characterization 
                                    :mod (p3 / previous))) 
                        :op1 (p2 / promote-01 
                              :ARG1 (f / figure) 
                              :mod (t3 / this)) 
                        :op2 (t2 / thing 
                              :name (n / name 
                                    :op1 "Clapham" 
                                    :op2 "et" 
                                    :op3 "al."))))) 
      :ARG1 (t / transgene) 
      :ARG2 (m / muscle-01 
            :ARG1 (d / date-entity 
                  :year 2000) 
            :mod (s / skeletal)) 
      :degree (l / less 
            :degree-of (h / heart)) 
      :mod (s2 / selectively) 
      :time (d2 / date-entity 
            :year 1993))

# ::snt Among different types of muscle fibers , the levels of VP16-PPAR expression appeared to be similar ( unpublished data ) .
# ::tok Among different types of muscle fibers , the levels of VP16-PPAR expression appeared to be similar ( unpublished data ) .
# ::alignments 18-19|0.0.1.0 17-18|0.0.1 15-16|0.1 12-13|0 11-12|0.0 10-11|0.0.0.0.0+0.0.0.0+0.0.0 8-9|0.1.0 5-6|0.0.2 4-5|0.0.2.0 2-3|0.0.2.1 1-2|0.0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:35.586
(a / appear-01 
      :ARG0 (e / express-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "VP16-PPAR")) 
            :ARG1 (u / unpublish 
                  :mod-of (d / data)) 
            :ARG2 (f / fiber 
                  :ARG1-of (m / muscle-01) 
                  :mod (t / type 
                        :ARG1-of (d2 / differ-02)))) 
      :ARG1 (r / resemble-01 
            :ARG1 (l / level)))

# ::snt As shown in Figure 1D for gastrocnemius muscle , VP16-PPAR fusion protein was produced at a level similar to that of endogenous PPAR in wild-type littermates .
# ::tok As shown in Figure 1D for gastrocnemius muscle , VP16-PPAR fusion protein was produced at a level similar to that of endogenous PPAR in wild-type littermates .
# ::alignments 25-26|0.0.1 22-23|0.0.0.0+0.0.0+0.0 21-22|0 19-20|0.0.1.0.0.1.1.0.0 17-18|0.0.1.0.0.1.1.0 16-17|0.0.1.0.0.1.1 13-14|0.0.1.0.0.1 11-12|0.0.1.0.0.1.0 10-11|0.0.1.0.0.1.0.0 9-10|0.0.1.0.0.1.0.1.0.0+0.0.1.0.0.1.0.1.0+0.0.1.0.0.1.0.1 7-8|0.0.1.0 6-7|0.0.1.0.1 3-4|0.0.1.0.0.0 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:35.868
(e / endogenou 
      :mod-of (o / organization 
            :name (n / name 
                  :op1 "PPAR") 
            :source (l / littermat 
                  :ARG1-of (m / muscle-01 
                        :ARG1-of (s / show-01 
                              :ARG0 (f2 / figure) 
                              :time-of (p / produce-01 
                                    :ARG1 (p2 / protein 
                                          :mod (f / fusion) 
                                          :mod (o2 / organization 
                                                :name (n2 / name 
                                                      :op1 "VP16-PPAR"))) 
                                    :location (l2 / level 
                                          :ARG1-of (r / resemble-01 
                                                :ARG2 (t / that))))) 
                        :mod (g / gastrocnemiu)))))

# ::snt Interestingly , the level of endogenous muscle PPAR protein in the transgenic mice was much higher than in the control littermates .
# ::tok Interestingly , the level of endogenous muscle PPAR protein in the transgenic mice was much higher than in the control littermates .
# ::alignments 20-21|0.0.1.0.1 19-20|0.0.1.0 15-16|0.0.1.1 14-15|0.0.1.0.2 12-13|0 8-9|0.0 7-8|0.0.0.1.0+0.0.0.1+0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 3-4|0.0.1 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:36.037
(m2 / mouse 
      :location-of (p / protein 
            :mod (o / organization 
                  :ARG0-of (m3 / muscle-01 
                        :ARG1 (e / endogenou)) 
                  :name (n / name 
                        :op1 "PPAR")) 
            :mod-of (l2 / level 
                  :ARG1-of (c / control-01 
                        :ARG0 (i / interesting) 
                        :mod-of (l / littermat) 
                        :op1-of (m / much)) 
                  :ARG1-of (h / high-02))))

# ::snt The substantial increase of endogenous PPAR may have been caused by a switch to type I fiber ( see below ) , which intrinsically expresses higher levels of PPAR ( Figure 1A and 1B ) .
# ::tok The substantial increase of endogenous PPAR may have been caused by a switch to type I fiber ( see below ) , which intrinsically expresses higher levels of PPAR ( Figure 1A and 1B ) .
# ::alignments 32-33|0.1 30-31|0.2.0 26-27|0.0.0.0.0.0 25-26|0.0.0.0.0.0.0 24-25|0.0.0.0.0 23-24|0.0.0.0.0.1 19-20|0.1.0.0 18-19|0.1.0 16-17|0.0.0.0 15-16|0.0.0 14-15|0.0.0.0.1 12-13|0.0 9-10|0 6-7|0.2 5-6|0.3.0.1.0+0.3.0.1+0.3.0 4-5|0.3.0.0 2-3|0.3 1-2|0.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:36.532
(c / cause-01 
      :ARG0 (s2 / switch-01 
            :ARG1 (i2 / i 
                  :mod-of (f2 / fib 
                        :ARG0-of (e / express-01 
                              :ARG1 (l / level 
                                    :ARG1-of (h / high-02)) 
                              :mod (i / intrinsic)) 
                        :mod (t / type)))) 
      :ARG1 (a / and 
            :ARG1-of (s / see-01 
                  :location (b / below))) 
      :ARG1-of (p / possible-01 
            :ARG0 (f / figure)) 
      :ARG2 (i3 / increase-01 
            :ARG1 (o / organization 
                  :mod (e2 / endogenou) 
                  :name (n / name 
                        :op1 "PPAR")) 
            :degree (s3 / substantial)))

# ::snt Type I muscle can be readily distinguished from type II or mixed muscle by its red color , because of its high concentration of myoglobin , a protein typically expressed in oxidative muscle fibers .
# ::tok Type I muscle can be readily distinguished from type II or mixed muscle by its red color , because of its high concentration of myoglobin , a protein typically expressed in oxidative muscle fibers .
# ::alignments 33-34|0.0.1.0.1 32-33|0.0.1.0.1.0 31-32|0.0.1.0.1.0.0 29-30|0.0.1.0 28-29|0.0.1.0.2 27-28|0.0.1.0.0 24-25|0.0.1.0.0.0.0 22-23|0.0.1.0.0.0 21-22|0.0.1.0.0.0.1 18-19|0.0.1 16-17|0.0.0.1.1.0 15-16|0.0.0.1.1.0.0 12-13|0.0.0.1.1 11-12|0.0.0.1.1.1 10-11|0.0.0.1 9-10|0.0.0.1.0.2+0.0.0.1.0.1.2+0.0.0.1.0.1.1+0.0.0.1.0.1.0+0.0.0.1.0.1+0.0.0.1.0 8-9|0.0.0.1.0.0 6-7|0.0 5-6|0.0.2 3-4|0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:37.120
(p2 / possible-01 
      :ARG1 (d / distinguish-01 
            :ARG1 (m5 / muscle-01 
                  :ARG0 (i / i) 
                  :ARG1 (o2 / or 
                        :op1 (w / war 
                              :mod (t2 / type) 
                              :name (n / name 
                                    :op1 "World" 
                                    :op2 "War" 
                                    :op3 "II") 
                              :wiki "World_War_II") 
                        :op2 (m3 / muscle-01 
                              :ARG1 (c3 / color 
                                    :mod (r / red)) 
                              :ARG3-of (m4 / mix-01))) 
                  :ARG1-of (t3 / type-01)) 
            :ARG1-of (c2 / cause-01 
                  :ARG0 (e / express-01 
                        :ARG0 (p / protein 
                              :ARG0-of (c / concentrate-02 
                                    :ARG1 (m2 / myoglobin) 
                                    :ARG1-of (h / high-02))) 
                        :ARG1 (f / fiber 
                              :ARG1-of (m / muscle-01 
                                    :ARG0 (o / oxidative))) 
                        :ARG1-of (t / typical-02))) 
            :ARG1-of (r2 / ready-02)))

# ::snt We found that muscles in the transgenic mice appeared redder ( Figure 2A ) , which is particularly evident in the mixed type I/II fibers of the hindlimb ( Figure 2B ) .
# ::tok We found that muscles in the transgenic mice appeared redder ( Figure 2A ) , which is particularly evident in the mixed type I/II fibers of the hindlimb ( Figure 2B ) .
# ::alignments 29-30|0.0.0.1.2 27-28|0.0.3 24-25|0.0 23-24|0.0.1.0.0+0.0.1.0+0.0.1 22-23|0.0.2 21-22|0.0.0 18-19|0 17-18|0.1 11-12|0.0.0.0 9-10|0.0.0.1.1 8-9|0.0.0.1 7-8|0.0.0.1.1.0.0.0 3-4|0.0.0.1.0 1-2|0.0.0.1.1.0 0-1|0.0.0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:37.573
(e / evident 
      :location (f2 / fiber 
            :ARG1-of (m / mix-01 
                  :ARG0 (f3 / figure) 
                  :manner-of (a / appear-01 
                        :ARG0 (m3 / muscle) 
                        :ARG1 (r / red 
                              :ARG1-of (f4 / find-01 
                                    :ARG0 (w / we 
                                          :mod-of (m2 / mouse)))) 
                        :ARG2 (f / figure))) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "I/II")) 
            :mod (t2 / type) 
            :poss (h / hindlimb)) 
      :mod (p / particular))

# ::snt Indeed , metachromatic staining revealed a substantial muscle fiber transformation ( Figure 2C ) .
# ::tok Indeed , metachromatic staining revealed a substantial muscle fiber transformation ( Figure 2C ) .
# ::alignments 11-12|0.2 9-10|0.1 8-9|0.1.0 7-8|0.1.1 6-7|0.1.2 4-5|0 3-4|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:37.664
(r / reveal-01 
      :ARG0 (s2 / stain-01 
            :mod (i / indeed)) 
      :ARG1 (t / transform-01 
            :ARG1 (f2 / fib) 
            :ARG1-of (m / muscle-01) 
            :mod (s / substantial)) 
      :ARG2 (f / figure))

# ::snt In gastrocnemius muscle , we estimated that there was a 2-fold increase of type I fibers .
# ::tok In gastrocnemius muscle , we estimated that there was a 2-fold increase of type I fibers .
# ::alignments 14-15|0.1.0 13-14|0.1.1 11-12|0.1 5-6|0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:37.701
(e / estimate-01 
      :ARG0 (w / we 
            :ARG0-of (m / muscle-01 
                  :mod (g / gastrocnemiu))) 
      :ARG1 (i2 / increase-01 
            :ARG0 (i / i) 
            :ARG1 (t / type)))

# ::snt A diagnostic component of oxidative fibers is their high myoglobin and mitochondrial content , which is supported by the mRNA analysis shown in Figure 3A .
# ::tok A diagnostic component of oxidative fibers is their high myoglobin and mitochondrial content , which is supported by the mRNA analysis shown in Figure 3A .
# ::alignments 23-24|0.0 21-22|0 20-21|0.1 19-20|0.1.1 16-17|0.1.0 12-13|0.1.0.0 10-11|0.1.0.0.1 9-10|0.1.0.0.1.0 8-9|0.1.0.0.1.0.0 5-6|0.1.0.0.1.0.0.0 4-5|0.1.0.0.1.0.0.0.0 2-3|0.1.0.0.0 1-2|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:37.866
(s / show-01 
      :ARG0 (f / figure) 
      :ARG1 (a / analyze-01 
            :ARG0-of (s2 / support-01 
                  :ARG1 (c / content 
                        :domain (c2 / component 
                              :mod (d / diagnostic)) 
                        :op2-of (a2 / and 
                              :op1 (m2 / myoglobin 
                                    :ARG1-of (h / high-02 
                                          :ARG0 (f2 / fiber 
                                                :mod (o / oxidative))))))) 
            :ARG1 (m / mrna)))

# ::snt In addition to myoglobin , mitochondrial components for electron transfer ( cytochrome c and cytochrome c oxidase [ COX ] II and IV ) and fatty-acid -oxidation enzymes were elevated ( Figure 3A ; unpublished data ) .
# ::tok In addition to myoglobin , mitochondrial components for electron transfer ( cytochrome c and cytochrome c oxidase [ COX ] II and IV ) and fatty-acid -oxidation enzymes were elevated ( Figure 3A ; unpublished data ) .
# ::alignments 35-36|0.0.2.3.1.0 34-35|0.0.2.3.1.0.0 33-34|0.0.2.3.1 31-32|0.0.2.0.1 29-30|0.0.2.0 27-28|0.0.2.2 24-25|0.0.2 21-22|0 20-21|0.0.2.3.0.1+0.0.2.3.0.0.2+0.0.2.3.0.0.1+0.0.2.3.0.0.0+0.0.2.3.0.0+0.0.2.3.0 18-19|0.0.2.0.2 16-17|0.0.2.0.2.1 15-16|0.0.2.0.0 13-14|0.0.2.3 12-13|0.0.0 9-10|0.0 8-9|0.0.1 6-7|0.0.2.1 3-4|0.0.2.0.2.2 1-2|0.0.2.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:38.305
(a3 / and 
      :ARG1-of (t / transfer-01 
            :ARG0 (c3 / c) 
            :mod (e3 / electron) 
            :op1-of (a2 / and 
                  :domain (e / elevate-01 
                        :ARG0 (c2 / c) 
                        :ARG1 (f / figure) 
                        :purpose (c / cox-01 
                              :ARG0 (a5 / addition) 
                              :ARG1 (o / oxidase) 
                              :ARG2 (m / myoglobin))) 
                  :location (c4 / component) 
                  :op2 (e2 / enzym) 
                  :op2-of (a4 / and 
                        :op1 (w / war 
                              :name (n / name 
                                    :op1 "World" 
                                    :op2 "War" 
                                    :op3 "II") 
                              :wiki "World_War_II") 
                        :op3 (a / and 
                              :op1 (d / data 
                                    :mod (u / unpublish)))))))

# ::snt These effects appear to be direct consequences of PPAR activation , as levels of PGC-1 , a coactivator involved in muscle fiber switch and mitochondrial biogenesis ( Wu et al. 1999 ; Lehman et al. 2000 ; Lin et al. 2002 ) , remained unchanged .
# ::tok These effects appear to be direct consequences of PPAR activation , as levels of PGC-1 , a coactivator involved in muscle fiber switch and mitochondrial biogenesis ( Wu et al. 1999 ; Lehman et al. 2000 ; Lin et al. 2002 ) , remained unchanged .
# ::alignments 44-45|0.1.0.1.4+0.1.0.1 43-44|0.1.0 40-41|0.1.0.1.2.0+0.1.0.1.2 37-38|0.1.2+0.1.1.0+0.1.1+0.1 35-36|0.1.0.0.0.1.0.0.0+0.1.0.0.0.1.0.0 32-34|0.1.0.1.3.0.0.1+0.1.0.1.3.0.0.0+0.1.0.1.3.0.0+0.1.0.1.3.0 31-32|0.1.0.1.3 30-31|0.1.0.1.0.0+0.1.0.1.0 27-30|0.1.0.0.0.0.0.2+0.1.0.0.0.0.0.1+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 25-26|0.1.0.0.0.1.1 23-24|0.1.0.0.0.1 22-23|0.1.0.0.0.1.0 21-22|0.1.0.0.0.1.0.1 20-21|0.1.0.0.0.1.0.2 18-19|0.1.0.0.0 17-18|0.1.0.0 12-13|0.1.0.1.1 9-10|0.0.1 8-9|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 6-7|0.0 5-6|0.0.0 2-3|0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:40.301
(a4 / appear-02 
      :ARG1 (c3 / consequence 
            :ARG1-of (d4 / direct-02 
                  :ARG0 (e2 / effect 
                        :mod (t3 / this))) 
            :mod (a3 / activation 
                  :mod (o / organization 
                        :name (n4 / name 
                              :op1 "PPAR")))) 
      :ARG2 (p / person 
            :ARG1-of (r / remain-01 
                  :ARG0 (c2 / coactivator 
                        :ARG1-of (i / involve-01 
                              :ARG0 (t2 / thing 
                                    :name (n3 / name 
                                          :op1 "Wu" 
                                          :op2 "et" 
                                          :op3 "al.")) 
                              :ARG2 (a2 / and 
                                    :op1 (s / switch-01 
                                          :ARG0 (d2 / date-entity 
                                                :year 2000) 
                                          :ARG1 (f / fib) 
                                          :ARG1-of (m / muscle-01)) 
                                    :op2 (b / biogenesi)))) 
                  :ARG3 (c / change-01 
                        :ARG0 (d3 / date-entity 
                              :year 1999) 
                        :ARG1 (l2 / level) 
                        :ARG2 (d / date-entity 
                              :year 2002) 
                        :op2-of (a / and 
                              :op1 (t / thing 
                                    :name (n2 / name 
                                          :op1 (l / Lehman) 
                                          :op2 (e / et)))) 
                        :polarity -)) 
            :name (n / name 
                  :op1 "Lin") 
            :wiki -))

# ::snt Southern blot analysis detected a substantially higher copy number of the mitochondrial genome -- encoded COXII DNA in the transgenic mice ( Figure 3B ) .
# ::tok Southern blot analysis detected a substantially higher copy number of the mitochondrial genome -- encoded COXII DNA in the transgenic mice ( Figure 3B ) .
# ::alignments 22-23|0.0.0 20-21|0.0.1.0.0.0.0.1 16-17|0.0.1.0.0.0.0.0 14-15|0.0.1.0.0.0.0 12-13|0.0.1.0.0 8-9|0.0.1.0.0.0 7-8|0.0.1.0.0.0.2.0+0.0.1.0.0.0.2 6-7|0.0.1.0.0.0.1 5-6|0 3-4|0.0.1.0 2-3|0.0.1 1-2|0.0 0-1|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:40.623
(s / substantial 
      :ARG1-of (b / blot-01 
            :ARG0 (f / figure) 
            :ARG1-of (a / analyze-01 
                  :ARG0-of (d2 / detect-01 
                        :ARG1 (g / genome 
                              :quant (n / number 
                                    :ARG1-of (e / encode-01 
                                          :ARG0 (d / DNA) 
                                          :ARG2 (m / mouse)) 
                                    :ARG1-of (h / high-02) 
                                    :mod (t / thing 
                                          :ARG2-of (c / copy-01))))) 
                  :manner (t2 / thing 
                        :name (n2 / name 
                              :op1 "Southern")))))

# ::snt Mitochondrial DNA was increased 2.3-fold in gastrocnemius muscle of the transgenic mice ( Figure 3C ) .
# ::tok Mitochondrial DNA was increased 2.3-fold in gastrocnemius muscle of the transgenic mice ( Figure 3C ) .
# ::alignments 13-14|0.1.0 11-12|0.1.1 7-8|0.1 6-7|0.1.2 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:40.663
(i / increase-01 
      :ARG1 (d / DNA) 
      :time (m2 / muscle-01 
            :ARG0 (f / figure) 
            :ARG1 (m / mouse) 
            :mod (g / gastrocnemiu)))

# ::snt These results reveal a marked stimulation of mitochondrial biogenesis and further support the idea that there is a muscle fiber switch .
# ::tok These results reveal a marked stimulation of mitochondrial biogenesis and further support the idea that there is a muscle fiber switch .
# ::alignments 20-21|0.2.1 19-20|0.2.1.0 18-19|0.2.1.1 13-14|0.2.0.0 11-12|0.2.0 10-11|0.2.0.1 9-10|0.2 8-9|0.1.1 7-8|0.1.1.0 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.0.0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:40.902
(r / reveal-01 
      :ARG0 (t / thing 
            :ARG2-of (r2 / result-01) 
            :mod (t2 / this)) 
      :ARG1 (s3 / stimulation 
            :ARG1-of (m3 / mark-01) 
            :mod (b / biogenesi 
                  :mod (m2 / mitochondrial))) 
      :op1-of (a / and 
            :op2 (s2 / support-01 
                  :ARG1 (i / idea) 
                  :quant (f2 / further)) 
            :op3 (s / switch-01 
                  :ARG1 (f / fib) 
                  :ARG1-of (m / muscle-01))))

# ::snt This conclusion was also confirmed by Western blot analysis .
# ::tok This conclusion was also confirmed by Western blot analysis .
# ::alignments 8-9|0.0 7-8|0.0.0 6-7|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 4-5|0 3-4|0.2 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:40.939
(c / confirm-01 
      :ARG0 (a / analyze-01 
            :ARG1-of (b / blot-01) 
            :mod (w / world-region 
                  :name (n / name 
                        :op1 "West") 
                  :wiki "Western_world")) 
      :ARG1 (c2 / conclude-01 
            :mod (t / this)) 
      :mod (a2 / also))

# ::snt As shown in Figure 3D , the characteristic type I fiber proteins , such as myoglobin and cytochrome c and b , were significantly increased .
# ::tok As shown in Figure 3D , the characteristic type I fiber proteins , such as myoglobin and cytochrome c and b , were significantly increased .
# ::alignments 24-25|0.0 23-24|0.0.2 20-21|0.0.0 19-20|0 18-19|0.0.2.1 17-18|0.0.1.2.2 16-17|0.0.1.2 15-16|0.0.1.2.1 13-14|0.0.1.2.0 11-12|0.0.1 10-11|0.0.1.3 9-10|0.0.1.0.0.0 8-9|0.0.1.0.0 7-8|0.0.1.0 4-5|0.0.2.0 3-4|0.0.1.1.0 1-2|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:41.499
(a / and 
      :op1 (i / increase-01 
            :ARG0 (b / b) 
            :ARG1 (p / protein 
                  :ARG1-of (c3 / characteristic-02 
                        :ARG0 (t / type 
                              :mod-of (i2 / i))) 
                  :ARG1-of (s3 / show-01 
                        :ARG0 (f2 / figure)) 
                  :example (a2 / and 
                        :op1 (s2 / such) 
                        :op2 (m / myoglobin) 
                        :op3 (c2 / cytochrome)) 
                  :mod (f / fib)) 
            :ARG2 (s / significant-02 
                  :ARG0 3D 
                  :ARG1 (c / c))))

# ::snt More importantly , the specialized contraction protein troponin I ( slow ) of type I fiber was robustly induced ; this was accompanied by a marked reduction of the specialized contraction protein troponin I ( fast ) of type II fiber , indicating a high degree of fiber transformation .
# ::tok More importantly , the specialized contraction protein troponin I ( slow ) of type I fiber was robustly induced ; this was accompanied by a marked reduction of the specialized contraction protein troponin I ( fast ) of type II fiber , indicating a high degree of fiber transformation .
# ::alignments 48-49|0.1.1 47-48|0.1.1.0 45-46|0.1 44-45|0.1.0 42-43|0 40-41|0.0 39-40|0.0.0.0.1+0.0.0.0.0.2+0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 38-39|0.0.0 35-36|0.2.0.0 33-34|0.2.1.0.1.0.0 31-32|0.2.1.0.1 30-31|0.2.1.0.1.1 29-30|0.2.1.0.1.0 26-27|0.2.1.0 25-26|0.2.1.0.2 22-23|0.2.1 20-21|0.2.1.1 19-20|0.2 18-19|0.2.0 17-18|0.2.0.3 15-16|0.2.0.2.0 14-15|0.2.0.2.0.0 13-14|0.2.0.2 10-11|0.2.1.0.0 8-9|0.2.0.1 7-8|0.2.0.1.0.0.0.0 6-7|0.2.0.1.0.0.0 5-6|0.2.0.1.0.0 4-5|0.2.0.1.0 1-2|0.2.1.0.2.0 0-1|0.2.1.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:43.674
(i / indicate-01 
      :ARG0 (f2 / fib 
            :mod (t2 / type 
                  :mod (w / war 
                        :name (n / name 
                              :op1 "World" 
                              :op2 "War" 
                              :op3 "II") 
                        :wiki "World_War_II"))) 
      :ARG1 (d / degree 
            :ARG1-of (h / high-02) 
            :mod (t / transform-01 
                  :ARG1 (f / fib))) 
      :op3-of (a2 / and 
            :op1 (i3 / induce-01 
                  :ARG0 (f3 / fast) 
                  :ARG1 (i5 / i 
                        :ARG0-of (s3 / specialize-01 
                              :ARG1 (c2 / contraction 
                                    :mod-of (p2 / protein 
                                          :mod-of (t5 / troponin))))) 
                  :ARG2 (t4 / type 
                        :mod-of (f4 / fib 
                              :mod (i4 / i))) 
                  :manner (r2 / robustly)) 
            :op2 (a / accompany-01 
                  :ARG0 (r / reduce-01 
                        :ARG0 (s2 / slow) 
                        :ARG1 (p / protein 
                              :ARG1-of (s / specialize-01 
                                    :ARG0 (i2 / i)) 
                              :mod (c / contraction)) 
                        :ARG1-of (m / mark-01 
                              :ARG0 (i6 / important 
                                    :degree (m2 / more)))) 
                  :ARG1 (t3 / this))))

# ::snt We next examined whether acute activation of endogenous PPAR would induce similar target genes .
# ::tok We next examined whether acute activation of endogenous PPAR would induce similar target genes .
# ::alignments 13-14|0.0.1.0.1 12-13|0.0.1.0.1.0 11-12|0.0.1.0.1.1 10-11|0.0.1.0 8-9|0.0.0.0+0.0.0+0.0 7-8|0 5-6|0.0.1 4-5|0.0.1.1 2-3|0.0.1.0.0 1-2|0.0.1.0.0.1 0-1|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:43.740
(e / endogenou 
      :mod-of (o / organization 
            :name (n / name 
                  :op1 "PPAR") 
            :poss-of (a / activation 
                  :ARG0-of (i / induce-01 
                        :ARG1-of (e2 / examine-01 
                              :ARG0 (w / we) 
                              :manner (n2 / next)) 
                        :ARG2 (g / gene 
                              :ARG1-of (t / target-01) 
                              :ARG1-of (r / resemble-01))) 
                  :mod (a2 / acute))))

# ::snt In agreement with the chronic effects in the transgenic mice , we found that , after treatment of wild-type C57B6J mice with the PPAR-specific agonist GW501516 for only 10 d , genes for slow fiber contractile proteins , mitochondrial biogenesis , and -oxidation were all upregulated ( Figure 3E ) .
# ::tok In agreement with the chronic effects in the transgenic mice , we found that , after treatment of wild-type C57B6J mice with the PPAR-specific agonist GW501516 for only 10 d , genes for slow fiber contractile proteins , mitochondrial biogenesis , and -oxidation were all upregulated ( Figure 3E ) .
# ::alignments 47-48|0.0.0.1.0.0.0 44-45|0.0.0.0.0.0.0.0.0 41-42|0.0.0.0.0 39-40|0.0.0.0.0.3 36-37|0.0.0.0.0.2 35-36|0.0.0.0.0.2.0 34-35|0.0.0.0.0.2.0.0 33-34|0.0.0.0.0.0.1 31-32|0.0.0.0 29-30|0.0.0.0.0.1 28-29|0.0.0.0.0.0.0.0.3 27-28|0.0.0.0.0.1.0 25-26|0.0.0.1.0 24-25|0.0.0.1 23-24|0.0.0.1.0.0.1.0+0.0.0.1.0.0.1+0.0.0.1.0.0 20-21|0.0 19-20|0 16-17|0.0.0 15-16|0.0.0.2 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0.0.0 9-10|0.0.0.0.0.0.0.0.2 5-6|0.0.0.0.0.0.0.0.1 4-5|0.0.0.0.0.0.0.0.1.0 1-2|0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:44.969
(c3 / C57B6J 
      :mod-of (m / mouse 
            :ARG1-of (t / treat-03 
                  :ARG0 (g / gene 
                        :op3-of (a2 / and 
                              :op1 (f3 / find-01 
                                    :ARG0 (w / we 
                                          :ARG0-of (a5 / agree-01 
                                                :ARG1 (a / all) 
                                                :ARG2 (e / effect 
                                                      :mod (c4 / chronic)) 
                                                :location (m2 / mouse) 
                                                :op1-of 10)) 
                                    :ARG2 (s / slow)) 
                              :op2 (d / d 
                                    :mod (o / only)) 
                              :op4 (p / protein 
                                    :mod (c / contractile 
                                          :mod (f2 / fib))) 
                              :op5 (b / biogenesi))) 
                  :location (a3 / agonist 
                        :mod-of (g2 / GW501516 
                              :mod (c2 / country 
                                    :mod-of (f / figure) 
                                    :name (n / name 
                                          :op1 "PPAR-specific")))) 
                  :op1-of (a4 / after))))

# ::snt This indicates that rapid , systematic , and coordinated changes of muscle fiber properties toward type I can be achieved by activation of the endogenous PPAR pathway .
# ::tok This indicates that rapid , systematic , and coordinated changes of muscle fiber properties toward type I can be achieved by activation of the endogenous PPAR pathway .
# ::alignments 26-27|0.2.2.0.2.0 25-26|0.2.2.0.2.1.0+0.2.2.0.2.1+0.2.2.0.2 24-25|0.2.2.0.2.0.0 21-22|0.2.2.0.0 19-20|0.2.2.0 17-18|0.2.2 16-17|0.2.2.0.1 15-16|0.2.1.0.1 13-14|0.2.1.0.0 12-13|0.2.1.0.0.1 11-12|0.2.1.0.0.0 9-10|0.2.1.0 8-9|0.2.1 7-8|0.2 5-6|0.1 3-4|0.2.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:45.515
(i2 / indicate-01 
      :ARG0 (t2 / this) 
      :ARG1 (s / systematic) 
      :op1-of (a3 / and 
            :op2 (r / rapid) 
            :op3 (c2 / coordinate-01 
                  :ARG1 (c / change-01 
                        :ARG1 (p3 / property 
                              :ARG1-of (m / muscle-01) 
                              :mod (f / fib)) 
                        :ARG2 (t / type))) 
            :op4 (p2 / possible-01 
                  :ARG1 (a2 / achieve-01 
                        :ARG0 (a / activation) 
                        :ARG1 (i / i) 
                        :prep-in (o / organization 
                              :mod-of (p / pathway 
                                    :mod (e / endogenou)) 
                              :name (n / name 
                                    :op1 "PPAR"))))))

# ::snt Muscle Fiber Switch by PPAR Protects Against Obesity .
# ::tok Muscle Fiber Switch by PPAR Protects Against Obesity .
# ::alignments 7-8|0.0.1 5-6|0.0 4-5|0.0.0.0.0+0.0.0.0+0.0.0 0-3|0.1.2+0.1.1+0.1.0+0.1+0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:45.560
(o3 / organization 
      :mod (p / protect-01 
            :ARG0 (o2 / organization 
                  :name (n / name 
                        :op1 "PPAR")) 
            :ARG1 (o / obesity)) 
      :name (n2 / name 
            :op1 "Muscle" 
            :op2 "Fiber" 
            :op3 "Switch"))

# ::snt A number of previous studies have shown that obese individuals have fewer oxidative fibers , implying that the presence of oxidative fibers alone may play a part in obesity resistance .
# ::tok A number of previous studies have shown that obese individuals have fewer oxidative fibers , implying that the presence of oxidative fibers alone may play a part in obesity resistance .
# ::alignments 29-30|0.1.1.0.0.1 28-29|0.1.1.0.0.1.1 24-25|0.1.1.0.0 23-24|0.1.1.0.0.2 22-23|0.1.0 21-22|0.1.1.0.0.0.0 20-21|0.1.1.0.0.0.0.0 18-19|0.1.1.0.0.0 15-16|0.1.1.0 13-14|0.1.1.0.1 12-13|0.1.1.0.1.0 11-12|0.1.1.0.1.1 9-10|0.1.1 8-9|0.1.1.0.0.1.0 6-7|0 4-5|0.1 3-4|0.1.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:45.992
(s / show-01 
      :ARG0 (n / number) 
      :ARG1 (s2 / study-01 
            :ARG1 (a / alone) 
            :location (i2 / individual 
                  :ARG0-of (i / imply-01 
                        :ARG1 (p / play-01 
                              :ARG0 (p3 / presence 
                                    :mod (f / fiber 
                                          :mod (o2 / oxidative))) 
                              :ARG1 (r / resist-01 
                                    :ARG1 (o4 / obese) 
                                    :mod (o / obesity)) 
                              :ARG1-of (p2 / possible-01)) 
                        :ARG2 (f2 / fiber 
                              :mod (o3 / oxidative) 
                              :quant (f3 / few)))) 
            :time (p4 / previous)))

# ::snt To test this possibility , we fed the transgenic mice and their wild-type littermates with a high-fat diet for 97 d. Although the initial body weights of the two groups were very similar , the transgenic mice had gained less than 50 % at day 47 , and only one-third at day 97 , of the weight gained by the wild-type animals ( Figure 4A ) .
# ::tok To test this possibility , we fed the transgenic mice and their wild-type littermates with a high-fat diet for 97 d. Although the initial body weights of the two groups were very similar , the transgenic mice had gained less than 50 % at day 47 , and only one-third at day 97 , of the weight gained by the wild-type animals ( Figure 4A ) .
# ::alignments 63-64|0.0.0.1.1.1 61-62|0.1.0.0.0.1.2 57-58|0.1.0.0.0.1 56-57|0.1.0.0.0.1.0 52-53|0.1.0.0.0.2.0 51-52|0.0.0.1.0.0 49-50|0.2 48-49|0.0.2 47-48|0 45-46|0.1.0.0.0.1.1 44-45|0.1 42-43|0.1.0.0 41-42|0.1.0.0.1 39-40|0.1.0 38-39|0.1.0.0.0 36-37|0.1.0.0.0.0 32-33|0.1.0.0.0.2 31-32|0.1.0.0.0.2.2 29-30|0.1.0.0.0.2.1.0 28-29|0.1.0.0.0.2.1.0.0 25-26|0.1.0.0.0.2.1 24-25|0.1.0.0.0.2.1.1 23-24|0.1.0.0.0.2.1.2 19-20|0.0.0.0 17-18|0.0.0.1.2 13-14|0.0.0.1.1.0 10-11|0.0.0.1.1 9-10|0.0.0.1.1.0.0 6-7|0.0.0.1 5-6|0.0.0.1.0 3-4|0.0 2-3|0.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:48.615
(a2 / and 
      :op1 (p2 / possible-01 
            :ARG1-of (t2 / test-01 
                  :ARG0 97 
                  :time-of (f2 / feed-up-03 
                        :ARG0 (w3 / we 
                              :poss-of (d / day)) 
                        :ARG1 (a3 / and 
                              :op1 (l2 / littermat 
                                    :poss (m2 / mouse)) 
                              :op2 (f / figure)) 
                        :ARG2 (d3 / diet))) 
            :mod (t / this) 
            :mod (o2 / only)) 
      :op2 (d2 / day 
            :quant (l / less 
                  :op1 (p / percentage-entity 
                        :ARG1-of (g2 / gain-02 
                              :ARG0 (m / mouse) 
                              :ARG2 (g / gain-02 
                                    :ARG0 (w / weight) 
                                    :ARG1 47 
                                    :ARG2 (a / animal)) 
                              :condition (r / resemble-01 
                                    :ARG0 97 
                                    :ARG2 (w2 / weight-01 
                                          :ARG0 (g3 / group 
                                                :quant 2) 
                                          :ARG1 (b / body) 
                                          :time (i / initial)) 
                                    :degree (v / very))) 
                        :value 50))) 
      :op3 (o / one-third))

# ::snt The transgenic mice displayed significantly higher oxygen consumption on the high-fat diet than the control littermates ( unpublished data ) .
# ::tok The transgenic mice displayed significantly higher oxygen consumption on the high-fat diet than the control littermates ( unpublished data ) .
# ::alignments 18-19|0.0.0.1 17-18|0.0.0.1.0 14-15|0.0.0.3 11-12|0.0.0.2.1 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0 4-5|0 3-4|0.0.0.2 2-3|0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:48.687
(s / significant-02 
      :ARG1 (h / high-02 
            :ARG1 (c2 / consume-01 
                  :ARG0 (o / oxygen) 
                  :ARG1 (d / data 
                        :mod (u / unpublish)) 
                  :ARG1-of (d3 / display-01 
                        :ARG0 (m / mouse) 
                        :ARG2 (d2 / diet)) 
                  :duration (c / control-01))))

# ::snt By the end of this experiment , the control littermates became obese , whereas the transgenic mice still maintained a normal body weight and fat mass composition ( Figure 4A ) .
# ::tok By the end of this experiment , the control littermates became obese , whereas the transgenic mice still maintained a normal body weight and fat mass composition ( Figure 4A ) .
# ::alignments 28-29|0.0.0.0.0 26-27|0.2.1.0 25-26|0.2.1.0.1 24-25|0.2.1.0.0 23-24|0.2.1 22-23|0.2.2 21-22|0.2.2.1 20-21|0.2.2.0 18-19|0.2 17-18|0.2.3 16-17|0.2.0 13-14|0.2.4 11-12|0.1 10-11|0 9-10|0.0 8-9|0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.2 2-3|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:49.228
(b2 / become-01 
      :ARG1 (l / littermat 
            :mod (c2 / control-01 
                  :ARG1 (e / experiment-01 
                        :ARG1 (f / figure) 
                        :ARG1-of (e2 / end-01) 
                        :mod (t / this)))) 
      :ARG2 (o / obese) 
      :time (m2 / maintain-01 
            :ARG0 (m3 / mouse) 
            :ARG1 (a / and 
                  :op1 (c / compose-01 
                        :ARG1-of (f2 / fat-03) 
                        :ARG2 (m / mass))) 
            :ARG2 (w / weight 
                  :ARG1-of (n / normal-02) 
                  :part-of (b / body)) 
            :mod (s / still) 
            :op1-of (w2 / whereas)))

# ::snt A histological analysis of inguinal fat pad revealed a much smaller cell size in the transgenic mice ( Figure 4B ) , due to the increased muscle oxidative capacity .
# ::tok A histological analysis of inguinal fat pad revealed a much smaller cell size in the transgenic mice ( Figure 4B ) , due to the increased muscle oxidative capacity .
# ::alignments 28-29|0.0.1.0.0.0 27-28|0.0.1.0.0.0.1 26-27|0.0.1.0.0 25-26|0.0.1.0.0.0.0 18-19|0.0.0 16-17|0.1.1 12-13|0.1 11-12|0.1.0 10-11|0.0.1.1 9-10|0.0.1.1.0 7-8|0 6-7|0.0.1 5-6|0.0.1.0 4-5|0.0.1.2 2-3|0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:49.494
(r / reveal-01 
      :ARG0 (a / analyze-01 
            :ARG0 (f / figure) 
            :ARG1 (p / pad 
                  :ARG1-of (f2 / fat-03 
                        :ARG1-of (m / muscle-01 
                              :ARG0 (c / capacity 
                                    :ARG1-of (i / increase-01) 
                                    :mod (o / oxidative)))) 
                  :domain-of (s2 / small 
                        :mod (m3 / much)) 
                  :mod (i2 / inguinal)) 
            :manner (h / histological)) 
      :ARG1 (s / size 
            :mod (c2 / cell) 
            :poss (m2 / mouse)))

# ::snt While there was no significant difference in intramuscular glycogen content , the triglyceride content was much less in the transgenic mice ( Figure 4C and 4D ) , which may explain their improved glucose tolerance ( Figure 4E ) .
# ::tok While there was no significant difference in intramuscular glycogen content , the triglyceride content was much less in the transgenic mice ( Figure 4C and 4D ) , which may explain their improved glucose tolerance ( Figure 4E ) .
# ::alignments 36-37|0.0.0.2.2.0 34-35|0.0.0 33-34|0.0.0.1 32-33|0.0 30-31|0.0.0.2 29-30|0.0.0.2.1 24-25|0 22-23|0.0.0.2.2.1.0 20-21|0.0.0.2.0 16-17|0.0.0.0 15-16|0.0.0.0.0 13-14|0.0.0.2.2.2.1.0 12-13|0.0.0.2.2.2.1.0.0 9-10|0.0.0.2.2.2 8-9|0.0.0.2.2.2.0 7-8|0.0.0.2.2.2.1 5-6|0.0.0.2.2 4-5|0.0.0.2.2.3 3-4|0.0.0.2.1.0 0-1|0.0.0.2.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:49.958
(a / and 
      :op1 (i / improve-01 
            :ARG1 (t / tolerate-01 
                  :ARG0 (l / less 
                        :degree (m2 / much)) 
                  :ARG1 (g / glucose) 
                  :ARG1-of (e / explain-01 
                        :ARG0 (m / mouse) 
                        :ARG1-of (p / possible-01 
                              :polarity -) 
                        :manner (d / differ-02 
                              :ARG0 (f / figure) 
                              :ARG0-of (w / while-01 
                                    :ARG1 (f2 / figure)) 
                              :ARG1 (c2 / content 
                                    :mod (g2 / glycogen) 
                                    :mod (i2 / intramuscular 
                                          :poss-of (c / content 
                                                :mod (t2 / triglyceride)))) 
                              :ARG1-of (s / significant-02))))))

# ::snt We also placed wild-type C57BJ6 mice on the high-fat diet and treated them with either vehicle or the PPAR agonist GW501516 for 2 mo. .
# ::tok We also placed wild-type C57BJ6 mice on the high-fat diet and treated them with either vehicle or the PPAR agonist GW501516 for 2 mo. .
# ::alignments 22-23|0.1.0 20-21|0.1.1.2 19-20|0.1.1.2.0 18-19|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 16-17|0.1.1 15-16|0.1.2 14-15|0.1.1.0 11-12|0.1 10-11|0 9-10|0.0.2 5-6|0.0.1 4-5|0.0.1.0 2-3|0.0 1-2|0.0.3 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:50.148
(a2 / and 
      :op1 (p / place-01 
            :ARG0 (w / we) 
            :ARG1 (m / mouse 
                  :mod (c / C57BJ6)) 
            :ARG2 (d / diet) 
            :mod (a3 / also)) 
      :op2 (t / treat-01 
            :ARG0 2 
            :ARG1 (o2 / or 
                  :mod (e / either) 
                  :op1 (o / organization 
                        :name (n / name 
                              :op1 "PPAR")) 
                  :op2 (g / GW501516 
                        :mod (a / agonist))) 
            :ARG2 (v / vehicle)))

# ::snt GW501516 produced a sustained induction of genes for type I muscle fibers ; this , at least in part , resulted in an only 30 % gain in body weight , a dramatically reduced fat mass accumulation , and improved glucose tolerance , compared to the vehicle-treated group ( Figure 5 ) .
# ::tok GW501516 produced a sustained induction of genes for type I muscle fibers ; this , at least in part , resulted in an only 30 % gain in body weight , a dramatically reduced fat mass accumulation , and improved glucose tolerance , compared to the vehicle-treated group ( Figure 5 ) .
# ::alignments 50-51|0.0.2.0 49-50|0.0.1.0.1 47-48|0.0.1.0 46-47|0.0.1.0.0 43-44|0.0.1 41-42|0.1 40-41|0.1.0 39-40|0.1.1 38-39|0 36-37|0.0 35-36|0.0.3 34-35|0.0.0 33-34|0.0.2 32-33|0.0.2.1 29-30|0.1.1.0.0.1.1 28-29|0.1.1.0.0.1.1.0 26-27|0.1.1.0.0.1 25-26|0.1.1.0.0.1.0 24-25|0.1.1.0.0.1.1.0.0.0.0.1.1.1.0 23-24|0.1.1.0.0.1.1.0.0.0.0.1.0 20-21|0.1.1.0.0 13-14|0.1.1.0.0.0 12-13|0.1.1.0 11-12|0.1.1.0.0.1.1.0.0.0.0 10-11|0.1.1.0.0.1.1.0.0.0 9-10|0.1.1.0.0.1.1.0.0 8-9|0.1.1.0.0.1.1.0.0.0.0.0 6-7|0.1.1.0.0.1.1.0.0.0.0.1.1.0 4-5|0.1.1.0.0.1.1.0.0.0.0.1.1 3-4|0.1.1.0.0.1.1.0.0.0.0.1.1.1 1-2|0.1.1.0.0.1.1.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:51.093
(a / and 
      :op1 (a2 / accumulation 
            :ARG1-of (f2 / fat-03) 
            :ARG1-of (c / compare-01 
                  :ARG2 (g / group 
                        :mod (v / vehicle-treat) 
                        :mod (f / figure))) 
            :ARG1-of (r / reduce-01 
                  :ARG0 5 
                  :degree (d / dramatic)) 
            :mod (m / mass)) 
      :op2 (t / tolerate-01 
            :ARG1 (g2 / glucose) 
            :ARG1-of (i / improve-01 
                  :op1-of (a3 / and 
                        :ARG1-of (r2 / result-01 
                              :ARG0 (t2 / this) 
                              :ARG2 (g3 / gain-02 
                                    :ARG0 (p / percentage-entity) 
                                    :ARG1 (w / weight 
                                          :part-of (b / body 
                                                :poss (i2 / i 
                                                      :ARG1-of (m2 / muscle-01 
                                                            :ARG0 (f3 / fiber 
                                                                  :mod (t3 / type) 
                                                                  :purpose-of (p2 / produce-01 
                                                                        :ARG0 (o / only) 
                                                                        :ARG1 (i3 / induct-02 
                                                                              :ARG1 (g4 / gene) 
                                                                              :ARG1-of (s / sustain-01 
                                                                                    :ARG0 30))))))))))))))

# ::snt Thus , muscle fiber conversion by stimulation with the PPAR agonist or the activated transgene has a protective role against obesity .
# ::tok Thus , muscle fiber conversion by stimulation with the PPAR agonist or the activated transgene has a protective role against obesity .
# ::alignments 20-21|0.1.0.0.0 18-19|0.1.0.0 17-18|0.1.0 14-15|0 13-14|0.0 11-12|0.1 10-11|0.1.2 9-10|0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 6-7|0.1.1 4-5|0.1.3 3-4|0.1.3.0 2-3|0.1.3.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:51.250
(t / transgene 
      :ARG1-of (a / activate-01 
            :ARG0 (t2 / thu)) 
      :op3-of (o2 / or 
            :ARG1-of (p / protect-01 
                  :mod-of (r / role 
                        :prep-against (o / obesity))) 
            :op1 (s / stimulation) 
            :op2 (a2 / agonist 
                  :mod (o3 / organization 
                        :name (n / name 
                              :op1 "PPAR"))) 
            :time-of (c / convert-01 
                  :ARG1 (f / fib) 
                  :ARG1-of (m / muscle-01))))

# ::snt Activation of PPAR Enhances Physical Performance .
# ::tok Activation of PPAR Enhances Physical Performance .
# ::alignments 5-6|0.0 3-5|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 2-3|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:51.279
(a / activation 
      :ARG2-of (p / perform-02 
            :ARG0 (o / organization 
                  :name (n2 / name 
                        :op1 "PPAR")) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 (e / Enhances) 
                        :op2 (p2 / Physical)))))

# ::snt Muscle oxidative capacity is a crucial factor for determining endurance and fatigue .
# ::tok Muscle oxidative capacity is a crucial factor for determining endurance and fatigue .
# ::alignments 11-12|0.0.0.1 10-11|0.0.0 9-10|0.0.0.0 8-9|0.0 6-7|0 5-6|0.2 2-3|0.1 1-2|0.1.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:51.545
(f2 / factor 
      :ARG0-of (d / determine-01 
            :ARG1 (a / and 
                  :op1 (e / endurance) 
                  :op2 (f / fatigue))) 
      :domain (c2 / capacity 
            :ARG0-of (m / muscle-01) 
            :mod (o / oxidative)) 
      :mod (c / crucial))

# ::snt Indeed , type I fibers adaptively generated through exercise training are considered to be fatigue resistant .
# ::tok Indeed , type I fibers adaptively generated through exercise training are considered to be fatigue resistant .
# ::alignments 15-16|0.0 14-15|0.1 11-12|0 9-10|0.0.0.0.1 8-9|0.0.0.0.1.0 6-7|0.0.0.0 4-5|0.0.0.0.2 3-4|0.0.0.0.0 2-3|0.0.0 0-1|0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:51.753
(c / consider-01 
      :ARG1 (r / resist-01 
            :ARG1 (t2 / type 
                  :ARG1-of (g / generate-01 
                        :ARG0 (i / i) 
                        :ARG2 (t / train-01 
                              :ARG1 (e / exercise-02 
                                    :ARG1 (i2 / indeed))) 
                        :domain-of (f2 / fiber)))) 
      :ARG2 (f / fatigue))

# ::snt However , whether the type I fibers generated molecularly via PPAR expression can contribute to enhanced performance in the absence of previous training is unclear .
# ::tok However , whether the type I fibers generated molecularly via PPAR expression can contribute to enhanced performance in the absence of previous training is unclear .
# ::alignments 24-25|0.1.1.0.1.0.0+0.1.1.0.1.0 22-23|0.1.1.0.0 21-22|0.1.1.0.0.0 19-20|0.1.1.0 16-17|0.1.1.0.1.2 15-16|0.1.1.0.1.2.0 13-14|0.1.1.0.1 12-13|0.1.1.0.1.1 11-12|0 10-11|0.0.0.0+0.0.0+0.0 7-8|0.1 6-7|0.1.0 5-6|0.1.2 4-5|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:52.678
(e2 / express-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "PPAR")) 
      :ARG1 (g / generate-01 
            :ARG0 (f / fiber) 
            :ARG1 (t2 / type 
                  :ARG0-of (a / absent-01 
                        :ARG1 (t / train-01 
                              :time (p / previous)) 
                        :ARG1-of (c2 / contribute-01 
                              :ARG1-of (c / clear-06 
                                    :polarity -) 
                              :ARG1-of (p3 / possible-01) 
                              :ARG2 (p2 / perform-02 
                                    :ARG1-of (e / enhance-01))))) 
            :ARG2 (i / i)))

# ::snt In fact , the consequence of genetically induced fiber switch on running capacity has to our knowledge never been evaluated .
# ::tok In fact , the consequence of genetically induced fiber switch on running capacity has to our knowledge never been evaluated .
# ::alignments 19-20|0.0.1.1.0 16-17|0.0.1.1 15-16|0.0.1.1.1 12-13|0.0.1 11-12|0.0.1.0 9-10|0.0 8-9|0 7-8|0.0.0 6-7|0.0.0.0 4-5|0.0.1.1.0.0 1-2|0.0.1.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:52.928
(f / fib 
      :ARG1-of (s / switch-01 
            :ARG1-of (i / induce-01 
                  :degree (g / genetics)) 
            :ARG2 (c / capacity 
                  :mod (r / run-02) 
                  :poss-of (k / knowledge 
                        :ARG2-of (e / evaluate-01 
                              :ARG1 (c2 / consequence) 
                              :prep-in (f2 / fact)) 
                        :poss (w / we)))))

# ::snt We thus compared exercise performance between untrained , body-weight-matched transgenic and wild-type littermates .
# ::tok We thus compared exercise performance between untrained , body-weight-matched transgenic and wild-type littermates .
# ::alignments 12-13|0.2 10-11|0 8-9|0.2.0 6-7|0.1 4-5|0.0 3-4|0.0.0 2-3|0.0.1 1-2|0.0.1.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:53.090
(a / and 
      :ARG0-of (p / perform-02 
            :ARG1 (e / exercise-02) 
            :ARG1-of (c / compare-01 
                  :ARG0 (w / we) 
                  :manner (t / thus-far))) 
      :op1 (u / untrain) 
      :op2 (l / littermat 
            :mod (b / body-weight-match)))

# ::snt Mice were run on oxygen-infused , enclosed treadmills until exhaustion .
# ::tok Mice were run on oxygen-infused , enclosed treadmills until exhaustion .
# ::alignments 9-10|0.1.0 8-9|0.1 7-8|0 6-7|0.0 4-5|0.1.1.1 2-3|0.1.1 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:53.119
(t / treadmill 
      :ARG1-of (e2 / enclose-01) 
      :time (u / until 
            :op1 (e / exhaustion) 
            :time-of (r / run-01 
                  :ARG1 (m / mouse) 
                  :ARG2 (o / oxygen-infus))))

# ::snt Strikingly , the running time and distance the transgenic mice were able to sustain were increased by 67 % and 92 % , respectively ( Figure 6A ; also see Videos S1 and S2 ) .
# ::tok Strikingly , the running time and distance the transgenic mice were able to sustain were increased by 67 % and 92 % , respectively ( Figure 6A ; also see Videos S1 and S2 ) .
# ::alignments 32-33|0.1 30-32|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 29-30|0.0 28-29|0.0.2 27-28|0 25-26|0.1.1 23-24|0.1.0.0.1.1.1 21-22|0.1.0.0.1.0.1 20-21|0.1.0.0.1.1.2.0 19-20|0.1.0.0.1.1.0.0 18-19|0.1.0.0.1.1.0.1 17-18|0.1.0.0.1.0.0 15-16|0.1.0.0.1.1.0 13-14|0.1.0.0 11-12|0.1.0 9-10|0.1.0.0.0 6-7|0.1.0.0.1.1.2 5-6|0.1.0.0.1.1 4-5|0.1.0.0.1 3-4|0.1.0.0.1.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:54.390
(a3 / and 
      :op1 (s2 / see-01 
            :ARG0 (s4 / strikingly) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 (v / Videos) 
                        :op2 (s / S1))) 
            :mod (a2 / also)) 
      :op3-of (a / and 
            :op1 (p3 / possible-01 
                  :ARG1 (s3 / sustain-01 
                        :ARG0 (m / mouse) 
                        :ARG1 (t2 / time 
                              :ARG2-of (r2 / run-02 
                                    :ARG0 67 
                                    :ARG1 (p / percentage-entity)) 
                              :op1-of (a5 / and 
                                    :ARG1-of (i / increase-01 
                                          :ARG0 (a4 / and) 
                                          :ARG2 (p2 / percentage-entity)) 
                                    :mod (r / respective) 
                                    :op2 (d / distance-01 
                                          :ARG0 92))))) 
            :op2 (f / figure)))

# ::snt The transgenic mice ran about 1 h longer than the controls , which translates to nearly a kilometer further .
# ::tok The transgenic mice ran about 1 h longer than the controls , which translates to nearly a kilometer further .
# ::alignments 18-19|0.2.1.2 17-18|0.2.1.1.0+0.2.1.1 15-16|0.2.0 13-14|0.2.1 10-11|0.2 6-7|0.1.0 5-6|0.2.1.0 4-5|0.1 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:54.497
(r / run-02 
      :ARG0 (m / mouse) 
      :ARG1 (a / about 
            :quant-of (h / h)) 
      :ARG2 (c / control-01 
            :ARG1 (n / nearly) 
            :ARG1-of (t / translate-01 
                  :ARG0 1 
                  :ARG2 (d / distance-quantity 
                        :unit (k / kilometer)) 
                  :degree (f / further))))

# ::snt No significant differences in muscle mass ( unpublished data ) and daily activity ( total counts of activity per hour : 1618  209 for transgenic versus 1987  301 for wild-type , p > 0.35 , n = 4 ) were observed between the transgenic and control mice .
# ::tok No significant differences in muscle mass ( unpublished data ) and daily activity ( total counts of activity per hour : 1618  209 for transgenic versus 1987  301 for wild-type , p > 0.35 , n = 4 ) were observed between the transgenic and control mice .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:54.500
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Thus , the remarkable increase in endurance is the physiologic manifestation of muscle fiber transformation .
# ::tok Thus , the remarkable increase in endurance is the physiologic manifestation of muscle fiber transformation .
# ::alignments 14-15|0.0 13-14|0.0.0 12-13|0.0.1 10-11|0 9-10|0.2 6-7|0.1.0 4-5|0.1 3-4|0.1.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:54.566
(m2 / manifest-01 
      :ARG1 (t / transform-01 
            :ARG1 (f / fib) 
            :ARG1-of (m / muscle-01 
                  :ARG0 (t2 / thu))) 
      :domain (i / increase-01 
            :ARG1 (e / endurance) 
            :ARG1-of (r / remarkable-02)) 
      :mod (p / physiologic))

# ::snt This suggests that genetically directed muscle fiber switch is physiologically and functionally relevant .
# ::tok This suggests that genetically directed muscle fiber switch is physiologically and functionally relevant .
# ::alignments 12-13|0.1.0 11-12|0.1.0.1 10-11|0.1 9-10|0.1.0.0.3 7-8|0.1.0.0 6-7|0.1.0.0.0 5-6|0.1.0.0.1 4-5|0.1.0.0.2 3-4|0.1.0.0.2.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:54.650
(s2 / suggest-01 
      :ARG0 (t / this) 
      :ARG1 (a / and 
            :op1 (r / relevant-01 
                  :ARG1 (s / switch-01 
                        :ARG1 (f2 / fib) 
                        :ARG1-of (m / muscle-01) 
                        :ARG1-of (d / direct-01 
                              :mod (g / genetics)) 
                        :domain-of (p / physiologically)) 
                  :manner (f / functionally))))

# ::snt In addition , we looked at what effect the absence of PPAR function has on exercise endurance .
# ::tok In addition , we looked at what effect the absence of PPAR function has on exercise endurance .
# ::alignments 16-17|0.0.1.0 15-16|0.0.1 12-13|0.0 11-12|0.0.0.0.0+0.0.0.0+0.0.0 9-10|0 7-8|0.1 6-7|0.1.1 4-5|0.1.0 3-4|0.1.0.0 1-2|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:54.770
(a / absent-01 
      :ARG1 (f / function-01 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "PPAR")) 
            :ARG1-of (e2 / exercise-02 
                  :mod-of (e / endurance))) 
      :ARG1-of (e3 / effect-03 
            :ARG1-of (l / look-01 
                  :ARG0 (w / we) 
                  :prep-in (a3 / addition)) 
            :ARG2 (a2 / amr-unknown)))

# ::snt In the treadmill test , the PPAR-null mice could sustain only 38 % of the running time and 34 % of the distance of their age - and weight-matched wild-type counterparts ( Figure 6B ) .
# ::tok In the treadmill test , the PPAR-null mice could sustain only 38 % of the running time and 34 % of the distance of their age - and weight-matched wild-type counterparts ( Figure 6B ) .
# ::alignments 32-33|0.0.1.0.0 30-31|0.0.1.1.1 28-29|0.0.1.1.1.0 27-28|0.0.1.1.0.1.0 25-26|0 22-23|0.0 19-20|0.0.1.0.1 18-19|0.0.1.0.1.0 17-18|0.0.1.1 16-17|0.0.1 15-16|0.0.1.0 12-13|0.0.1.2 11-12|0.0.1.1.0.1.0.0 10-11|0.0.0 9-10|0.0.1.1.0 8-9|0.0.1.1.0.1 7-8|0.0.1.1.0.0 3-4|0.0.1.1.0.0.0 2-3|0.0.1.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:55.395
(a2 / age-01 
      :ARG1-of (d / distance-01 
            :ARG0 (o / only) 
            :time (t / time 
                  :duration-of (r / run-01 
                        :ARG0 (f / figure) 
                        :ARG1 (p / percentage-entity 
                              :value 34)) 
                  :op1-of (a3 / and 
                        :ARG1-of (s / sustain-01 
                              :ARG0 (m / mouse 
                                    :ARG1-of (t2 / test-01 
                                          :mod (t3 / treadmill))) 
                              :ARG1-of (p3 / possible-01 
                                    :op1-of (a / and 
                                          :quant 38))) 
                        :op2 (c / counterpart 
                              :mod (w / weight-match))) 
                  :quant (p2 / percentage-entity))))

# ::snt These results further support a role for PPAR in enhancement of physical performance .
# ::tok These results further support a role for PPAR in enhancement of physical performance .
# ::alignments 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0.0.0 9-10|0.0.0.0.0 7-8|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 5-6|0.0.0.0 3-4|0.0.0 2-3|0.0.0.1 1-2|0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:55.447
(r2 / result-01 
      :ARG2 (t / thing 
            :ARG0-of (s / support-01 
                  :ARG1 (r / role 
                        :ARG2-of (e / enhance-01 
                              :ARG1 (p / perform-02 
                                    :ARG2 (p2 / physical))) 
                        :beneficiary (o / organization 
                              :name (n / name 
                                    :op1 "PPAR"))) 
                  :quant (f / further)) 
            :mod (t2 / this)))

# ::snt Our data reveal that a PPAR-mediated transcriptional pathway can regulate muscle fiber specification , enabling the generation of a strain of mice with a `` long-distance running '' phenotype .
# ::tok Our data reveal that a PPAR-mediated transcriptional pathway can regulate muscle fiber specification , enabling the generation of a strain of mice with a `` long-distance running '' phenotype .
# ::alignments 28-29|0.2.1 26-27|0.2 25-26|0.2.0 21-22|0.1.3.0.0.0 19-20|0.1.3.0.0.1+0.1.3.0.0 16-17|0.1.3.0 14-15|0.1.3 12-13|0.1.1 11-12|0.1.1.1 10-11|0.1.1.0 9-10|0.1 8-9|0.1.2 7-8|0.1.0 6-7|0.1.0.0 5-6|0.1.0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:56.006
(r3 / reveal-01 
      :ARG0 (d / data 
            :poss (w / we)) 
      :ARG1 (r2 / regulate-01 
            :ARG0 (p3 / pathway 
                  :mod (t / transcriptional) 
                  :mod (p4 / ppar-mediat)) 
            :ARG1 (s2 / specification 
                  :ARG1-of (m2 / muscle-01) 
                  :mod (f / fib)) 
            :ARG1-of (p2 / possible-01) 
            :purpose (e / enable-01 
                  :ARG1 (g / generation 
                        :consist-of (s / strain 
                              :mod-of (m / mouse) 
                              :wiki "Influenza_A_virus_subtype_H5N1")))) 
      :ARG2-of (r / run-01 
            :ARG0 (l / long-distance) 
            :ARG1 (p / phenotype)))

# ::snt We show that targeted expression of an activated form of PPAR produces profound and coordinated increases in oxidation enzymes , mitochondrial biogenesis , and production of specialized type I fiber contractile proteins -- the three hallmarks for muscle fiber type switching ( Figure 6C ) .
# ::tok We show that targeted expression of an activated form of PPAR produces profound and coordinated increases in oxidation enzymes , mitochondrial biogenesis , and production of specialized type I fiber contractile proteins -- the three hallmarks for muscle fiber type switching ( Figure 6C ) .
# ::alignments 42-43|0.2.0 40-41|0.2.3.0.1 39-40|0.2.3.0 38-39|0.2.3.0.0 37-38|0.2.3 35-36|0.2.4.1.0 34-35|0.2.4.1.0.0 31-32|0.2.4.1.1 30-31|0.2.4.1.1.1 29-30|0.5 28-29|0.4 27-28|0.3 26-27|0.2.4.1.1.0 24-25|0.2.4.1 23-24|0.2.4 21-22|0.2.4.0 18-19|0.2.1 17-18|0.2.1.0 15-16|0.2 14-15|0.2.2 13-14|0 12-13|0.1 11-12|0.0 10-11|0.0.0.0.0+0.0.0.0+0.0.0 8-9|0.0.0.1 7-8|0.0.0.1.1 4-5|0.0.0.1.0 3-4|0.0.0.1.0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:56.892
(a2 / and 
      :ARG1-of (p4 / produce-01 
            :ARG0 (o2 / organization 
                  :name (n / name 
                        :op1 "PPAR") 
                  :poss-of (f4 / form 
                        :ARG1-of (e2 / express-01 
                              :ARG1-of (t3 / target-01)) 
                        :ARG1-of (a3 / activate-01))) 
            :ARG1-of (s3 / show-01 
                  :ARG0 (w / we))) 
      :op1 (p3 / profound) 
      :op2 (i2 / increase-01 
            :ARG0 (f / figure) 
            :ARG1 (e / enzym 
                  :mod (o / oxidation)) 
            :ARG1-of (c2 / coordinate-01) 
            :ARG2-of (m / muscle-01 
                  :mod-of (t / type 
                        :mod (f2 / fib) 
                        :mod-of (s / switch))) 
            :op1-of (a / and 
                  :op2 (b / biogenesi) 
                  :op3 (p2 / produce-01 
                        :ARG0 (h / hallmark 
                              :quant 3) 
                        :ARG1 (p / protein 
                              :ARG1-of (s2 / specialize-01) 
                              :mod (c / contractile))))) 
      :op3 (t2 / type) 
      :op4 (i / i) 
      :op5 (f3 / fib))

# ::snt While induction of muscle oxidation enzymes by PPAR has been seen both in vivo and in vitro ( Muoio et al. 2002 ; Dressel et al. 2003 ; Luquet et al. 2003 ; Tanaka et al. 2003 ; Wang et al. 2003 ) , its effects shown here on muscle fiber switching are unexpected .
# ::tok While induction of muscle oxidation enzymes by PPAR has been seen both in vivo and in vitro ( Muoio et al. 2002 ; Dressel et al. 2003 ; Luquet et al. 2003 ; Tanaka et al. 2003 ; Wang et al. 2003 ) , its effects shown here on muscle fiber switching are unexpected .
# ::alignments 53-54|0.0.1.0.2+0.0.1.0 51-52|0.0.1.0.0.0.2 50-51|0.0.1.0.0.0.2.1 49-50|0.0.1.0.0.0.2.0 47-48|0.0.1.0.0.0.1 46-47|0.0.1.0.0.0 45-46|0.0.1.0.0 41-42|0.0.7.0+0.0.7 36-37|0.0.6.0+0.0.6 33-35|0.0.3.0.1+0.0.3.0.0+0.0.3.0+0.0.3 31-32|0.0.4.0+0.0.4 28-30|0.0.1.0.1.0.1+0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 26-27|0.0.5.0+0.0.5 23-25|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 22-23|0.1 21-22|0.0.1.2.0+0.0.1.2 18-21|0.0.1.0.0.0.0.0.2+0.0.1.0.0.0.0.0.1+0.0.1.0.0.0.0.0.0+0.0.1.0.0.0.0.0+0.0.1.0.0.0.0 14-15|0 13-14|0.0.2 11-12|0.1.0 10-11|0.0 7-8|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 5-6|0.0.0.0 4-5|0.0.0.0.0 3-4|0.0.1.1 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:52:59.661
(a2 / and 
      :manner-of (s3 / see-01 
            :ARG1 (i / induct-02 
                  :ARG1 (e6 / enzym 
                        :mod (o2 / oxidation) 
                        :mod (o / organization 
                              :name (n5 / name 
                                    :op1 "PPAR")))) 
            :ARG1-of (w / while-01 
                  :ARG0 (e / expect-01 
                        :ARG0 (e2 / effect 
                              :ARG1-of (s2 / show-01 
                                    :ARG0 (t5 / thing 
                                          :name (n4 / name 
                                                :op1 "Muoio" 
                                                :op2 "et" 
                                                :op3 "al.")) 
                                    :location (h / here) 
                                    :time (s / switch 
                                          :ARG1-of (m / muscle-01) 
                                          :mod (f / fib)))) 
                        :ARG1 (t3 / thing 
                              :name (n2 / name 
                                    :op1 (l / Luquet) 
                                    :op2 (e4 / et))) 
                        :polarity -) 
                  :ARG2 (m2 / muscle-01) 
                  :op1-of (d6 / date-entity 
                        :year 2002)) 
            :ARG2 (v / vivo) 
            :manner (t / thing 
                  :name (n / name 
                        :op1 (t2 / Tanaka) 
                        :op2 (e3 / et))) 
            :time (d3 / date-entity 
                  :year 2003) 
            :time (d4 / date-entity 
                  :year 2003) 
            :time (d2 / date-entity 
                  :year 2003) 
            :time (d / date-entity 
                  :year 2003)) 
      :op1-of (a / and 
            :mod (b / both) 
            :op2 (t4 / thing 
                  :name (n3 / name 
                        :op1 (d5 / Dressel) 
                        :op2 (e5 / et)))))

# ::snt These progressive changes in oxidative capacity in conjunction with eventual changes in type I muscle fiber lead to a dramatically improved exercise profile and protection against obesity .
# ::tok These progressive changes in oxidative capacity in conjunction with eventual changes in type I muscle fiber lead to a dramatically improved exercise profile and protection against obesity .
# ::alignments 26-27|0.2.0.1.0 24-25|0.2.0.1 23-24|0.2 22-23|0.2.0.0 21-22|0.2.0.0.0 20-21|0.2.0 19-20|0.2.0.2 16-17|0 15-16|0.1.1 14-15|0.1.1.0 13-14|0.2.0.0.0.0 12-13|0.1.1.1 10-11|0.1 9-10|0.1.2 7-8|0.0.0 5-6|0.1.0 4-5|0.1.0.0 2-3|0.0 1-2|0.0.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:00.685
(l / lead-03 
      :ARG0 (c4 / change-01 
            :ARG1 (c2 / conjunction) 
            :ARG1-of (p3 / progressive-02) 
            :mod (t2 / this)) 
      :ARG1 (c / change-01 
            :ARG0 (c3 / capacity 
                  :mod (o2 / oxidative)) 
            :ARG1 (f / fib 
                  :ARG1-of (m / muscle-01) 
                  :mod (t / type)) 
            :mod (e2 / eventual)) 
      :ARG2 (a / and 
            :op1 (i / improve-01 
                  :ARG0 (p2 / profile 
                        :mod (e / exercise-02 
                              :ARG0 (i2 / i))) 
                  :ARG1 (p / protect-01 
                        :ARG2 (o / obesity)) 
                  :manner (d / dramatic))))

# ::snt This does not solely depend on achieving a directed muscle fiber type switch but also requires all the associated changes in neural innervation , motor neuron function , and peripheral metabolic adaptation to enable a new integrated physiological response .
# ::tok This does not solely depend on achieving a directed muscle fiber type switch but also requires all the associated changes in neural innervation , motor neuron function , and peripheral metabolic adaptation to enable a new integrated physiological response .
# ::alignments 38-39|0.1.0.0.1.1.0.0.0 37-38|0.1.0.0.1.1.0.0.0.2 36-37|0.1.0.0.1.1.0.0.0.0 35-36|0.1.0.0.1.1.0.0.0.1 33-34|0.1.0.0.1.1.0.0 31-32|0.1.0.0.1.1.0+0.1.0.0.1.1 30-31|0.1.0.0.1.1.0.2 29-30|0.1.0.0.1.1.0.1 28-29|0.1.0.0.1 26-27|0.1.0.0.1.0 25-26|0.1.0.0.1.0.0 24-25|0.1.0.0.1.0.1 22-23|0.1.0.0 21-22|0.1.0.0.0 19-20|0.1.0 18-19|0.1.0.1 16-17|0.1.0.1.0 15-16|0.1 14-15|0.1.1 13-14|0 12-13|0.0.1.0 11-12|0.0.1.0.0 10-11|0.0.1.0.0.0 9-10|0.0.1.0.2 8-9|0.0.1.0.1 6-7|0.0.1 4-5|0.0 3-4|0.0.2 2-3|0.0.3 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:02.315
(c2 / contrast-01 
      :ARG1 (d2 / depend-01 
            :ARG0 (t3 / this) 
            :ARG1 (a6 / achieve-01 
                  :ARG1 (s / switch-01 
                        :ARG1 (t2 / type 
                              :mod (f2 / fib)) 
                        :ARG1-of (d / direct-01) 
                        :ARG1-of (m3 / muscle-01))) 
            :manner (s2 / sole) 
            :polarity -) 
      :ARG2 (r2 / require-01 
            :ARG1 (c / change-01 
                  :ARG1 (i2 / innervation 
                        :mod (n3 / neural) 
                        :op1-of (a2 / and 
                              :op2 (f / function-01 
                                    :ARG1 (n2 / neuron) 
                                    :mod (m2 / motorcycle)) 
                              :op3 (t / thing 
                                    :ARG1-of (a / adapt-01 
                                          :ARG2 (e / enable-01 
                                                :ARG1 (r / respond-01 
                                                      :ARG1-of (i / integrate-01) 
                                                      :mod (n / new) 
                                                      :mod (p / physiological))) 
                                          :mod (p2 / peripheral) 
                                          :mod (m / metabolic))))) 
                  :ARG2-of (a3 / associate-01 
                        :ARG1 (a4 / all))) 
            :mod (a5 / also)))

# ::snt Accordingly , activation of muscle PPAR essentially recapitulates the effects of exercise training even in the absence of training itself .
# ::tok Accordingly , activation of muscle PPAR essentially recapitulates the effects of exercise training even in the absence of training itself .
# ::alignments 18-19|0.2.0 16-17|0.2 13-14|0.2.1 12-13|0.2.0.0 11-12|0.2.0.0.0 9-10|0.1 7-8|0 6-7|0.3 5-6|0.0.0.1.0+0.0.0.1+0.0.0 4-5|0.0.0.0 2-3|0.0 0-1|0.2.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:02.693
(r / recapitulate-01 
      :ARG0 (a2 / activation 
            :poss (o / organization 
                  :ARG0-of (m / muscle-01) 
                  :name (n / name 
                        :op1 "PPAR"))) 
      :ARG1 (e3 / effect) 
      :ARG2 (a / absent-01 
            :ARG1 (t / train-01 
                  :ARG1 (t2 / train-01 
                        :ARG1 (e2 / exercise-02 
                              :ARG1 (a3 / accordingly)))) 
            :mod (e / even)) 
      :manner (e4 / essential))

# ::snt To our knowledge , this has not been directly described for any other transcriptional factor .
# ::tok To our knowledge , this has not been directly described for any other transcriptional factor .
# ::alignments 14-15|0.3 12-13|0.3.0 11-12|0.3.1 9-10|0 8-9|0.2 6-7|0.4 4-5|0.1 2-3|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:02.822
(d / describe-01 
      :ARG0 (w / we 
            :poss-of (k / knowledge)) 
      :ARG1 (t / this) 
      :ARG1-of (d2 / direct-02) 
      :ARG2 (f / factor 
            :mod (o / other) 
            :mod (a / any)) 
      :polarity -)

# ::snt The muscle phenotypes described here are remarkably similar to those of transgenic mice expressing either calcineurin , calmodulin-dependent kinase , or PGC-1 ( Naya et al. 2000 ; Lin et al. 2002 ; Wu et al. 2002 ) , indicating that PPAR could be one of the hypothetical downstream transcription factors of these pathways .
# ::tok The muscle phenotypes described here are remarkably similar to those of transgenic mice expressing either calcineurin , calmodulin-dependent kinase , or PGC-1 ( Naya et al. 2000 ; Lin et al. 2002 ; Wu et al. 2002 ) , indicating that PPAR could be one of the hypothetical downstream transcription factors of these pathways .
# ::alignments 53-54|0.0.0 52-53|0.0 50-51|0.0.0.0 49-50|0.0.0.0.1 48-49|0.0.0.0.2 47-48|0.0.0.0.0 42-43|0.1 39-40|0 36-37|0.0.0.0.0.0.0+0.0.0.0.0.0 33-34|0.1.0.2.1+0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 31-32|0.1.1.0.0.0.0+0.1.1.0.0.0 28-30|0.1.1.0.1.1+0.1.1.0.1.0+0.1.1.0.1+0.1.1.0 27-28|0.1.1 26-27|0.1.1.0.0.1.0.0.0+0.1.1.0.0.1.0.0 23-26|0.1.1.0.0.1.1.0.0.2+0.1.1.0.0.1.1.0.0.1+0.1.1.0.0.1.1.0.0.0+0.1.1.0.0.1.1.0.0+0.1.1.0.0.1.1.0 20-21|0.1.0 18-19|0.1.0.1 15-16|0.1.0.0.1 14-15|0.1.0.0.2 13-14|0.1.0.0 12-13|0.1.0.0.0 7-8|0.1.1.0.0 6-7|0.1.1.0.0.2 4-5|0.1.1.0.0.1.0.1 3-4|0.1.1.0.0.1.0 2-3|0.1.1.0.0.1 1-2|0.1.1.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:06.591
(i / indicate-01 
      :ARG0 (t / this 
            :mod-of (p / pathway 
                  :mod-of (f / factor 
                        :ARG1-of (h / hypothetical-02 
                              :ARG0 (d2 / date-entity 
                                    :year 2002)) 
                        :mod (t2 / transcription) 
                        :mod (d / downstream)))) 
      :ARG1 (p2 / possible-01 
            :ARG1 (o / or 
                  :ARG2-of (e3 / express-01 
                        :ARG0 (m / mouse) 
                        :ARG1 (c / calcineurin) 
                        :mod (e2 / either)) 
                  :op1 (k / kinase) 
                  :op2 (p3 / person 
                        :name (n / name 
                              :op1 "Wu") 
                        :wiki -)) 
            :op2-of (a / and 
                  :op1 (t3 / thing 
                        :ARG2-of (r / resemble-01 
                              :ARG0 (d3 / date-entity 
                                    :year 2002) 
                              :ARG1 (p4 / phenotyp 
                                    :ARG1-of (d5 / describe-01 
                                          :ARG0 (d4 / date-entity 
                                                :year 2000) 
                                          :location (h2 / here)) 
                                    :ARG1-of (m2 / muscle-01 
                                          :ARG0 (t4 / thing 
                                                :name (n3 / name 
                                                      :op1 "Naya" 
                                                      :op2 "et" 
                                                      :op3 "al.")))) 
                              :ARG1-of (r2 / remarkable-02)) 
                        :name (n2 / name 
                              :op1 (l / Lin) 
                              :op2 (e / et))))))

# ::snt It is important to note that , from our ligand and gain-of-function transgenic studies , PPAR needs to be activated in order to direct the muscle fiber switch .
# ::tok It is important to note that , from our ligand and gain-of-function transgenic studies , PPAR needs to be activated in order to direct the muscle fiber switch .
# ::alignments 27-28|0.0.1.0.0 26-27|0.0.1.0.0.0 25-26|0.0.1.0.0.1 23-24|0.0.1.0 19-20|0.0.1 16-17|0.0 15-16|0.0.0.0.0+0.0.0.0+0.0.0 13-14|0.1.0 10-11|0 9-10|0.1.1.0+0.1.1 8-9|0.1 4-5|0.0.2 2-3|0.0.2.1 0-1|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:06.754
(a2 / and 
      :op1 (n / need-01 
            :ARG0 (o / organization 
                  :name (n2 / name 
                        :op1 "PPAR")) 
            :ARG1 (a / activate-01 
                  :purpose (d / direct-02 
                        :ARG1 (s / switch-01 
                              :ARG1 (f / fib) 
                              :ARG1-of (m / muscle-01)))) 
            :ARG1-of (n3 / note-01 
                  :ARG0 (i2 / it) 
                  :domain-of (i / important))) 
      :poss (w / we 
            :ARG0-of (s2 / study-01) 
            :poss-of (l / ligand 
                  :wiki "HRG_(gene)")))

# ::snt Indeed , in a recent report by Luquet et al. ( 2003 ) , simple overexpression of wild-type PPAR in muscle was found not to be sufficient to promote a fiber switch or obesity resistance , although certain oxidation enzymes were increased .
# ::tok Indeed , in a recent report by Luquet et al. ( 2003 ) , simple overexpression of wild-type PPAR in muscle was found not to be sufficient to promote a fiber switch or obesity resistance , although certain oxidation enzymes were increased .
# ::alignments 41-42|0.3.1.0.0 39-40|0.3.1.0 38-39|0.3.1.0.1 37-38|0.3.1.0.2 34-35|0 33-34|0.2 32-33|0.3 31-32|0.3.1.1 30-31|0.3.1.1.0 28-29|0.3.1 26-27|0.3.1.2 23-24|0.3.1.2.2.0 22-23|0.3.1.2.2 20-21|0.3.1.2.1 18-19|0.3.1.2.0.1 15-16|0.3.1.2.0 14-15|0.3.1.2.0.0 11-12|0.1.0+0.1 7-10|0.3.0.0.2+0.3.0.0.1+0.3.0.0.0+0.3.0.0+0.3.0 5-6|0.3.1.2.2.1 4-5|0.3.1.2.2.1.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:07.213
(r / resist-01 
      :ARG0 (i2 / indeed) 
      :ARG1 (d / date-entity 
            :year 2003) 
      :mod (o2 / obesity) 
      :op3-of (o3 / or 
            :op1 (t / thing 
                  :name (n / name 
                        :op1 "Luquet" 
                        :op2 "et" 
                        :op3 "al.")) 
            :op2 (p / promote-02 
                  :ARG0 (e / enzym 
                        :ARG1-of (i / increase-01) 
                        :mod (o / oxidation) 
                        :mod (c / certain)) 
                  :ARG1 (s / switch-01 
                        :ARG1 (f / fib)) 
                  :ARG2-of (s2 / suffice-01 
                        :ARG0 (o4 / overexpression 
                              :ARG1-of (s3 / simple-02) 
                              :mod (p2 / PPAR)) 
                        :ARG1 (m / muscle-01) 
                        :ARG2-of (f2 / find-01 
                              :ARG1 - 
                              :medium (r2 / report 
                                    :time (r3 / recent)))))))

# ::snt This supports the model in Figure 6C that the activating signal or ligand , but not the receptor , is limiting .
# ::tok This supports the model in Figure 6C that the activating signal or ligand , but not the receptor , is limiting .
# ::alignments 20-21|0.0.0 17-18|0.0.4 15-16|0.0.0.0 14-15|0 12-13|0.0.3.0+0.0.3 11-12|0.0 10-11|0.0.2 9-10|0.0.2.0 5-6|0.0.1.1.0 3-4|0.0.1.1 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:07.402
(c / contrast-01 
      :ARG1 (o / or 
            :ARG0-of (l / limit-01 
                  :ARG1 -) 
            :op1 (s2 / support-01 
                  :ARG0 (t / this) 
                  :ARG1 (m / model 
                        :location (f / figure))) 
            :op2 (s / signal 
                  :ARG1-of (a / activate-01)) 
            :op3 (l2 / ligand 
                  :wiki "HRG_(gene)") 
            :op4 (r / receptor)))

# ::snt Thus , PPAR activation , rather than merely an increase of PPAR levels , is an essential element for fiber switching and its associated functional manifestations .
# ::tok Thus , PPAR activation , rather than merely an increase of PPAR levels , is an essential element for fiber switching and its associated functional manifestations .
# ::alignments 25-26|0.0 24-25|0 23-24|0.0.0 21-22|0.0.0.0.1 20-21|0.0.0.0 19-20|0.0.0.0.0 17-18|0.0.0.0.1.1 16-17|0.0.0.0.1.1.1 12-13|0.0.0.0.1.0.0 9-10|0.0.0.0.1.0 7-8|0.0.0.1 3-4|0.0.0.0.1.1.0 2-3|0.0.0.0.1.1.0.0.0.0+0.0.0.0.1.1.0.0.0+0.0.0.0.1.1.0.0 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:07.650
(f / functional 
      :mod-of (m / manifestation 
            :ARG1-of (a / associate-01 
                  :ARG2 (s / switch 
                        :mod (f2 / fib) 
                        :op2-of (a2 / and 
                              :op1 (i / increase-01 
                                    :ARG1 (l / level)) 
                              :purpose-of (e / element 
                                    :domain (a3 / activation 
                                          :mod (o / organization 
                                                :name (n / name 
                                                      :op1 "PPAR"))) 
                                    :mod (e2 / essential)))) 
                  :op1-of (m2 / mere) 
                  :op1-of (t / thu))))

# ::snt How might endogenous PPAR become activated naturally by exercise training ?
# ::tok How might endogenous PPAR become activated naturally by exercise training ?
# ::alignments 10-11|0.2 9-10|0.0.1.0 8-9|0.0.1.0.0 6-7|0.0.1.1 5-6|0.0.1 4-5|0.0 3-4|0.0.0.1.0+0.0.0.1+0.0.0 2-3|0.0.0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:07.701
(p / possible-01 
      :ARG1 (b / become-01 
            :ARG1 (o / organization 
                  :mod (e2 / endogenou) 
                  :name (n2 / name 
                        :op1 "PPAR")) 
            :ARG2 (a / activate-01 
                  :ARG1 (t / train-01 
                        :ARG1 (e / exercise-02)) 
                  :ARG1-of (n / natural-03))) 
      :manner (a2 / amr-unknown) 
      :mode (i / interrogative))

# ::snt First , it is possible that exercise generates or increases endogenous ligands for PPAR as tissues are undergoing substantial increases in fatty-acid internalization and burning .
# ::tok First , it is possible that exercise generates or increases endogenous ligands for PPAR as tissues are undergoing substantial increases in fatty-acid internalization and burning .
# ::alignments 24-25|0.2.1.1.2 23-24|0.2.1.1 22-23|0.2.1.1.1 19-20|0.2.1 18-19|0.2.1.0 17-18|0.2 15-16|0.2.0 13-14|0.2.1.1.0.0.0+0.2.1.1.0.0+0.2.1.1.0 11-12|0.1.1 10-11|0.1.1.1 9-10|0.1.1.0 8-9|0 7-8|0.1 6-7|0.1.0 4-5|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:07.874
(o2 / or 
      :ARG1-of (p / possible-01) 
      :op1 (g / generate-01 
            :ARG0 (e2 / exercise-02) 
            :ARG1 (l / ligand 
                  :ARG1-of (i3 / increase-01) 
                  :mod (e / endogenou))) 
      :time (u / undergo-01 
            :ARG0 (t / tissue) 
            :ARG1 (i2 / increase-01 
                  :degree (s / substantial) 
                  :op2-of (a / and 
                        :op1 (o / organization 
                              :name (n / name 
                                    :op1 "PPAR")) 
                        :op3 (i / internalization) 
                        :op4 (b / burn-01)))))

# ::snt Fatty acids and their metabolites can activate PPAR .
# ::tok Fatty acids and their metabolites can activate PPAR .
# ::alignments 7-8|0.0.1.0.0+0.0.1.0+0.0.1 6-7|0.0 5-6|0 4-5|0.0.0.0 2-3|0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:07.941
(p / possible-01 
      :ARG1 (a / activate-01 
            :ARG0 (a2 / and 
                  :op1 (m / metabolit 
                        :poss (a3 / acid 
                              :mod (f / fatty)))) 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "PPAR"))))

# ::snt A second model is that exercise may induce expression of PGC-1 ( Goto et al. 2000 ) and thereby activate PPAR .
# ::tok A second model is that exercise may induce expression of PGC-1 ( Goto et al. 2000 ) and thereby activate PPAR .
# ::alignments 19-20|0.0.1 18-19|0.0.1.0 17-18|0.0.1.1 15-16|0.0.2.0.0.0+0.0.2.0.0 12-15|0.1.2+0.1.1+0.1.0+0.1+0 8-9|0.0 7-8|0.0.2 6-7|0.0.2.1 5-6|0.0.2.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:08.048
(t2 / thing 
      :ARG0-of (e / express-01 
            :ARG1 (m / model) 
            :ARG1-of (a / activate-01 
                  :manner (t / thereby) 
                  :op1-of (a2 / and)) 
            :ARG2-of (i / induce-01 
                  :ARG1 (e2 / exercise-02 
                        :ARG1 (d / date-entity 
                              :year 2000)) 
                  :ARG1-of (p / possible-01))) 
      :name (n / name 
            :op1 "Goto" 
            :op2 "et" 
            :op3 "al."))

# ::snt This is consistent with previous work in which we have shown that PGC-1 physically associates with PPAR in muscle tissue and can powerfully activate it even in the absence of ligands ( Wang et al. 2003 ) .
# ::tok This is consistent with previous work in which we have shown that PGC-1 physically associates with PPAR in muscle tissue and can powerfully activate it even in the absence of ligands ( Wang et al. 2003 ) .
# ::alignments 35-36|0.3.0.0.0.0+0.3.0.0.0 32-35|0.4.0.0.2+0.4.0.0.1+0.4.0.0.0+0.4.0.0+0.4.0 30-31|0.4.1 28-29|0.4 25-26|0.4.2 23-24|0.3.0 22-23|0.3.0.2 21-22|0.3 20-21|0 19-20|0.3.0.1 18-19|0.3.0.1.0 16-17|0.3.0.0.1.0.0+0.3.0.0.1.0+0.3.0.0.1 14-15|0.3.0.0 13-14|0.2 10-11|0.1 8-9|0.1.0 5-6|0.0 4-5|0.0.1 2-3|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:08.376
(a3 / and 
      :ARG1-of (w2 / work-01 
            :ARG2-of (c / consistent-01 
                  :ARG1 (t3 / this)) 
            :time (p4 / previous)) 
      :ARG1-of (s / show-01 
            :ARG0 (w / we)) 
      :op1 (p3 / physical) 
      :op2 (p2 / possible-01 
            :ARG1 (a2 / activate-01 
                  :ARG1 (a4 / associate-01 
                        :ARG0 (d / date-entity 
                              :year 2003) 
                        :ARG1 (o / organization 
                              :name (n2 / name 
                                    :op1 "PPAR"))) 
                  :ARG2 (t2 / tissue 
                        :ARG1-of (m / muscle-01)) 
                  :manner (p / powerfully))) 
      :time (a / absent-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "Wang" 
                        :op2 "et" 
                        :op3 "al.")) 
            :ARG1 (l / ligand) 
            :mod (e / even)))

# ::snt Alternatively , PPAR may be activated by a distal upstream signaling component such as a kinase cascade .
# ::tok Alternatively , PPAR may be activated by a distal upstream signaling component such as a kinase cascade .
# ::alignments 16-17|0.0.1.0 15-16|0.0.1.0.0 12-13|0.0.0.0.0 11-12|0.0.0 10-11|0.0.0.0 9-10|0.0.0.1 8-9|0.0.0.2 5-6|0.0 3-4|0 2-3|0.0.1.1.0+0.0.1.1+0.0.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:08.537
(p / possible-01 
      :ARG1 (a / activate-01 
            :ARG0 (c2 / component 
                  :ARG1-of (s2 / signal-01 
                        :ARG0 (s / such)) 
                  :mod (u / upstream) 
                  :mod (d / distal)) 
            :ARG1 (o / organization 
                  :ARG0-of (c / cascade-01 
                        :ARG1 (k / kinase)) 
                  :name (n / name 
                        :op1 "PPAR"))) 
      :location (a2 / alternatively))

# ::snt Further dissecting the interactions between PPAR and its regulatory components will be necessary to fully understand the molecular basis of muscle fiber determination pertinent to exercise training .
# ::tok Further dissecting the interactions between PPAR and its regulatory components will be necessary to fully understand the molecular basis of muscle fiber determination pertinent to exercise training .
# ::alignments 26-27|0.1.1.1 25-26|0.1.1.1.1 23-24|0.1.1.1.1.1 22-23|0.1.1.1.1.0 21-22|0.1.1.1.1.0.0 20-21|0.1.1.1.1.0.1 17-18|0.1.1.1.0 15-16|0.1.1 14-15|0.1.1.0 9-10|0.1 8-9|0.1.0 6-7|0 5-6|0.1.2.0.0+0.1.2.0+0.1.2 3-4|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:08.972
(a / and 
      :ARG0-of (d2 / dissect-01 
            :ARG1 (i / interaction) 
            :mod (f3 / further)) 
      :op1 (c / component 
            :ARG0-of (r / regulate-01) 
            :ARG1-of (u / understand-01 
                  :degree (f2 / full) 
                  :purpose (t / train-01 
                        :ARG1 (m2 / molecule) 
                        :ARG1-of (e / exercise-01 
                              :ARG0 (d / determine-01 
                                    :ARG1 (f / fib) 
                                    :ARG1-of (m / muscle-01)) 
                              :domain-of (p / pertinent)))) 
            :poss (o / organization 
                  :name (n / name 
                        :op1 "PPAR"))))

# ::snt Skeletal muscle is a major site to regulate whole-body fatty-acid and glucose metabolism .
# ::tok Skeletal muscle is a major site to regulate whole-body fatty-acid and glucose metabolism .
# ::alignments 12-13|0.0 11-12|0 10-11|0.0.0 7-8|0.0.0.0 5-6|0.0.0.0.0.0 4-5|0.0.0.0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:09.084
(g / glucose 
      :mod-of (m / metabolism 
            :op1-of (a / and 
                  :ARG1-of (r / regulate-01 
                        :ARG0 (m3 / muscle-01 
                              :domain-of (s / site 
                                    :ARG1-of (m2 / major-02)) 
                              :mod (s2 / skeletal))))))

# ::snt We show that mice with increased oxidative fibers are resistant to high-fat-induced obesity and glucose intolerance .
# ::tok We show that mice with increased oxidative fibers are resistant to high-fat-induced obesity and glucose intolerance .
# ::alignments 15-16|0.2.1.0 14-15|0.2.1.0.0 13-14|0.2.1 12-13|0.2.0 11-12|0.2.0.0 9-10|0.2 7-8|0.1.0 6-7|0.1.0.0 5-6|0.1 3-4|0.2.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:09.308
(s / show-01 
      :ARG0 (w / we) 
      :ARG0-of (i2 / increase-01 
            :ARG1 (f / fiber 
                  :mod (o2 / oxidative))) 
      :ARG1 (r / resist-01 
            :ARG1 (o / obesity 
                  :degree (h / high-fat-induc)) 
            :ARG2 (a / and 
                  :op1 (i / intolerance 
                        :mod (g / glucose))) 
            :domain (m / mouse)))

# ::snt Moreover , ligand studies provide compelling evidence that activation of endogenous PPAR can produce similar effects .
# ::tok Moreover , ligand studies provide compelling evidence that activation of endogenous PPAR can produce similar effects .
# ::alignments 15-16|0.0.1.0.0 14-15|0.0.1.0.0.0 13-14|0.0.1.0 12-13|0.0.1.0.1 11-12|0.0.0.0+0.0.0+0.0 10-11|0 8-9|0.0.1 6-7|0.0.1.0.2 5-6|0.0.1.0.2.0 4-5|0.0.1.0.2.1 3-4|0.0.1.0.2.1.0 2-3|0.0.1.0.2.1.0.0.0+0.0.1.0.2.1.0.0 0-1|0.0.1.0.2.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:09.583
(e2 / endogenou 
      :mod-of (o / organization 
            :name (n / name 
                  :op1 "PPAR") 
            :poss-of (a / activation 
                  :ARG0-of (p / produce-01 
                        :ARG1 (e / effect 
                              :ARG1-of (r / resemble-01)) 
                        :ARG1-of (p2 / possible-01) 
                        :ARG1-of (e3 / evidence-01 
                              :ARG1-of (c / compel-01) 
                              :ARG1-of (p3 / provide-01 
                                    :ARG0 (s / study-01 
                                          :ARG1 (l / ligand 
                                                :wiki "HRG_(gene)")) 
                                    :duration (m / moreover)))))))

# ::snt Might PPAR have any beneficial effects on glucose metabolism in the lean condition ?
# ::tok Might PPAR have any beneficial effects on glucose metabolism in the lean condition ?
# ::alignments 13-14|0.0.0.0.1 12-13|0.0.0.0.0 11-12|0.0.0.0 8-9|0.3 7-8|0.3.0 5-6|0 4-5|0.1 3-4|0.2 1-2|0.0.1.0+0.0.1+0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:09.673
(e / effect 
      :ARG0 (o / organization 
            :mod (m2 / may 
                  :ARG0-of (l / lean-01 
                        :ARG1 (c / condition) 
                        :mode (i / interrogative))) 
            :name (n / name 
                  :op1 "PPAR")) 
      :ARG0-of (b / benefit-01) 
      :mod (a / any) 
      :topic (m / metabolism 
            :mod (g / glucose)))

# ::snt This has not been explored ; however , insulin resistance in the elderly is confined mostly to skeletal muscle and may be due to reduction of mitochondrial number and/or function ( Petersen et al. 2003 ) .
# ::tok This has not been explored ; however , insulin resistance in the elderly is confined mostly to skeletal muscle and may be due to reduction of mitochondrial number and/or function ( Petersen et al. 2003 ) .
# ::alignments 34-35|0.1.0.0.0.0+0.1.0.0.0 31-34|0.1.0.1.0.1.0.0.2+0.1.0.1.0.1.0.0.1+0.1.0.1.0.1.0.0.0+0.1.0.1.0.1.0.0+0.1.0.1.0.1.0 29-30|0.1.0.1.0 27-28|0.0 24-25|0.1.0.1.0.1 20-21|0 19-20|0.1 18-19|0.1.0.1 17-18|0.1.0.1.1 15-16|0.1.0.1.0.0 14-15|0.1.0 12-13|0.1.0.2 9-10|0.1.0.0 8-9|0.1.0.0.1 5-6|0.1.1 4-5|0.1.1.0 2-3|0.1.1.0.1 0-1|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:10.048
(p / possible-01 
      :ARG1 (n2 / number) 
      :op2-of (a / and 
            :op1 (c / confine-01 
                  :ARG1 (r2 / resist-01 
                        :ARG0 (d / date-entity 
                              :year 2003) 
                        :ARG1 (i / insulin)) 
                  :ARG2 (m / muscle-01 
                        :ARG1 (f / function-01 
                              :ARG0 (m2 / most) 
                              :ARG1-of (r / reduce-01 
                                    :ARG0 (t / thing 
                                          :name (n / name 
                                                :op1 "Petersen" 
                                                :op2 "et" 
                                                :op3 "al.")))) 
                        :mod (s / skeletal)) 
                  :manner (e / elderly)) 
            :op2-of (a2 / and 
                  :op1 (e2 / explore-01 
                        :ARG1 (t2 / this) 
                        :polarity -))))

# ::snt The ability of PPAR to stimulate mitochondrial biogenesis and oxidative function suggests that PPAR could be important for control of insulin resistance during normal aging .
# ::tok The ability of PPAR to stimulate mitochondrial biogenesis and oxidative function suggests that PPAR could be important for control of insulin resistance during normal aging .
# ::alignments 24-25|0 23-24|0.0 21-22|0.1.0 20-21|0.1.0.0 18-19|0.1 16-17|0.1.1.0 14-15|0.1.1 11-12|0.1.1.1 10-11|0.1.1.1.0.2 9-10|0.1.1.1.0.2.0 8-9|0.1.1.1.0 7-8|0.1.1.1.0.1 5-6|0.1.1.1.0.0 3-4|0.1.1.1.0.0.0.0.0+0.1.1.1.0.0.0.0+0.1.1.1.0.0.0 1-2|0.1.1.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:10.866
(a / age-01 
      :ARG1-of (n / normal-02) 
      :ARG2-of (c / control-01 
            :ARG1 (r / resist-01 
                  :ARG1 (i / insulin)) 
            :time-of (p / possible-01 
                  :ARG1 (i2 / important) 
                  :ARG1-of (s / suggest-01 
                        :ARG0 (a2 / and 
                              :ARG1-of (s2 / stimulate-01 
                                    :ARG0 (o2 / organization 
                                          :name (n2 / name 
                                                :op1 "PPAR")) 
                                    :domain-of (a3 / ability)) 
                              :op1 (b / biogenesi) 
                              :op2 (f / function-01 
                                    :ARG1 (o / oxidative)))))))

# ::snt Together , these data indicate that PPAR and its ligands comprise a key molecular switch to regulate muscle fiber specification , obesity resistance , insulin sensitivity , and , most surprisingly , physical endurance .
# ::tok Together , these data indicate that PPAR and its ligands comprise a key molecular switch to regulate muscle fiber specification , obesity resistance , insulin sensitivity , and , most surprisingly , physical endurance .
# ::alignments 33-34|0.1.0.0.0.0.3 32-33|0.1.0.0.0.0.3.1 30-31|0.1.0.0.0.0.3.0 29-30|0.1.0.0.0.0.3.0.0 27-28|0.1.0.0.0.0 25-26|0.1.0.0.0.0.2 24-25|0.1.0.0.0.0.2.0 22-23|0.1.0.0.0.0.1 21-22|0.1.0.0.0.0.1.1 19-20|0.1.0.0.0.0.0 18-19|0.1.0.0.0.0.0.1 17-18|0.1.0.0.0.0.0.0 16-17|0.1.0.0.0 14-15|0.1.0.0 13-14|0.1.0.0.2 12-13|0.1.0.0.1 10-11|0.1.0 9-10|0.1.1 7-8|0.1 6-7|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 4-5|0 3-4|0.0 2-3|0.0.0 0-1|0.1.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:12.041
(i2 / indicate-01 
      :ARG1 (d / data 
            :mod (t / this)) 
      :op1-of (a2 / and 
            :ARG0-of (c / comprise-01 
                  :ARG1 (s4 / switch-01 
                        :ARG1 (r2 / regulate-01 
                              :ARG1 (a / and 
                                    :op1 (s3 / specification 
                                          :ARG1-of (m2 / muscle-01) 
                                          :mod (f / fib)) 
                                    :op2 (r / resist-01 
                                          :ARG0 (t2 / together) 
                                          :ARG1 (o / obesity)) 
                                    :op3 (s2 / sensitivity 
                                          :mod (i / insulin)) 
                                    :op4 (e / endurance 
                                          :ARG2-of (s / surprise-01 
                                                :degree (m / most)) 
                                          :mod (p / physical)))) 
                        :ARG1-of (k / key-02) 
                        :mod (m3 / molecule))) 
            :op2 (l / ligand 
                  :poss (o2 / organization 
                        :name (n / name 
                              :op1 "PPAR")))))

# ::snt This work demonstrates that complex physiologic properties such as fatigue , endurance , and running capacity can be genetically manipulated .
# ::tok This work demonstrates that complex physiologic properties such as fatigue , endurance , and running capacity can be genetically manipulated .
# ::alignments 19-20|0.1 18-19|0.1.0 16-17|0.1.1 15-16|0.2.3 14-15|0.2.3.0 13-14|0.2 11-12|0.2.2 9-10|0.2.1 7-8|0.0.0 6-7|0.2.0 5-6|0.2.0.0 4-5|0.2.0.1 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:12.222
(d / demonstrate-01 
      :ARG0 (w / work-01 
            :ARG1 (s / such) 
            :mod (t / this)) 
      :ARG1 (m / manipulate-02 
            :ARG1 (g / genetics) 
            :ARG1-of (p / possible-01)) 
      :ARG2 (a / and 
            :example-of (p2 / property 
                  :mod (p3 / physiologic) 
                  :mod (c2 / complex)) 
            :op1 (f / fatigue) 
            :op2 (e / endurance) 
            :op3 (c / capacity 
                  :ARG0-of (r / run-01))))

# ::snt Animals .
# ::tok Animals .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:12.226
(a / animal)

# ::snt The transactivation domain ( 78 amino acid residues , corresponding to residues 413 -- 490 ) of VP16 was fused in frame with the N-terminus of mouse PPAR .
# ::tok The transactivation domain ( 78 amino acid residues , corresponding to residues 413 -- 490 ) of VP16 was fused in frame with the N-terminus of mouse PPAR .
# ::alignments 27-28|0.1.0.2.1.0.0+0.1.0.2.1.0+0.1.0.2.1 26-27|0.1.0.2 24-25|0.1.0.2.1.1 21-22|0.1.0.1 19-20|0.1.0 17-18|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 14-15|0.1.0.2.0.0 9-10|0.1.0.2.0 7-8|0 6-7|0.0 5-6|0.1 4-5|0.2 2-3|0.1.0.0 1-2|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:12.488
(r / residu 
      :mod (a / acid) 
      :mod (a2 / amino 
            :ARG0-of (f2 / fuse-01 
                  :ARG1 (d / domain 
                        :mod (t / transactivation) 
                        :poss (c / country 
                              :name (n3 / name 
                                    :op1 "VP16"))) 
                  :ARG2 (f / frame) 
                  :time (m / mouse 
                        :ARG0-of (c2 / correspond-01 
                              :ARG1 490) 
                        :mod-of (o / organization 
                              :name (n / name 
                                    :op1 "PPAR") 
                              :poss-of (n2 / n-terminu))))) 
      :quant 78)

# ::snt The VP16-PPAR fusion cDNA was placed downstream of the human -skeletal actin promoter ( Brennan and Hardeman 1993 ) , and upstream of the SV40 intron/poly ( A ) sequence .
# ::tok The VP16-PPAR fusion cDNA was placed downstream of the human -skeletal actin promoter ( Brennan and Hardeman 1993 ) , and upstream of the SV40 intron/poly ( A ) sequence .
# ::alignments 29-30|0.0.1.1.0 24-25|0.2.0.0+0.2.0+0.2 21-22|0.0.1.2 20-21|0.0.1 17-18|0.0.1.0.0.0.0+0.0.1.0.0.0 16-17|0.1.0.0+0.1.0+0.1 15-16|0 14-15|0.0.0.0+0.0.0+0.0 12-13|0.0.1.1 11-12|0.0.1.1.1 9-10|0.0.1.0.1 6-7|0.0.1.0 5-6|0.0.1.0.0 3-4|0.0.1.0.0.1 2-3|0.0.1.0.0.1.0 1-2|0.0.1.0.0.1.1.0.0+0.0.1.0.0.1.1.0+0.0.1.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:13.486
(a2 / and 
      :op1 (p2 / person 
            :name (n3 / name 
                  :op1 "Brennan") 
            :op3-of (a / and 
                  :op1 (d2 / downstream 
                        :ARG1-of (p4 / place-01 
                              :ARG0 (d / date-entity 
                                    :year 1993) 
                              :ARG2 (c / cdna 
                                    :mod (f / fusion) 
                                    :mod (o / organization 
                                          :name (n4 / name 
                                                :op1 "VP16-PPAR")))) 
                        :poss (h / human)) 
                  :op2 (p3 / promote-01 
                        :ARG0 (s / sequence) 
                        :ARG1 (a3 / actin)) 
                  :op4 (u / upstream))) 
      :op2 (p / person 
            :name (n2 / name 
                  :op1 "Hardeman")) 
      :op3 (t / thing 
            :name (n / name 
                  :op1 "SV40")))

# ::snt The transgene was purified and injected into C57BL/6J  CBA F1 zygotes .
# ::tok The transgene was purified and injected into C57BL/6J  CBA F1 zygotes .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:13.487
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Transgenic mice were backcrossed with C57BL/6J for two generations .
# ::tok Transgenic mice were backcrossed with C57BL/6J for two generations .
# ::alignments 8-9|0.0.0 7-8|0.0.0.0 5-6|0.0.1.0+0.0.1+0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:13.507
(m / mouse 
      :domain-of (p / person 
            :location (g / generation 
                  :quant 2) 
            :name (n / name 
                  :op1 "C57BL/6J")))

# ::snt Wild-type littermates were used as controls throughout the study .
# ::tok Wild-type littermates were used as controls throughout the study .
# ::alignments 8-9|0.1.0 6-7|0.1.0.0 5-6|0.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:13.528
(u / use-01 
      :ARG1 (l / littermat) 
      :ARG2 (c / control-01 
            :ARG1 (s / study-01 
                  :op1-of (t / throughout))))

# ::snt On normal chow diet , the transgenic mice and control littermates used here had similar body weights .
# ::tok On normal chow diet , the transgenic mice and control littermates used here had similar body weights .
# ::alignments 16-17|0.0 15-16|0.0.0 14-15|0.0.1 12-13|0.2.1 11-12|0.2 10-11|0.2.0 9-10|0.1.0 8-9|0 7-8|0.1 3-4|0.1.0.0.0 2-3|0.1.0.0.0.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:13.679
(a / and 
      :ARG0-of (w / weight-01 
            :ARG1 (b / body) 
            :ARG1-of (r / resemble-01)) 
      :op1 (m / mouse 
            :ARG0-of (c / control-01 
                  :ARG1 (n / normal-02 
                        :ARG1 (d / diet 
                              :mod (c2 / chow))))) 
      :op2 (u / use-01 
            :ARG1 (l / littermat) 
            :location (h / here)))

# ::snt PPAR-null mice were previously generated ( Barak et al. 2002 ) .
# ::tok PPAR-null mice were previously generated ( Barak et al. 2002 ) .
# ::alignments 9-10|0.0.1.0+0.0.1 6-9|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 4-5|0 3-4|0.2 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:13.857
(g / generate-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 "Barak" 
                  :op2 "et" 
                  :op3 "al.") 
            :time (d / date-entity 
                  :year 2002)) 
      :ARG1 (m / mouse) 
      :time (p / previous))

# ::snt Mice were fed either a standard chow with 4 % ( w/w ) fat content ( Harlan Teklad , Harlan , Indianapolis , Indiana , United States ) or a high-fat diet containing 35 % ( w/w ) fat content ( product F3282 , Bioserv , Frenchtown , New Jersey , United States ) as indicated .
# ::tok Mice were fed either a standard chow with 4 % ( w/w ) fat content ( Harlan Teklad , Harlan , Indianapolis , Indiana , United States ) or a high-fat diet containing 35 % ( w/w ) fat content ( product F3282 , Bioserv , Frenchtown , New Jersey , United States ) as indicated .
# ::alignments 55-56|0.0.0.2 51-53|0.0.0.2.0.1+0.0.0.2.0.0.1+0.0.0.2.0.0.0+0.0.0.2.0.0+0.0.0.2.0 48-50|0.0.3.0.1+0.0.3.0.0+0.0.3.0+0.0.3 46-47|0.0.1.0.0+0.0.1.0+0.0.1 42-43|0.0.0.2.1.0 41-42|0.0.0.2.1 39-40|0.0.0.0 38-39|0.0.0 34-35|0.0.0.1.0.0.0.0.0 33-34|0.0.0.1.0.0.0.0.0.0 32-33|0.0.0.1.0.0.0.0 31-32|0.0.0.1.0.1.1 28-29|0.0.0.1.0.1 25-27|0.0.2.1+0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 23-24|0.0.0.1.0.0.2.0.0+0.0.0.1.0.0.2.0+0.0.0.1.0.0.2 21-22|0.0.0.3.1+0.0.0.3.0.0+0.0.0.3.0+0.0.0.3 16-18|0.0.0.1.0.1.0.0.1+0.0.0.1.0.1.0.0.0+0.0.0.1.0.1.0.0+0.0.0.1.0.1.0 14-15|0.0.0.1.0 13-14|0.0.0.1 9-10|0.0.0.1.0.0.0.0.1 8-9|0.0.0.1.0.0.0.0.1.0 6-7|0 5-6|0.0 3-4|0.0.0.1.0.0.1 2-3|0.0.0.1.0.0 0-1|0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:17.465
(c10 / chow 
      :ARG1-of (s / standard-02 
            :ARG2 (f2 / fat-03 
                  :ARG1 (c4 / content) 
                  :ARG2-of (f3 / fat-03 
                        :ARG1 (c9 / content 
                              :ARG1-of (f4 / feed-up-03 
                                    :ARG2 (m / mouse 
                                          :ARG0-of (c5 / contain-01 
                                                :ARG1 (p2 / percentage-entity 
                                                      :value 35) 
                                                :ARG2 (p4 / percentage-entity 
                                                      :value 4))) 
                                    :mod (e / either) 
                                    :op1-of (c7 / country 
                                          :name (n5 / name 
                                                :op1 "Indiana"))) 
                              :op1-of (o / or 
                                    :op2 (p3 / person 
                                          :name (n7 / name 
                                                :op1 "Harlan" 
                                                :op2 "Teklad")) 
                                    :op3 (d / diet)))) 
                  :manner-of (i / indicate-01 
                        :ARG2 (c / country 
                              :name (n / name 
                                    :op1 "United" 
                                    :op2 "States") 
                              :wiki "United_States") 
                        :op1-of (p / product 
                              :mod-of (f / F3282))) 
                  :op1-of (c8 / city 
                        :name (n6 / name 
                              :op1 "Indianapolis") 
                        :wiki "Indianapolis")) 
            :op1-of (c3 / country 
                  :name (n3 / name 
                        :op1 "Frenchtown")) 
            :op1-of (c6 / country 
                  :name (n4 / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :op1-of (c2 / country 
                  :name (n2 / name 
                        :op1 "New" 
                        :op2 "Jersey"))))

# ::snt For ligand experiments , we synthesized the GW501516 compound and mice were orally gavaged daily ( 10 mg/kg or vehicle alone ) .
# ::tok For ligand experiments , we synthesized the GW501516 compound and mice were orally gavaged daily ( 10 mg/kg or vehicle alone ) .
# ::alignments 20-21|0.0.0.1.0 19-20|0.0.0.1.0.0 18-19|0.0.0.1.0.0.0 16-17|0.0.0.0.0 12-13|0.0.0.2 10-11|0.0.1 9-10|0 8-9|0.0.0.1 5-6|0.0 4-5|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.1.0+0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:17.747
(a2 / and 
      :op1 (s / synthesize-01 
            :ARG0 (w / we 
                  :ARG0-of (e / experiment-01 
                        :ARG1 10 
                        :mod (l / ligand 
                              :wiki "HRG_(gene)")) 
                  :ARG0-of (c / compound-01 
                        :ARG1 (a / alone 
                              :mod-of (v / vehicle 
                                    :op1-of (o / or)))) 
                  :domain-of (o2 / orally)) 
            :ARG1 (m / mouse)))

# ::snt Gene expression analysis and physiological studies .
# ::tok Gene expression analysis and physiological studies .
# ::alignments 5-6|0.1 4-5|0.1.0 3-4|0 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:17.774
(a / and 
      :op1 (a2 / analyze-01 
            :ARG1 (e / express-01 
                  :ARG0 (p2 / person 
                        :name (n / name 
                              :op1 "Gene")))) 
      :op2 (s / study-01 
            :ARG1 (p / physiological)))

# ::snt Mouse EST clones were obtained from ATCC ( Manassas , Virginia , United States ) , verified by sequencing , and used as Northern probes .
# ::tok Mouse EST clones were obtained from ATCC ( Manassas , Virginia , United States ) , verified by sequencing , and used as Northern probes .
# ::alignments 24-25|0.0.1 23-24|0.0.1.0 21-22|0.0 20-21|0 16-17|0.1.1.2 12-14|0.2.1+0.2.0.1+0.2.0.0+0.2.0+0.2 10-11|0.1.1.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 8-9|0.0.0.0.0+0.0.0.0+0.0.0 6-7|0.1.0.0.0+0.1.0.0+0.1.0 4-5|0.1 2-3|0.1.1 0-2|0.1.1.1.0.1+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:18.342
(a / and 
      :ARG1-of (u / use-01 
            :ARG0 (o / organization 
                  :name (n3 / name 
                        :op1 "Manassas")) 
            :ARG2 (p / probe 
                  :mod "Northern_Ireland")) 
      :op1 (o3 / obtain-01 
            :ARG0 (o2 / organization 
                  :name (n4 / name 
                        :op1 "ATCC")) 
            :ARG1 (c2 / clone-01 
                  :ARG0 (s / state 
                        :name (n2 / name 
                              :op1 "Virginia") 
                        :wiki "Virginia") 
                  :ARG1 (t / thing 
                        :name (n5 / name 
                              :op1 (m / Mouse) 
                              :op2 (e / EST))) 
                  :ARG1-of (v / verify-01))) 
      :op2 (c / country 
            :name (n / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States"))

# ::snt Antibodies were obtained from Santa Cruz Biotechnology ( Santa Cruz , California , United States ) .
# ::tok Antibodies were obtained from Santa Cruz Biotechnology ( Santa Cruz , California , United States ) .
# ::alignments 13-15|0.2.0.0.0.0.1+0.2.0.0.0.0.0.1+0.2.0.0.0.0.0.0+0.2.0.0.0.0.0+0.2.0.0.0.0 11-12|0.2.0.0.0.2.1+0.2.0.0.0.2.0.0+0.2.0.0.0.2.0+0.2.0.0.0.2 8-10|0.0.0.1+0.0.0.0+0.0.0+0.0 5-7|0.2.0.1+0.2.0.0+0.2.0+0.2 4-5|0.2.0.0.0.3+0.2.0.0.0.1.0+0.2.0.0.0.1+0.2.0.0.0 2-3|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:18.732
(o / obtain-01 
      :ARG0 (c2 / country 
            :name (n3 / name 
                  :op1 "Santa" 
                  :op2 "Cruz")) 
      :ARG1 (a / antibodi) 
      :ARG2 (t / thing 
            :name (n4 / name 
                  :op1 (c3 / Cruz 
                        :mod (p / person 
                              :mod (c / country 
                                    :name (n / name 
                                          :op1 "United" 
                                          :op2 "States") 
                                    :wiki "United_States") 
                              :name (n5 / name 
                                    :op1 "Santa") 
                              :poss-of (s / state 
                                    :name (n2 / name 
                                          :op1 "California") 
                                    :wiki "California") 
                              :wiki "Santa_Claus")) 
                  :op2 (b / Biotechnology))))

# ::snt Total muscle protein extracts ( Lin et al. 2002 ) and nuclear proteins ( Wang et al. 2003 ) were prepared as described .
# ::tok Total muscle protein extracts ( Lin et al. 2002 ) and nuclear proteins ( Wang et al. 2003 ) were prepared as described .
# ::alignments 22-23|0.1.1 20-21|0.1 17-18|0.1.0.1.0.0+0.1.0.1.0 12-13|0.1.1.1 11-12|0.1.1.1.0 10-11|0 8-9|0.1.1.0.0+0.1.1.0 5-8|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 3-4|0.1.0.0+0.1.0.0.0 2-3|0.1.0 1-2|0.1.0.1 0-1|0.1.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:19.318
(a / and 
      :op1 (t / thing 
            :name (n2 / name 
                  :op1 "Lin" 
                  :op2 "et" 
                  :op3 "al.")) 
      :op2 (p / prepare-02 
            :ARG0 (p3 / protein 
                  :ARG0-of (e / extract-01 
                        :ARG1 (t2 / thing)) 
                  :ARG1-of (m / muscle-01 
                        :ARG0 (d2 / date-entity 
                              :year 2003) 
                        :ARG1-of (t3 / total-01))) 
            :ARG1 (d / describe-01 
                  :ARG0 (d3 / date-entity 
                        :year 2002) 
                  :ARG1 (p2 / protein 
                        :mod (n / nucleus)))))

# ::snt Prior to the exercise performance test , the mice were accustomed to the treadmill ( Columbus Instruments , Columbus , Ohio , United States ) with a 5-min run at 7 m/min once per day for 2 d .
# ::tok Prior to the exercise performance test , the mice were accustomed to the treadmill ( Columbus Instruments , Columbus , Ohio , United States ) with a 5-min run at 7 m/min once per day for 2 d .
# ::alignments 37-38|0.4 36-37|0.5 34-35|0.6 32-33|0.3 30-31|0.0.1.1 28-29|0.0.0 22-24|0.0.1.0.1+0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 20-21|0.0.1.2.0.0.0.0+0.0.1.2.0.0.0+0.0.1.2.0.0 15-17|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 13-14|0.1 10-11|0 8-9|0.0 5-6|0.0.1 4-5|0.0.1.2 3-4|0.0.1.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:19.974
(a / accustom-01 
      :ARG1 (m / mouse 
            :ARG0-of (r / run-13 
                  :ARG1 (c3 / country 
                        :name (n3 / name 
                              :op1 "Columbus" 
                              :op2 "Instruments"))) 
            :ARG1-of (t2 / test-01 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States") 
                  :ARG2 7 
                  :mod (p / perform-02 
                        :ARG1 (e / exercise-02 
                              :ARG0 (c2 / country 
                                    :name (n2 / name 
                                          :op1 "Ohio")))))) 
      :ARG2 (t / treadmill) 
      :ARG4 (p2 / prior) 
      :op1-of (o / once) 
      :op1-of (d / d) 
      :op1-of 2 
      :op1-of (d2 / day))

# ::snt The exercise test regimen was 10 m/min for the first 60 min , followed by 1 m/min increment increases at 15-min intervals .
# ::tok The exercise test regimen was 10 m/min for the first 60 min , followed by 1 m/min increment increases at 15-min intervals .
# ::alignments 21-22|0 18-19|0.0 17-18|0.0.0 15-16|0.0.1.1.1.0.0 13-14|0.0.1 11-12|0.0.1.0 10-11|0.0.1.1.0 5-6|0.0.2 3-4|0.0.1.1.1 2-3|0.0.1.1 1-2|0.0.1.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:20.165
(i / interval 
      :ARG0-of (i2 / increase-01 
            :ARG1 (i3 / increment) 
            :ARG1-of (f / follow-01 
                  :ARG0 (m / min) 
                  :ARG2 (t / test-01 
                        :ARG0 60 
                        :purpose-of (r / regimen 
                              :ARG1-of (e / exercise-02 
                                    :ARG0 1)))) 
            :ARG2 10))

# ::snt Exhaustion was defined when mice were unable to avoid repetitive electrical shocks .
# ::tok Exhaustion was defined when mice were unable to avoid repetitive electrical shocks .
# ::alignments 11-12|0.0 10-11|0.0.2 9-10|0 8-9|0.0.1 4-5|0.0.1.0 2-3|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:20.237
(r / repetitive 
      :mod-of (s / shock-01 
            :ARG1 (d / define-01 
                  :ARG1 (e2 / exhaustion)) 
            :ARG1-of (a / avoid-01 
                  :ARG0 (m / mouse)) 
            :mod (e / electricity)))

# ::snt Muscle fiber typing and mitochondrial DNA isolation .
# ::tok Muscle fiber typing and mitochondrial DNA isolation .
# ::alignments 6-7|0.1.0.0 5-6|0.1.0.0.0 3-4|0.0 2-3|0.1 1-2|0.1.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:20.374
(m / muscle-01 
      :ARG0 (a / and) 
      :ARG1 (t / type-01 
            :ARG0 (f / fib 
                  :mod-of (i / isolate-01 
                        :ARG1 (d / DNA)))))

# ::snt Muscle fiber typing was essentially performed using metachromatic dye -- ATPase methods as described ( Ogilvie and Feeback 1990 ) .
# ::tok Muscle fiber typing was essentially performed using metachromatic dye -- ATPase methods as described ( Ogilvie and Feeback 1990 ) .
# ::alignments 18-19|0.0.0.2.1.0+0.0.0.2.1 16-17|0 15-16|0.0.1.0+0.0.1+0.0 13-14|0.0.0.3 11-12|0.0.0.3.0 8-9|0.0.0.0 6-7|0.0.0 5-6|0.0.0.1 4-5|0.0.0.1.0 2-3|0.0.0.2 1-2|0.0.0.2.0 0-1|0.0.0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:20.583
(a / and 
      :op1 (p / person 
            :ARG0-of (u / use-01 
                  :ARG1 (d3 / dye-01) 
                  :ARG1-of (p2 / perform-02 
                        :manner (e / essential)) 
                  :ARG2 (t / type-01 
                        :ARG0 (f / fib) 
                        :ARG1 (d / date-entity 
                              :year 1990) 
                        :ARG1-of (m2 / muscle-01)) 
                  :ARG2-of (d2 / describe-01 
                        :ARG1 (m / method))) 
            :name (n / name 
                  :op1 "Ogilvie")))

# ::snt Muscle mitochondria were isolated ( Scholte et al. 1997 ) .
# ::tok Muscle mitochondria were isolated ( Scholte et al. 1997 ) .
# ::alignments 8-9|0.2.0+0.2 5-8|0.1.2+0.1.1+0.1.0+0.1+0 3-4|0.0 0-2|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:20.786
(t / thing 
      :ARG0-of (i / isolate-01 
            :ARG1 (t2 / thing 
                  :name (n2 / name 
                        :op1 (m / Muscle) 
                        :op2 (m2 / mitochondria)))) 
      :name (n / name 
            :op1 "Scholte" 
            :op2 "et" 
            :op3 "al.") 
      :time (d / date-entity 
            :year 1997))

# ::snt Mitochondrial DNA was prepared and analyzed on 1 % agarose gel .
# ::tok Mitochondrial DNA was prepared and analyzed on 1 % agarose gel .
# ::alignments 10-11|0.2 9-10|0.2.0 8-9|0.2.0.0 7-8|0.2.0.0.0 5-6|0.1 4-5|0 3-4|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:20.854
(a3 / and 
      :op1 (p2 / prepare-02 
            :ARG1 (d / DNA)) 
      :op2 (a2 / analyze-01) 
      :op3 (g / gel 
            :mod (a / agarose 
                  :mod (p / percentage-entity 
                        :value 1))))

# ::snt Number of mice for each group used in experiments is indicated in figure legends .
# ::tok Number of mice for each group used in experiments is indicated in figure legends .
# ::alignments 13-14|0.1 12-13|0.1.0 10-11|0 8-9|0.0.0.0.0 6-7|0.0.0.0 5-6|0.0.0 4-5|0.0.0.1 2-3|0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:20.931
(i / indicate-01 
      :ARG1 (n / number-01 
            :ARG0 (g / group 
                  :ARG1-of (u / use-01 
                        :ARG2 (e / experiment-01)) 
                  :mod (e2 / each)) 
            :ARG1 (m / mouse)) 
      :ARG2 (l / legend 
            :mod (f / figure)))

# ::snt Values are presented as mean  SEM .
# ::tok Values are presented as mean  SEM .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:20.932
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt A two-tailed Student 's t test was used to calculate p-values .
# ::tok A two-tailed Student 's t test was used to calculate p-values .
# ::alignments 10-11|0.0.0.0.1.0.0 9-10|0.0.0.0.1.0 7-8|0.0.0.0.1 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0+0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:20.972
(t3 / two-tail 
      :ARG1-of (s / study-01 
            :ARG0 (p2 / person 
                  :ARG0-of (t / test-01 
                        :ARG1 (t2 / t) 
                        :ARG1-of (u / use-01 
                              :ARG2 (c / calculate-01 
                                    :ARG1 (p / p-valu)))))))

# ::snt Beginning of Running Test .
# ::tok Beginning of Running Test .
# ::alignments 3-4|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:20.985
(b / begin-01 
      :ARG1 (t / test 
            :ARG1-of (r / run-01)))

# ::snt This video shows the exercise performance of a representative of the transgenic mice ( right chamber ) and a representative of wild-type control littermates ( left chamber ) on the treadmill 15 min into the exercise challenge .
# ::tok This video shows the exercise performance of a representative of the transgenic mice ( right chamber ) and a representative of wild-type control littermates ( left chamber ) on the treadmill 15 min into the exercise challenge .
# ::alignments 36-37|0.1 35-36|0.1.1 32-33|0.1.0 31-32|0.1.0.1 30-31|0.1.0.0 26-27|0.0.2.0.0 25-26|0.0.2.0 23-24|0.0.1.0.0.1 22-23|0.0.1.0.0.1.0 19-20|0.0.1.0.0 17-18|0.0.1.0 15-16|0.0.1.0.0.0 14-15|0.0.1.0.0.0.0 12-13|0.0.1.1 8-9|0.0.1 5-6|0.0 4-5|0.0.2 2-3|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:21.907
(s / show-01 
      :ARG1 (p / perform-02 
            :ARG0 (v / video 
                  :mod (t2 / this)) 
            :ARG1 (r3 / represent-01 
                  :ARG0 (a / and 
                        :op1 (r / represent-01 
                              :ARG0 (c4 / chamber 
                                    :mod (r2 / right)) 
                              :ARG1 (l2 / littermat 
                                    :mod (c3 / control-01)))) 
                  :ARG1 (m2 / mouse)) 
            :mod (e2 / exercise-02 
                  :ARG1 (l / left 
                        :mod-of (c2 / chamber)))) 
      :ARG2 (c / challenge-01 
            :ARG1 (m / min 
                  :mod (t / treadmill) 
                  :quant 15) 
            :ARG2 (e / exercise-02)))

# ::snt ( 52.4 MB MOV ) .
# ::tok ( 52.4 MB MOV ) .
# ::alignments 2-4|0.0.1+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:21.916
(o / organization 
      :name (n / name 
            :op1 "MB" 
            :op2 "MOV"))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:21.934
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Running Test 90 Min Later .
# ::tok Running Test 90 Min Later .
# ::alignments 4-5|0.0 3-4|0.0.0.2+0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.0.0.1 1-2|0.0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:21.958
(r / run-01 
      :ARG1 (l / late 
            :mod (p / person 
                  :name (n / name 
                        :op1 "Min") 
                  :quant 90 
                  :wiki "Hla_Min") 
            :mod (t / test)))

# ::snt This video shows the exercise performance of a representative of the transgenic mice ( right chamber ) and a representative of wild-type control littermates ( left chamber ) on the treadmill 90 min into the exercise challenge .
# ::tok This video shows the exercise performance of a representative of the transgenic mice ( right chamber ) and a representative of wild-type control littermates ( left chamber ) on the treadmill 90 min into the exercise challenge .
# ::alignments 36-37|0.1 35-36|0.1.1 32-33|0.1.0 31-32|0.0.1.0.0.1.0.0 30-31|0.1.0.0 26-27|0.0.2.0.0 25-26|0.0.2.0 23-24|0.0.1.0.0.1 22-23|0.0.1.0.0.1.0 19-20|0.0.1.0.0 17-18|0.0.1.0 15-16|0.0.1.0.0.0 14-15|0.0.1.0.0.0.0 12-13|0.0.1.1 8-9|0.0.1 5-6|0.0 4-5|0.0.2 2-3|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:22.812
(s / show-01 
      :ARG1 (p / perform-02 
            :ARG0 (v / video 
                  :mod (t2 / this)) 
            :ARG1 (r3 / represent-01 
                  :ARG0 (a / and 
                        :op1 (r / represent-01 
                              :ARG0 (c4 / chamber 
                                    :mod (r2 / right)) 
                              :ARG1 (l2 / littermat 
                                    :mod (c3 / control-01 
                                          :ARG1 90)))) 
                  :ARG1 (m2 / mouse)) 
            :mod (e2 / exercise-02 
                  :ARG1 (l / left 
                        :mod-of (c2 / chamber)))) 
      :ARG2 (c / challenge-01 
            :ARG1 (m / min 
                  :mod (t / treadmill)) 
            :ARG2 (e / exercise-02)))

# ::snt ( 41.7 MB MOV ) .
# ::tok ( 41.7 MB MOV ) .
# ::alignments 2-4|0.0.1+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:22.819
(o / organization 
      :name (n / name 
            :op1 "MB" 
            :op2 "MOV"))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:22.835
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt We thank Dr. M. Downes for providing the -skeletal actin promoter ; Dr. G. D. Barish for comments on the manuscript ; M.A. Lawrence for histology ; Dr. S. Pfaff for the use of microscopes and photographic equipment ; M. Lieberman and K.L. Schnoeker for photography ; J.M. Shelton for advice on fiber staining ; and E. Stevens and E. Ong for administrative assistance .
# ::tok We thank Dr. M. Downes for providing the -skeletal actin promoter ; Dr. G. D. Barish for comments on the manuscript ; M.A. Lawrence for histology ; Dr. S. Pfaff for the use of microscopes and photographic equipment ; M. Lieberman and K.L. Schnoeker for photography ; J.M. Shelton for advice on fiber staining ; and E. Stevens and E. Ong for administrative assistance .
# ::alignments 63-64|0.0.1.1.0 62-63|0.0.1.1.0.0 59-61|0.0.1.0.4.0.1+0.0.1.0.4.0.0+0.0.1.0.4.0+0.0.1.0.4 58-59|0.0.1.0 56-58|0.0.1.1.2.1.1+0.0.1.1.2.1.0+0.0.1.1.2.1+0.0.1.1.2 55-56|0.0.1.1 53-54|0.0.1.1.2.0 52-53|0.0.1.1.2.0.0 50-51|0.0.1.1.2.0.1 47-49|0.0.1.0.3.0.1+0.0.1.0.3.0.0+0.0.1.0.3.0+0.0.1.0.3 45-46|0.0.1.1.1.2.0 42-44|0.0.0.1+0.0.0.0+0.0.0+0.0 41-42|0.0.2 40-41|0.0.2.0.1+0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 37-38|0.0.1.0.2.1.0.1 36-37|0.0.1.0.2.1.0.1.0 35-36|0.0.1.0.2.1.0 34-35|0.0.1.0.2.1.0.0 32-33|0.0.1.0.2.1 28-30|0.0.1.0.2.0.1+0.0.1.0.2.0.0+0.0.1.0.2.0+0.0.1.0.2 25-26|0.0.1.1.1.2.1 22-24|0.0.1.0.1.0.1+0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 20-21|0.1 17-18|0 13-16|0.0.1.0.0.0.2+0.0.1.0.0.0.1+0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 11-12|0.0.1 10-11|0.0.1.1.1 9-10|0.0.1.1.1.1 6-7|0.0.1.1.1.2 3-5|0.0.1.1.1.2.2.1.0.1+0.0.1.1.1.2.2.1.0.0+0.0.1.1.1.2.2.1.0+0.0.1.1.1.2.2.1 2-3|0.0.1.1.1.0 1-2|0.0.1.1.1.2.2 0-1|0.0.1.1.1.2.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:26.163
(c / comment-01 
      :ARG0 (p5 / person 
            :name (n4 / name 
                  :op1 "K.L." 
                  :op2 "Schnoeker") 
            :op1-of (a8 / and 
                  :op1-of (a3 / and 
                        :op2 (p10 / person 
                              :name (n8 / name 
                                    :op1 "G." 
                                    :op2 "D." 
                                    :op3 "Barish")) 
                        :op3 (p9 / person 
                              :name (n7 / name 
                                    :op1 "M.A." 
                                    :op2 "Lawrence")) 
                        :op4 (p8 / person 
                              :name (n6 / name 
                                    :op1 "S." 
                                    :op2 "Pfaff") 
                              :purpose (u / use-01 
                                    :ARG1 (a7 / and 
                                          :op1 (m / microscop) 
                                          :op2 (e / equipment 
                                                :mod (p7 / photography))))) 
                        :op5 (p3 / person 
                              :name (n3 / name 
                                    :op1 "J.M." 
                                    :op2 "Shelton")) 
                        :op6 (p / person 
                              :name (n / name 
                                    :op1 "E." 
                                    :op2 "Ong"))) 
                  :op2-of (a4 / and 
                        :ARG0-of (a / assist-01 
                              :mod (a2 / administrate-01)) 
                        :op1 (p11 / promote-01 
                              :ARG0 (d / dr.) 
                              :ARG1 (a9 / actin) 
                              :ARG1-of (p12 / provide-01 
                                    :ARG0 (p4 / photography) 
                                    :ARG2 (h / histology) 
                                    :ARG2-of (t / thank-01 
                                          :ARG0 (w / we) 
                                          :ARG1 (p13 / person 
                                                :name (n9 / name 
                                                      :op1 "M." 
                                                      :op2 "Downes"))))) 
                        :op3 (p2 / person 
                              :ARG0-of (s / stain-01 
                                    :ARG1 (f / fib) 
                                    :ARG1-of (a5 / advise-01)) 
                              :name (n2 / name 
                                    :op1 "E." 
                                    :op2 "Stevens")))) 
            :op2-of (a6 / and 
                  :op1 (p6 / person 
                        :name (n5 / name 
                              :op1 "Lieberman") 
                        :wiki "Joe_Lieberman"))) 
      :ARG3 (m2 / manuscript))

# ::snt YXW was supported by a postdoctoral fellowship from California Tobacco-Related Disease Research Program .
# ::tok YXW was supported by a postdoctoral fellowship from California Tobacco-Related Disease Research Program .
# ::alignments 10-13|0.0.1.1.2+0.0.1.1.1+0.0.1.1.0+0.0.1.1+0.0.1 8-10|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 6-7|0.0 5-6|0.0.0 2-3|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:26.227
(s / support-01 
      :ARG0 (f / fellowship 
            :mod (p / postdoctoral) 
            :source (o / organization 
                  :mod (c / country 
                        :name (n2 / name 
                              :op1 "California" 
                              :op2 "Tobacco-Related")) 
                  :name (n / name 
                        :op1 "Disease" 
                        :op2 "Research" 
                        :op3 "Program"))) 
      :ARG1 (o2 / organization 
            :name (n3 / name 
                  :op1 "YXW")))

# ::snt JH was supported by the BK21 program , Ministry of Education , Korea .
# ::tok JH was supported by the BK21 program , Ministry of Education , Korea .
# ::alignments 12-13|0.2 10-11|0.3 8-9|0.3.0 6-7|0.0 5-6|0.0.0.0.0+0.0.0.0+0.0.0 2-3|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:26.419
(s / support-01 
      :ARG0 (p / program 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "BK21"))) 
      :ARG1 (o / organization 
            :name (n2 / name 
                  :op1 "JH")) 
      :op1-of "Korea" 
      :op1-of (e / education 
            :mod-of (m / ministry)))

# ::snt HK was supported by grant M1 -- 0311-00 -- 0145 from the Molecular and Cellular BioDiscovery Research Program , Ministry of Science and Technology , Korea .
# ::tok HK was supported by grant M1 -- 0311-00 -- 0145 from the Molecular and Cellular BioDiscovery Research Program , Ministry of Science and Technology , Korea .
# ::alignments 25-26|0.0.0 19-24|0.0.2.0.4+0.0.2.0.3+0.0.2.0.2+0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 14-18|0.0.1.1.0.0.3+0.0.1.1.0.0.2+0.0.1.1.0.0.1+0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 13-14|0.0.1.1 12-13|0.0.1.0.0+0.0.1.0+0.0.1 9-10|0.0.3.0+0.0.3 7-8|0.0.4.2+0.0.4.1+0.0.4.0+0.0.4 5-6|0.0.0.0 4-5|0.0 2-3|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:27.593
(s / support-01 
      :ARG0 (g / grant-01 
            :ARG0 (K / "Korea" 
                  :poss-of (m / m1)) 
            :ARG1 (c / country 
                  :name (n3 / name 
                        :op1 "Molecular") 
                  :op1-of (a / and 
                        :op2 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "Cellular" 
                                    :op2 "BioDiscovery" 
                                    :op3 "Research" 
                                    :op4 "Program")))) 
            :ARG2 (o / organization 
                  :name (n / name 
                        :op1 "Ministry" 
                        :op2 "of" 
                        :op3 "Science" 
                        :op4 "and" 
                        :op5 "Technology")) 
            :time (d / date-entity 
                  :year 0145) 
            :time (d2 / date-entity 
                  :day 0 
                  :month 11 
                  :year 03)) 
      :ARG1 (c2 / country 
            :name (n4 / name 
                  :op1 "HK")))

# ::snt RME is an Investigator of the Howard Hughes Medical Institute at the Salk Institute for Biological Studies and March of Dimes Chair in Molecular and Developmental Biology .
# ::tok RME is an Investigator of the Howard Hughes Medical Institute at the Salk Institute for Biological Studies and March of Dimes Chair in Molecular and Developmental Biology .
# ::alignments 25-27|0.1.1.1.1.0.1+0.1.1.1.1.0.0+0.1.1.1.1.0+0.1.1.1.1 24-25|0.1.1.1 12-24|0.1.1.0.3+0.1.1.0.2+0.1.1.0.1+0.1.1.0.11+0.1.1.0.10+0.1.1.0.9+0.1.1.0.8+0.1.1.0.7+0.1.1.0.6+0.1.1.0.5+0.1.1.0.4+0.1.1.0.0+0.1.1.0+0.1.1 9-10|0.1 7-9|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 6-7|0.1.1.1.0.1+0.1.1.1.0.0.0+0.1.1.1.0.0+0.1.1.1.0 3-4|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:27.899
(i2 / investigator 
      :domain (o3 / organization 
            :name (n5 / name 
                  :op1 "RME")) 
      :poss (i / institute-01 
            :ARG0 (t / thing 
                  :name (n3 / name 
                        :op1 (h / Hughes) 
                        :op2 (m / Medical))) 
            :ARG1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "Salk" 
                        :op10 "Chair" 
                        :op11 "in" 
                        :op12 "Molecular" 
                        :op2 "Institute" 
                        :op3 "for" 
                        :op4 "Biological" 
                        :op5 "Studies" 
                        :op6 "and" 
                        :op7 "March" 
                        :op8 "of" 
                        :op9 "Dimes") 
                  :op2-of (a / and 
                        :op1 (p / person 
                              :name (n4 / name 
                                    :op1 "Howard") 
                              :wiki "John_Howard") 
                        :op3 (o / organization 
                              :name (n / name 
                                    :op1 "Developmental" 
                                    :op2 "Biology"))))))

# ::snt This work was supported by the Howard Hughes Medical Institute and the Hillblom Foundation .
# ::tok This work was supported by the Howard Hughes Medical Institute and the Hillblom Foundation .
# ::alignments 12-14|0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 10-11|0.0 9-10|0.0.1 7-9|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 6-7|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.066
(s / support-01 
      :ARG0 (a / and 
            :op1 (p / person 
                  :name (n3 / name 
                        :op1 "Howard") 
                  :wiki "John_Howard") 
            :op2 (i / institute-01 
                  :ARG1 (t / thing 
                        :name (n2 / name 
                              :op1 (h / Hughes) 
                              :op2 (m / Medical)))) 
            :op3 (o / organization 
                  :name (n / name 
                        :op1 "Hillblom" 
                        :op2 "Foundation"))) 
      :ARG1 (w / work-01 
            :mod (t2 / this)))

# ::snt COX - cytochrome c oxidase .
# ::tok COX - cytochrome c oxidase .
# ::alignments 4-5|0.0 3-4|0.0.0 2-3|0.0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.080
(c3 / cox-01 
      :ARG0 (o / oxidase 
            :mod (c / c) 
            :mod (c2 / cytochrome)))

# ::snt mCPT1 - muscle carnitine palmitoyltransferase-1 .
# ::tok mCPT1 - muscle carnitine palmitoyltransferase-1 .
# ::alignments 3-4|0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.091
(m2 / mCPT1 
      :mod-of (m / muscle-01 
            :ARG1 (c / carnitine)))

# ::snt PGC-1 - Peroxisome proliferator-activated receptor-gamma coactivator 1 .
# ::tok PGC-1 - Peroxisome proliferator-activated receptor-gamma coactivator 1 .
# ::alignments 6-7|0.0 5-6|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.101
(c / coactivator 
      :mod 1)

# ::snt PPAR - peroxisome proliferator-activated receptor .
# ::tok PPAR - peroxisome proliferator-activated receptor .
# ::alignments 4-5|0 3-4|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.114
(r / receptor 
      :mod (p / proliferator-activat 
            :degree (o / organization 
                  :name (n / name 
                        :op1 "PPAR"))))

# ::snt UCP - uncoupling protein .
# ::tok UCP - uncoupling protein .
# ::alignments 3-4|0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.126
(p / protein 
      :mod (u / uncouple 
            :degree (u2 / UCP)))

# ::snt Expression of Endogenous PPAR and VP16-PPAR Transgene in Muscle .
# ::tok Expression of Endogenous PPAR and VP16-PPAR Transgene in Muscle .
# ::alignments 8-9|0.0.1.0 6-7|0.0.1.1 5-6|0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 4-5|0.0.1 2-4|0.0.0.1+0.0.0.0+0.0.0+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.174
(e2 / expression 
      :mod-of (t2 / thing 
            :name (n2 / name 
                  :op1 (e / Endogenous) 
                  :op2 (p / PPAR)) 
            :op1-of (a / and 
                  :ARG1-of (m / muscle-01) 
                  :op2 (t / transgene 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "VP16-PPAR"))))))

# ::snt ( A ) Pooled RNA isolated from various muscles of five wild-type male C57B6 mice was hybridized with indicated probes .
# ::tok ( A ) Pooled RNA isolated from various muscles of five wild-type male C57B6 mice was hybridized with indicated probes .
# ::alignments 19-20|0.0.1.0.1 18-19|0.0.1.0.1.0 16-17|0.0.1.0 14-15|0.0.1.0.0 13-14|0.0.1.0.0.0 12-13|0.0.0 10-11|0.0.1.0.1.0.0 8-9|0 7-8|0.1 5-6|0.0 3-5|0.0.1.1.1+0.0.1.1.0+0.0.1.1+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.366
(m3 / muscle 
      :beneficiary-of (i2 / isolate-01 
            :ARG0 (m2 / male) 
            :ARG1 (t / thing 
                  :ARG1-of (h / hybridize-01 
                        :ARG0 (m / mouse 
                              :mod (c / C57B6)) 
                        :ARG2 (p / probe 
                              :ARG1-of (i / indicate-01 
                                    :ARG0 5))) 
                  :name (n / name 
                        :op1 (p2 / Pooled) 
                        :op2 (r / RNA)))) 
      :mod (v / various))

# ::snt EDL , extensor digitorum longus ; Gastro , gastrocnemius .
# ::tok EDL , extensor digitorum longus ; Gastro , gastrocnemius .
# ::alignments 8-9|0.1.0.0.0 5-6|0 4-5|0.1 3-4|0.1.0 2-3|0.1.0.0 0-1|0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.401
(a / and 
      :op1 (p / political-party 
            :name (n / name 
                  :op1 "EDL") 
            :wiki "English_Defence_League") 
      :op2 (l / longu 
            :mod (d / digitorum 
                  :mod (e / extensor 
                        :op1-of (g / gastrocnemiu)))))

# ::snt ( B ) Pooled nuclear proteins ( 15 g/lane ) isolated from muscles of five wild-type male C57B6 were probed with anti-PPAR antibody .
# ::tok ( B ) Pooled nuclear proteins ( 15 g/lane ) isolated from muscles of five wild-type male C57B6 were probed with anti-PPAR antibody .
# ::alignments 22-23|0.0.0.2.1 19-20|0.0.0.2 17-18|0.0.0.2.0 16-17|0.0.0.0 14-15|0.0.2 12-13|0.0.1 10-11|0.0 7-8|0.0.0.2.2 5-6|0 4-5|0.1 3-4|0.0.0 1-2|0.0.0.1.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.859
(p2 / protein 
      :ARG0-of (i / isolate-01 
            :ARG1 (p3 / pool-01 
                  :ARG0 (m / male) 
                  :ARG1 (l / location 
                        :name (n2 / name 
                              :op1 "B") 
                        :wiki -) 
                  :ARG1-of (p / probe-01 
                        :ARG0 (c / C57B6) 
                        :ARG2 (a / antibody) 
                        :op1-of 15)) 
            :ARG2 (m2 / muscle) 
            :time 5) 
      :mod (n / nucleus))

# ::snt RNA polymerase II ( Pol II ) is shown as a loading control .
# ::tok RNA polymerase II ( Pol II ) is shown as a loading control .
# ::alignments 12-13|0.1 11-12|0.1.0 8-9|0 4-6|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 2-3|0.0.2+0.0.1.2+0.0.1.1+0.0.1.0+0.0.1+0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.946
(s / show-01 
      :ARG1 (w / war 
            :mod (p2 / polymerase 
                  :mod (r / rna)) 
            :name (n2 / name 
                  :op1 "World" 
                  :op2 "War" 
                  :op3 "II") 
            :wiki "World_War_II") 
      :ARG2 (c / control-01 
            :ARG1 (l / load-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (p / Pol) 
                              :op2 (i / II))))))

# ::snt ( C ) Expression of the VP16-PPAR transgene in various tissues .
# ::tok ( C ) Expression of the VP16-PPAR transgene in various tissues .
# ::alignments 10-11|0.1.1 9-10|0.1.1.0 6-7|0.1.0.0+0.1.0+0.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:28.972
(e / expression 
      :mod-of (c / C) 
      :poss (o / organization 
            :name (n / name 
                  :op1 "VP16-PPAR") 
            :topic-of (t / tissue 
                  :mod (v / various))))

# ::snt 10 g of total RNA from each tissue was hybridized with a VP16 cDNA probe .
# ::tok 10 g of total RNA from each tissue was hybridized with a VP16 cDNA probe .
# ::alignments 14-15|0.2 13-14|0.2.1 12-13|0.2.0.0.0+0.2.0.0+0.2.0 9-10|0 7-8|0.2.2.0 6-7|0.2.2 4-5|0.1.0 3-4|0.1 1-2|0.0 0-1|0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:29.157
(h / hybridize-01 
      :ARG1 (g / g) 
      :ARG1-of (t2 / total-01 
            :ARG2 (r / rna)) 
      :ARG2 (p / probe-01 
            :ARG0 (c2 / country 
                  :name (n / name 
                        :op1 "VP16") 
                  :quant 10) 
            :ARG1 (c / cdna) 
            :ARG2 (e / each 
                  :mod-of (t / tissue))))

# ::snt Gastrocnemius muscle was used here .
# ::tok Gastrocnemius muscle was used here .
# ::alignments 4-5|0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:29.169
(u / use-01 
      :ARG1 (m / muscle-01 
            :mod (g / gastrocnemiu)) 
      :location (h / here))

# ::snt ( D ) Nuclear proteins ( 15 g/lane ) isolated from gastrocnemius muscle of the transgenic mice ( TG ) and the wild-type littermates ( WT ) were probed with indicated antibodies .
# ::tok ( D ) Nuclear proteins ( 15 g/lane ) isolated from gastrocnemius muscle of the transgenic mice ( TG ) and the wild-type littermates ( WT ) were probed with indicated antibodies .
# ::alignments 31-32|0.1.2 30-31|0.1.2.0 28-29|0.1 23-24|0.1.1 20-21|0 18-19|0.1.0.0.0+0.1.0.0+0.1.0 16-17|0.0.2.1 12-13|0.0.2 11-12|0.0.2.0 9-10|0.0 6-7|0.1.2.0.0 4-5|0.0.1 3-4|0.0.1.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:29.529
(a2 / and 
      :op1 (i2 / isolate-01 
            :ARG0 (d / D) 
            :ARG1 (p2 / protein 
                  :mod (n2 / nucleus)) 
            :ARG2 (m2 / muscle-01 
                  :ARG0 (g / gastrocnemiu) 
                  :ARG1 (m / mouse))) 
      :op2 (p / probe-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "TG")) 
            :ARG1 (l / littermat) 
            :instrument (a / antibodi 
                  :ARG1-of (i / indicate-01 
                        :ARG0 15))))

# ::snt The upper , nonspecific band that cross-reacted with the anti-PPAR antibody serves a loading control .
# ::tok The upper , nonspecific band that cross-reacted with the anti-PPAR antibody serves a loading control .
# ::alignments 14-15|0.1 13-14|0.1.0 11-12|0 10-11|0.1.1 4-5|0.0 3-4|0.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:29.583
(s / serve-01 
      :ARG0 (b / band 
            :mod (n / nonspecific) 
            :mod (u / upper)) 
      :ARG1 (c / control-01 
            :ARG1 (l / load-01) 
            :manner (a / antibody)))

# ::snt Increased Oxidative Type I Fibers in the Transgenic Mice .
# ::tok Increased Oxidative Type I Fibers in the Transgenic Mice .
# ::alignments 8-9|0.0.1 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:29.638
(o / oxidative 
      :ARG0-of (t / type-01 
            :ARG1 (f / fiber 
                  :mod-of (i / i)) 
            :location (m / mouse)) 
      :ARG1-of (i2 / increase-01))

# ::snt ( A and B ) Muscles in transgenic mice ( TG ) are redder than those in wild-type mice ( WT ) .
# ::tok ( A and B ) Muscles in transgenic mice ( TG ) are redder than those in wild-type mice ( WT ) .
# ::alignments 18-19|0.1.0 13-14|0.1.2 10-11|0.2.0.0+0.2.0+0.2 8-9|0.1.1 5-6|0.1 3-4|0.0.1+0.0.0.0+0.0.0+0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:29.723
(a / and 
      :op1 (l / location 
            :name (n2 / name 
                  :op1 "B") 
            :wiki -) 
      :op2 (m3 / muscle-01 
            :ARG0 (m / mouse) 
            :ARG1 (m2 / mouse) 
            :domain-of (r / red)) 
      :op3 (o / organization 
            :name (n / name 
                  :op1 "TG")))

# ::snt ( C ) Metachromatic staining of the type II plantaris muscle .
# ::tok ( C ) Metachromatic staining of the type II plantaris muscle .
# ::alignments 10-11|0.0.0 9-10|0.0.0.0 8-9|0.0.0.0.0.2+0.0.0.0.0.1.2+0.0.0.0.0.1.1+0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 7-8|0.0.0.0.0.0 4-5|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:29.795
(c / C 
      :ARG0-of (s / stain-01 
            :ARG1 (m / muscle-01 
                  :ARG1 (p / plantari 
                        :mod (w / war 
                              :mod-of (t / type) 
                              :name (n / name 
                                    :op1 "World" 
                                    :op2 "War" 
                                    :op3 "II") 
                              :wiki "World_War_II")))))

# ::snt Type I fibers are stained dark blue .
# ::tok Type I fibers are stained dark blue .
# ::alignments 6-7|0.0.1 5-6|0.0.1.0 4-5|0.0 2-3|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:29.936
(f / fiber 
      :ARG2-of (s / stain-01 
            :ARG0 (i / i 
                  :ARG1-of (t / type-01)) 
            :ARG1 (b / blue 
                  :ARG1-of (d / dark-02))))

# ::snt Activation of PPAR Induces Genes Typical for Type I Fibers and Promotes Mitochondrial Biogenesis .
# ::tok Activation of PPAR Induces Genes Typical for Type I Fibers and Promotes Mitochondrial Biogenesis .
# ::alignments 12-14|0.3.0.1+0.3.0.0+0.3.0+0.3 11-12|0.0.1 10-11|0 9-10|0.2 8-9|0.2.0 7-8|0.0.3 5-6|0.1 3-4|0.0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:30.011
(a / and 
      :op1 (i2 / induce-01 
            :ARG0 (o / organization 
                  :name (n2 / name 
                        :op1 "PPAR")) 
            :ARG0-of (p / promote-01) 
            :ARG1 (a2 / activation) 
            :ARG1-of (t2 / type-01)) 
      :op2 (t3 / typical) 
      :op3 (f / fiber 
            :mod (i / i)) 
      :op4 (t / thing 
            :name (n / name 
                  :op1 (m / Mitochondrial) 
                  :op2 (b / Biogenesis))))

# ::snt ( A ) Total RNA ( 10 g/lane ) prepared from gastrocnemius muscle of transgenic ( TG ) and wild-type ( WT ) littermates was probed with indicated probes .
# ::tok ( A ) Total RNA ( 10 g/lane ) prepared from gastrocnemius muscle of transgenic ( TG ) and wild-type ( WT ) littermates was probed with indicated probes .
# ::alignments 28-29|0.0.0.0.0 27-28|0.0.0.0 25-26|0.0.0.1 23-24|0.0.0 18-19|0 16-17|0.1.0.0+0.1.0+0.1 12-13|0.0 11-12|0.0.2 9-10|0.0.1 6-7|0.0.0.0.1 4-5|0.0.1.0 3-4|0.0.1.0.0.0+0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:30.205
(a / and 
      :ARG0-of (m / muscle-01 
            :ARG1 (l / littermat 
                  :ARG0-of (i / indicate-01 
                        :ARG1 (p / probe) 
                        :ARG2 10) 
                  :ARG1-of (p2 / probe-01)) 
            :ARG2-of (p3 / prepare-02 
                  :ARG1 (r / rna 
                        :name (n2 / name 
                              :op1 "Total"))) 
            :mod (g / gastrocnemiu)) 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "TG")))

# ::snt The fold increase of induction of each gene is shown .
# ::tok The fold increase of induction of each gene is shown .
# ::alignments 9-10|0 7-8|0.0 6-7|0.0.1 4-5|0.0.0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:30.230
(s / show-01 
      :ARG1 (g / gene 
            :ARG1-of (i / induct-02) 
            :mod (e / each)) 
      :ARG2 (i2 / increase-01 
            :ARG1 (f / fold)))

# ::snt ( B ) Total genomic DNA ( 10 g/lane ) prepared from gastrocnemius muscle was digested with Nco1 and subjected to Southern analysis with COXII ( mitochondrial genome -- encoded ) and MCIP1 ( nuclear genome -- encoded ) DNA probes .
# ::tok ( B ) Total genomic DNA ( 10 g/lane ) prepared from gastrocnemius muscle was digested with Nco1 and subjected to Southern analysis with COXII ( mitochondrial genome -- encoded ) and MCIP1 ( nuclear genome -- encoded ) DNA probes .
# ::alignments 40-41|0.0.0.1.1.0.1.0.0 39-40|0.0.0.1.1.0.1.0 37-38|0.0.0.1.1.0.1 35-36|0.0.0.1.0.0.0.0 34-35|0.0.0.1.0.0.0 32-33|0.1.0.0+0.1.0+0.1 31-32|0 29-30|0.0.0.1.0.0.1 27-28|0.0.0.1.0.0.2.0.0.0 24-25|0.0.1.0+0.0.1+0.0 22-23|0.0.0 21-22|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 19-20|0.0.0.1 18-19|0.0.0.1.1 17-18|0.0.0.1.1.0.0.0.0+0.0.0.1.1.0.0.0+0.0.0.1.1.0.0 15-16|0.0.0.1.1.0 13-14|0.0.0.1.0.0 12-13|0.0.0.1.0 10-11|0.0.0.1.0.0.2 7-8|0.0.0.1.0.0.1.0 5-6|0.0.0.1.0.0.2.0 3-4|0.0.0.1.0.0.2.0.0 1-2|0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:31.043
(a / and 
      :op1 (p3 / person 
            :ARG1-of (a2 / analyze-01 
                  :ARG0 (l / location 
                        :name (n6 / name 
                              :op1 "B") 
                        :wiki -) 
                  :ARG2-of (s / subject-01 
                        :ARG1 (g3 / gastrocnemiu 
                              :ARG1-of (m / muscle-01 
                                    :ARG0 (n / nucleus 
                                          :mod-of (g / genome)) 
                                    :ARG1-of (e2 / encode-01 
                                          :ARG0 10) 
                                    :ARG2-of (p4 / prepare-02 
                                          :ARG1 (d3 / DNA 
                                                :ARG1-of (t3 / total-01 
                                                      :ARG0 (g2 / genome)))))) 
                        :op2-of (a3 / and 
                              :op1 (d2 / digest-01 
                                    :ARG1 (t2 / thing 
                                          :name (n5 / name 
                                                :op1 "Nco1")) 
                                    :ARG2 (e / encode-01 
                                          :ARG1 (d / DNA 
                                                :mod-of (p / probe)))))) 
                  :manner (t / thing 
                        :name (n4 / name 
                              :op1 "Southern"))) 
            :name (n3 / name 
                  :op1 "COXII")) 
      :op2 (p2 / person 
            :name (n2 / name 
                  :op1 "MCIP1")))

# ::snt ( C ) Equal amounts of gastrocnemius muscle were collected from both transgenic mice and control littermates .
# ::tok ( C ) Equal amounts of gastrocnemius muscle were collected from both transgenic mice and control littermates .
# ::alignments 16-17|0.0.1 15-16|0.2.0 14-15|0.0 13-14|0.2 11-12|0.0.0 9-10|0 7-8|0.1.1 6-7|0.1.1.0 4-5|0.1.0 3-4|0.1 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:31.123
(c2 / collect-01 
      :ARG0 (a / and 
            :mod (b / both) 
            :op1 (l / littermat)) 
      :ARG1 (e / equal-01 
            :ARG0 (a2 / amount) 
            :ARG1 (m2 / muscle-01 
                  :mod (g / gastrocnemiu))) 
      :ARG2 (m / mouse 
            :ARG0-of (c / control-01 
                  :ARG1 (c3 / C))))

# ::snt Total mitochondrial DNA was isolated and separated on 1 % agarose gel .
# ::tok Total mitochondrial DNA was isolated and separated on 1 % agarose gel .
# ::alignments 11-12|0.1.0 10-11|0.1.0.0 9-10|0.1.0.0.0 8-9|0.1.0.0.0.0 6-7|0.1 5-6|0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:31.190
(a2 / and 
      :op1 (i / isolate-01 
            :ARG1 (d / DNA 
                  :ARG1-of (t / total-01) 
                  :mod (m / mitochondrial))) 
      :op2 (s / separate-01 
            :ARG0 (g / gel 
                  :mod (a / agarose 
                        :mod (p / percentage-entity 
                              :value 1)))))

# ::snt The relative abundance of mitochondrial DNA in transgenic and wild-type mice is presented .
# ::tok The relative abundance of mitochondrial DNA in transgenic and wild-type mice is presented .
# ::alignments 12-13|0.0 10-11|0.1 8-9|0 5-6|0.2 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:31.247
(a / and 
      :ARG2-of (p / present-01 
            :ARG1 (a2 / abundance 
                  :mod (r / relative))) 
      :op1 (m / mouse) 
      :quant (d / DNA))

# ::snt ( D ) Western blot analysis of muscle fiber markers and mitochondrial components .
# ::tok ( D ) Western blot analysis of muscle fiber markers and mitochondrial components .
# ::alignments 12-13|0.0.0.0.2.0 11-12|0 10-11|0.0.0.0.2 9-10|0.0.0 8-9|0.0.0.1 7-8|0.0 5-6|0.0.0.0 4-5|0.0.0.0.0 3-4|0.0.0.0.1.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:31.471
(m / mitochondrial 
      :ARG0-of (m3 / muscle-01 
            :ARG1 (m2 / marker 
                  :ARG1-of (a2 / analyze-01 
                        :ARG1-of (b / blot-01 
                              :ARG0 (d / D)) 
                        :mod (w / world-region 
                              :name (n / name 
                                    :op1 "West") 
                              :wiki "Western_world") 
                        :op1-of (a / and 
                              :op2 (c / component))) 
                  :mod (f / fib))))

# ::snt Each lane was loaded with 80 g of total gastrocnemius muscle extracts .
# ::tok Each lane was loaded with 80 g of total gastrocnemius muscle extracts .
# ::alignments 11-12|0.0.0.1+0.0.0.1.0 10-11|0.0.0 9-10|0.0.0.0 8-9|0.0.0.1.0.0 5-6|0.0.0.1.0.0.0 3-4|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:31.662
(l / load-01 
      :ARG1 (l2 / lane-01 
            :ARG0-of (m / muscle-01 
                  :ARG1 (g / gastrocnemiu) 
                  :ARG2-of (e / extract-01 
                        :ARG1 (t / thing 
                              :ARG2-of (t2 / total-01 
                                    :ARG1 80)))) 
            :mod (e2 / each)))

# ::snt ( E ) Wild-type C57B6 mice were treated with vehicle or PPAR agonist GW501516 for 10 d. Total RNA ( 10 g/lane ) prepared from the gastrocnemius muscle was probed with indicated probes .
# ::tok ( E ) Wild-type C57B6 mice were treated with vehicle or PPAR agonist GW501516 for 10 d. Total RNA ( 10 g/lane ) prepared from the gastrocnemius muscle was probed with indicated probes .
# ::alignments 32-33|0.0.2.1 31-32|0.0.2.1.0 29-30|0.0.2 27-28|0.0.2.1.1 26-27|0.0.2.1.1.2 23-24|0.0.2.1.1.1 20-21|0.0.2.1.1.0 18-19|0.0.2.1.1.1.0 17-18|0.0.2.1.1.1.0.0.0+0.0.2.1.1.1.0.0 15-16|0.0.2.0 13-14|0.0.3.1.0+0.0.3.1+0.0.3 12-13|0.0.3.0 11-12|0.0.3.0.0.0.0+0.0.3.0.0.0+0.0.3.0.0 10-11|0 9-10|0.1 7-8|0.0 5-6|0.0.1 4-5|0.0.0 1-2|0.0.2.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:32.067
(o3 / or 
      :op1 (t / treat-01 
            :ARG0 (c / C57B6) 
            :ARG1 (m2 / mouse) 
            :ARG1-of (p2 / probe-01 
                  :ARG0 10 
                  :ARG2 (p / probe 
                        :ARG1-of (i / indicate-01 
                              :ARG0 (e / E)) 
                        :location-of (m / muscle-01 
                              :ARG1 10 
                              :ARG2-of (p3 / prepare-02 
                                    :ARG1 (r / rna 
                                          :name (n / name 
                                                :op1 "Total"))) 
                              :mod (g / gastrocnemiu)))) 
            :ARG2 (o / organization 
                  :mod (a / agonist 
                        :mod (o2 / organization 
                              :name (n3 / name 
                                    :op1 "PPAR"))) 
                  :name (n2 / name 
                        :op1 "GW501516"))) 
      :op2 (v / vehicle))

# ::snt Resistance to High-Fat-Induced Obesity in the Transgenic Mice .
# ::tok Resistance to High-Fat-Induced Obesity in the Transgenic Mice .
# ::alignments 7-8|0.1 3-4|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:32.081
(r / resist-01 
      :ARG2 (o / obesity 
            :mod (h / high-fat-induc)) 
      :purpose (m / mouse))

# ::snt ( A ) Seven-week-old transgenic ( TG ) and wild-type ( WT ) littermates ( n = 5 -- 6 for each group ) were fed with a high-fat diet for 97 d. Left panel shows net body weight gain , which was calculated for individual mice and then averaged .
# ::tok ( A ) Seven-week-old transgenic ( TG ) and wild-type ( WT ) littermates ( n = 5 -- 6 for each group ) were fed with a high-fat diet for 97 d. Left panel shows net body weight gain , which was calculated for individual mice and then averaged .
# ::alignments 49-50|0.2 48-49|0.2.2 47-48|0 46-47|0.1.0 45-46|0.1.0.0 43-44|0.1 39-40|0.2.1 38-39|0.2.1.3 37-38|0.2.1.2 36-37|0.2.1.4 35-36|0.2.1.1 34-35|0.2.1.1.1 33-34|0.2.1.1.1.0 31-32|0.2.0 29-30|0.2.1.1.0.0.1 25-26|0.2.1.1.0.0 22-23|0.2.1.0.0 21-22|0.2.1.0 19-20|0.1.1 17-18|0.2.1.1.0.0.0 13-14|0.2.1.1.0.2 8-9|0.2.1.1.0 6-7|0.0.0.0+0.0.0+0.0 4-5|0.2.1.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:33.483
(a2 / and 
      :op1 (o / organization 
            :name (n2 / name 
                  :op1 "TG")) 
      :op2 (c / calculate-01 
            :ARG1 (m / mouse 
                  :mod (i / individual)) 
            :ARG2 6) 
      :op3 (a / average-01 
            :ARG0 97 
            :ARG1 (g / gain-02 
                  :ARG0 (e / each 
                        :mod-of (g2 / group)) 
                  :ARG0-of (s / show-01 
                        :ARG1 (a3 / and 
                              :ARG1-of (f / feed-up-03 
                                    :ARG0 5 
                                    :ARG2 (d / diet)) 
                              :op1 (t2 / transgenic) 
                              :op2 (l2 / littermat)) 
                        :manner (p / panel 
                              :ARG1-of (l / leave-01))) 
                  :ARG1 (b / body) 
                  :ARG2 (w / weight) 
                  :mod (n / net)) 
            :time (t / then)))

# ::snt Right panel shows the body weights before ( Day 0 ) and after ( Day 97 ) high-fat feeding .
# ::tok Right panel shows the body weights before ( Day 0 ) and after ( Day 97 ) high-fat feeding .
# ::alignments 18-19|0.3.0.0.0 15-16|0.1.0 12-13|0.3.0.0 11-12|0.3.0 9-10|0.3.0.0.0.0 8-9|0.2 6-7|0.3 5-6|0.1 4-5|0.1.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:33.613
(s / show-01 
      :ARG0 (p / panel 
            :mod (r / right)) 
      :ARG1 (w / weight-01 
            :ARG0 97 
            :ARG1 (b2 / body)) 
      :ARG2 (d / day) 
      :time (b / before 
            :op1-of (a2 / and 
                  :op2 (a / after 
                        :op1 (f / feed-01 
                              :ARG1 0)))))

# ::snt ( B ) Histology of inguinal fat pad in the transgenic and wild-type littermates under a high-fat diet for 2 mo. ( C and D ) Intramuscular glycogen content ( C ) and triglyceride content ( D ) of mice in ( A ) after high-fat feeding ( n = 6 ) .
# ::tok ( B ) Histology of inguinal fat pad in the transgenic and wild-type littermates under a high-fat diet for 2 mo. ( C and D ) Intramuscular glycogen content ( C ) and triglyceride content ( D ) of mice in ( A ) after high-fat feeding ( n = 6 ) .
# ::alignments 50-51|0.4.0.0 46-47|0.4.0 44-45|0.4 39-40|0.4.0.1 36-37|0.1.1.0.1.0.1 34-35|0.1.1.2 32-33|0.1.1 30-31|0.1.1.0.1.0.0 28-29|0.1.1.1 27-28|0.1.1.1.0 24-25|0.3 23-24|0 22-23|0.2 19-20|0.4.0.2 17-18|0.1.1.0.0 13-14|0.1.0 11-12|0.1 7-8|0.1.1.0.1 6-7|0.1.1.0.1.0 5-6|0.1.1.0.1.1 3-4|0.1.1.0 1-2|0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:34.067
(a3 / and 
      :op1 (l2 / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :op2 (a4 / and 
            :op1 (l / littermat) 
            :op2-of (a2 / and 
                  :op1 (h / histology 
                        :mod (d3 / diet) 
                        :poss (p / pad 
                              :ARG1-of (f2 / fat-03 
                                    :ARG2 (c2 / C) 
                                    :op1-of (d / D)) 
                              :mod (i / inguinal))) 
                  :op3 (c3 / content 
                        :mod (g / glycogen)) 
                  :op4 (c / content))) 
      :op3 (c4 / C) 
      :op4 (d2 / D) 
      :time (a / after 
            :op1 (f / feed-01 
                  :ARG1 6 
                  :ARG2 (m / mouse) 
                  :op1-of 2)))

# ::snt ( E ) Glucose tolerance test .
# ::tok ( E ) Glucose tolerance test .
# ::alignments 5-6|0.0 4-5|0.0.1 3-4|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:34.080
(g / glucose 
      :op1 (t / test-01 
            :ARG0 (e / E) 
            :ARG1 (t2 / tolerate-01)))

# ::snt Mice in ( A ) after high-fat feeding were fasted for 6 h and then injected with glucose at a concentration of 1g/kg body weight .
# ::tok Mice in ( A ) after high-fat feeding were fasted for 6 h and then injected with glucose at a concentration of 1g/kg body weight .
# ::alignments 24-25|0.0.3.0 23-24|0.0.3.0.0 20-21|0.0.3 17-18|0.0.1 15-16|0.0 14-15|0.0.2 13-14|0 12-13|0.0.1.0 11-12|0.0.1.0.0 7-8|0.0.3.1 5-6|0.0.3.1.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:34.224
(a / and 
      :op1 (i / inject-01 
            :ARG1 (m / mouse) 
            :ARG2 (g / glucose 
                  :consist (h / h 
                        :quant 6)) 
            :time (t / then) 
            :time (c / concentrate-02 
                  :ARG1 (w / weight 
                        :part-of (b / body)) 
                  :ARG1-of (f / feed-01 
                        :op1-of (a2 / after)))))

# ::snt Then blood glucose levels were measured periodically over 2 h ( n = 6 ) .
# ::tok Then blood glucose levels were measured periodically over 2 h ( n = 6 ) .
# ::alignments 13-14|0.0.0.0 9-10|0.2 8-9|0.2.0 6-7|0.1 5-6|0 3-4|0.0 2-3|0.0.1 1-2|0.0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:34.453
(m / measure-01 
      :ARG1 (l / level 
            :mod (b / blood 
                  :poss 6) 
            :mod (g / glucose)) 
      :ARG2 (p / periodic) 
      :duration (h / h 
            :quant 2) 
      :time (t / then))

# ::snt PPAR Agonists Counteract Obesity Induced by High-Fat Diet .
# ::tok PPAR Agonists Counteract Obesity Induced by High-Fat Diet .
# ::alignments 6-8|0.0.0.1+0.0.0.0+0.0.0+0.0 4-5|0 3-4|0.1 2-3|0.2 1-2|0.2.1 0-1|0.2.0.0.0+0.2.0.0+0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:34.613
(i / induce-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "High-Fat" 
                  :op2 "Diet")) 
      :ARG1 (o2 / obesity) 
      :ARG3-of (c / counteract-01 
            :ARG1 (o3 / organization 
                  :name (n2 / name 
                        :op1 "PPAR")) 
            :ARG2 (a / agonist)))

# ::snt ( A ) Eleven-week-old wild-type C57B6 mice were fed a high-fat diet in combination with vehicle or GW501516 for 57 d. Total RNA ( 10 g/lane ) prepared from the gastrocnemius muscle was probed with indicated probes .
# ::tok ( A ) Eleven-week-old wild-type C57B6 mice were fed a high-fat diet in combination with vehicle or GW501516 for 57 d. Total RNA ( 10 g/lane ) prepared from the gastrocnemius muscle was probed with indicated probes .
# ::alignments 36-37|0.0.0.0.1.0 35-36|0.0.0.0.1.0.0 33-34|0.0.0.0.1 31-32|0.0.0.0.1.0.0.0 30-31|0.0.0.0.1.0.0.0.2 27-28|0.0.0.0.1.0.0.0.1 24-25|0.0.0.0.1.0.0.0.0 22-23|0.0.0.0.2 21-22|0.0.0.0.2.0.0+0.0.0.0.2.0 19-20|0.0.0.0.1.0.0.0.1.0 17-18|0.2.0.0+0.2.0+0.2 16-17|0 15-16|0.1 13-14|0.0 11-12|0.0.0.0.0 8-9|0.0.0.0 6-7|0.0.0 5-6|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:35.567
(o2 / or 
      :ARG1-of (c / combine-01 
            :ARG0 (m2 / mouse 
                  :ARG1-of (f / feed-up-03 
                        :ARG0 (d / diet) 
                        :ARG1-of (p2 / probe-01 
                              :instrument (p / probe 
                                    :ARG1-of (i / indicate-01 
                                          :ARG0 (m / muscle-01 
                                                :ARG1 10 
                                                :ARG2-of (p3 / prepare-02 
                                                      :ARG1 57) 
                                                :mod (g / gastrocnemiu))))) 
                        :ARG2 (r / rna 
                              :name (n / name 
                                    :op1 "Total"))) 
                  :mod (c2 / C57B6))) 
      :op1 (v / vehicle) 
      :op2 (o / organization 
            :name (n2 / name 
                  :op1 "GW501516")))

# ::snt ( B ) Net body weight gain for mice in ( A ) after treatment was calculated for individual mice and averaged .
# ::tok ( B ) Net body weight gain for mice in ( A ) after treatment was calculated for individual mice and averaged .
# ::alignments 21-22|0.1 20-21|0 19-20|0.0.1 18-19|0.0.1.1 16-17|0.0 14-15|0.0.1.0 13-14|0.0.1.0.0 8-9|0.0.0.3 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.1 3-4|0.0.0.2 1-2|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:35.831
(a2 / and 
      :op1 (c / calculate-01 
            :ARG1 (g / gain-02 
                  :ARG0 (w / weight) 
                  :ARG1 (b / body) 
                  :mod (n / net) 
                  :purpose (m2 / mouse)) 
            :beneficiary (m / mouse 
                  :location-of (t / treat-03 
                        :op1-of (a3 / after)) 
                  :mod (i / individual))) 
      :op2 (a / average-01 
            :ARG1 (l / location 
                  :name (n2 / name 
                        :op1 "B") 
                  :wiki -)))

# ::snt Initial body weights were 28.54  1.04 g for vehicle group ( n = 5 ) and 28.86  0.80 g for GW501516 group ( n = 5 ) .
# ::tok Initial body weights were 28.54  1.04 g for vehicle group ( n = 5 ) and 28.86  0.80 g for GW501516 group ( n = 5 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:35.833
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( C ) Various tissue weights for mice in ( A ) after treatment .
# ::tok ( C ) Various tissue weights for mice in ( A ) after treatment .
# ::alignments 13-14|0.2 12-13|0.2.0 7-8|0.3 5-6|0 4-5|0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:35.887
(w / weight-01 
      :ARG0 (c / C) 
      :ARG1 (t2 / tissue) 
      :ARG1-of (t / treat-03 
            :op1-of (a / after)) 
      :ARG2 (m / mouse))

# ::snt ifat , inguinal fat ; rdfat , reproductive fat ; retrofat , retroperitoneal fat .
# ::tok ifat , inguinal fat ; rdfat , reproductive fat ; retrofat , retroperitoneal fat .
# ::alignments 13-14|0.1.1 9-10|0 8-9|0.1 7-8|0.0 4-5|0.1.0.0.0 3-4|0.1.0.0 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:35.932
(a / and 
      :op1 (r / reproductive) 
      :op2 (f2 / fat-03 
            :ARG0 (i / inguinal 
                  :mod-of (f3 / fat 
                        :op1-of (a2 / and))) 
            :ARG1 (f / fat)))

# ::snt ( D ) Glucose tolerance test .
# ::tok ( D ) Glucose tolerance test .
# ::alignments 5-6|0.0.0 4-5|0.0 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:35.979
(g / glucose 
      :ARG1-of (t2 / tolerate-01 
            :ARG1-of (t / test-01)) 
      :mod-of (d / D))

# ::snt Mice in ( A ) after treatment were fasted for 6 h and then injected with glucose at a concentration of 1g/kg body weight .
# ::tok Mice in ( A ) after treatment were fasted for 6 h and then injected with glucose at a concentration of 1g/kg body weight .
# ::alignments 23-24|0.0.3.0 22-23|0.0.3.0.0 19-20|0.0.3 16-17|0.0.1 14-15|0.0 13-14|0.0.2 12-13|0 11-12|0.0.1.0 10-11|0.0.1.0.0 6-7|0.0.3.1 5-6|0.0.3.1.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:36.116
(a / and 
      :op1 (i / inject-01 
            :ARG1 (m / mouse) 
            :ARG2 (g / glucose 
                  :consist (h / h 
                        :quant 6)) 
            :time (t / then) 
            :time (c / concentrate-02 
                  :ARG1 (w / weight 
                        :part-of (b / body)) 
                  :ARG1-of (t2 / treat-03 
                        :op1-of (a2 / after)))))

# ::snt Blood glucose levels were then measured periodically over 2 h. PPAR Regulates Exercise Endurance .
# ::tok Blood glucose levels were then measured periodically over 2 h. PPAR Regulates Exercise Endurance .
# ::alignments 12-14|0.1.0.0.0.0.1+0.1.0.0.0+0.1.0.0.0.0+0.1.0.0.0.0.0 10-12|0.1.0.0.1.1+0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 8-9|0.0 6-7|0.2 5-6|0 4-5|0.3 2-3|0.1 1-2|0.1.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:36.575
(m / measure-01 
      :ARG0 2 
      :ARG1 (l / level 
            :ARG1-of (b / blood-01 
                  :ARG0 (t2 / thing 
                        :mod-of (e / Exercise 
                              :op1-of (n / name 
                                    :name-of (t / thing) 
                                    :op2 (e2 / Endurance))) 
                        :name (n2 / name 
                              :op1 (p / PPAR) 
                              :op2 (r / Regulates)))) 
            :mod (g / glucose)) 
      :ARG2 (p2 / periodic) 
      :time (t3 / then))

# ::snt ( A ) Enhanced exercise performance in the transgenic mice .
# ::tok ( A ) Enhanced exercise performance in the transgenic mice .
# ::alignments 9-10|0 5-6|0.0 4-5|0.0.0 3-4|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:36.616
(m / mouse 
      :ARG2-of (p / perform-02 
            :ARG1 (e / exercise-02) 
            :ARG1-of (e2 / enhance-01)))

# ::snt Fourteen-week-old male transgenic and wild-type littermates with similar body weights ( n = 4 for each group ) were subjected to a forced treadmill exercise test .
# ::tok Fourteen-week-old male transgenic and wild-type littermates with similar body weights ( n = 4 for each group ) were subjected to a forced treadmill exercise test .
# ::alignments 25-26|0.1 24-25|0.1.3 23-24|0.1.3.1 22-23|0.1.2 19-20|0 16-17|0.1.3.0 15-16|0.1.3.0.0 13-14|0.1.0 9-10|0.0.0.0 8-9|0.0.0.0.0 7-8|0.0.0 5-6|0.1.1 3-4|0.0 1-2|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:36.835
(s / subject-01 
      :ARG1 (a / and 
            :op1 (r / resemble-01 
                  :ARG1 (w / weight-01 
                        :ARG1 (b / body)))) 
      :ARG2 (t / test-01 
            :ARG0 4 
            :ARG1 (l / littermat) 
            :ARG1-of (f / force-01 
                  :ARG0 (m / male)) 
            :mod (e / exercise-02 
                  :ARG0 (g / group 
                        :mod (e2 / each)) 
                  :ARG1 (t2 / treadmill))))

# ::snt ( B ) Compromised exercise performance in PPAR-null mice .
# ::tok ( B ) Compromised exercise performance in PPAR-null mice .
# ::alignments 8-9|0.1.1 5-6|0.1 4-5|0 3-4|0.1.0 1-2|0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:36.919
(e / exercise-02 
      :ARG0 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :ARG1 (p / perform-02 
            :ARG0 (c / compromise-01) 
            :ARG1 (m / mouse)))

# ::snt Two-month-old male PPAR-null mice and wild-type controls with similar body weights ( n = 6 for each group ) were subjected to a forced treadmill exercise test .
# ::tok Two-month-old male PPAR-null mice and wild-type controls with similar body weights ( n = 6 for each group ) were subjected to a forced treadmill exercise test .
# ::alignments 26-27|0.1 25-26|0.1.2 24-25|0.1.1.1 23-24|0.1.1 20-21|0 17-18|0.0.0.0 16-17|0.0.0.0.0 14-15|0.1.2.0 10-11|0.0.0.1 9-10|0.0.0.1.0 8-9|0.0.0.1.1 6-7|0.0.0 4-5|0.0 3-4|0.1.0 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.167
(s / subject-01 
      :ARG1 (a / and 
            :op1 (c / control-01 
                  :ARG0 (g / group 
                        :mod (e2 / each)) 
                  :ARG1 (w / weight-01 
                        :ARG1 (b / body) 
                        :ARG1-of (r / resemble-01)))) 
      :ARG2 (t / test-01 
            :ARG1 (m / mouse) 
            :ARG2-of (f / force-01 
                  :ARG0 (m2 / male) 
                  :ARG1 (t2 / treadmill)) 
            :mod (e / exercise-02 
                  :ARG1 6)))

# ::snt ( C ) Functions of PPAR in skeletal muscle .
# ::tok ( C ) Functions of PPAR in skeletal muscle .
# ::alignments 8-9|0.0.0 7-8|0.0.0.0 5-6|0.0.1.0+0.0.1+0.0 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.200
(f / function-01 
      :ARG1 (o / organization 
            :ARG1-of (m / muscle-01 
                  :mod (s / skeletal)) 
            :name (n / name 
                  :op1 "PPAR")) 
      :op1-of (c / C))

# ::snt Conflicts of interest .
# ::tok Conflicts of interest .
# ::alignments 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.206
(c / conflict-01 
      :ARG1 (i / interest-01))

# ::snt The authors have declared that no conflicts of interest exist .
# ::tok The authors have declared that no conflicts of interest exist .
# ::alignments 9-10|0.0.0 8-9|0.0.0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.248
(d / declare-01 
      :ARG1 (a / author-01 
            :ARG2 (e / exist-01 
                  :ARG1 (c / conflict-01 
                        :ARG2-of (i / interest-01) 
                        :polarity -))))

# ::snt Author contributions .
# ::tok Author contributions .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.253
(c / contribute-01 
      :ARG1-of (a / author-01))

# ::snt YXW and RME conceived and designed the experiments .
# ::tok YXW and RME conceived and designed the experiments .
# ::alignments 7-8|0.1.1 5-6|0.1 4-5|0 3-4|0.1.2.0 2-3|0.0.0.0+0.0.0+0.0 1-2|0.1.2 0-1|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.321
(a / and 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "RME")) 
      :op2 (d / design-01 
            :ARG0 (o2 / organization 
                  :name (n2 / name 
                        :op1 "YXW")) 
            :ARG1 (e / experiment-01) 
            :op1-of (a2 / and 
                  :ARG0-of (c / conceive-01))))

# ::snt YXW , CLZ , RTY , MCN , and CRBO performed the experiments .
# ::tok YXW , CLZ , RTY , MCN , and CRBO performed the experiments .
# ::alignments 12-13|0.0.0 10-11|0.0 9-10|0.2.0.0+0.2.0+0.2 8-9|0 2-3|0.1.0.0+0.1.0+0.1 0-1|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.621
(a / and 
      :ARG0-of (p / perform-02 
            :ARG1 (e / experiment-01 
                  :ARG0 (o3 / organization 
                        :name (n3 / name 
                              :op1 "YXW")))) 
      :op1 (o2 / organization 
            :name (n2 / name 
                  :op1 "CLZ")) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "CRBO")))

# ::snt YXW , CLZ , and RME analyzed the data .
# ::tok YXW , CLZ , and RME analyzed the data .
# ::alignments 8-9|0.1 6-7|0 5-6|0.0.2.0.0+0.0.2.0+0.0.2 4-5|0.0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.670
(a / analyze-01 
      :ARG0 (a2 / and 
            :op1 (o3 / organization 
                  :name (n3 / name 
                        :op1 "YXW")) 
            :op2 (o2 / organization 
                  :name (n2 / name 
                        :op1 "CLZ")) 
            :op3 (o / organization 
                  :name (n / name 
                        :op1 "RME"))) 
      :ARG1 (d / data))

# ::snt HKC , JH , and HK contributed reagents/materials/analysis tools .
# ::tok HKC , JH , and HK contributed reagents/materials/analysis tools .
# ::alignments 8-9|0.1 7-8|0.1.0 6-7|0 5-6|0.0.2.0.0+0.0.2.0+0.0.2 4-5|0.0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.714
(c / contribute-01 
      :ARG0 (a / and 
            :op1 (o2 / organization 
                  :name (n3 / name 
                        :op1 "HKC")) 
            :op2 (o / organization 
                  :name (n2 / name 
                        :op1 "JH")) 
            :op3 (c2 / country 
                  :name (n / name 
                        :op1 "HK"))) 
      :ARG1 (t / tool 
            :purpose (r / reagents/materials/analysi)))

# ::snt YXW and RME wrote the paper .
# ::tok YXW and RME wrote the paper .
# ::alignments 5-6|0.1 3-4|0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.891
(w / write-01 
      :ARG0 (a / and 
            :op1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "YXW")) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "RME"))) 
      :ARG1 (p / paper))

# ::snt Academic Editor : Steve O'Rahilly , University of Cambridge .
# ::tok Academic Editor : Steve O'Rahilly , University of Cambridge .
# ::alignments 6-9|0.0.1.0.0.2+0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 3-5|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 1-2|0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:37.998
(e / editor 
      :ARG2-of (h / have-org-role-91 
            :ARG0 (p / person 
                  :name (n2 / name 
                        :op1 "Steve" 
                        :op2 "O'Rahilly")) 
            :ARG1 (a / academic 
                  :mod-of (o / organization 
                        :name (n / name 
                              :op1 "University" 
                              :op2 "of" 
                              :op3 "Cambridge")))))

# ::snt Citation : Wang YX , Zhang CL , Yu RT , Cho HK , Nelson MC , et al. ( 2004 ) Regulation of muscle fiber type and running endurance by PPAR .
# ::tok Citation : Wang YX , Zhang CL , Yu RT , Cho HK , Nelson MC , et al. ( 2004 ) Regulation of muscle fiber type and running endurance by PPAR .
# ::alignments 29-30|0.1.0.0.0 28-29|0.1.0.0 27-28|0.1.0.0.0.0 26-27|0.1 25-26|0.1.0 24-25|0 22-23|0.1.0.0.0.0.5 20-21|0.1.0.0.0.0.5.0.0+0.1.0.0.0.0.5.0 14-16|0.1.0.0.0.0.4.0.1+0.1.0.0.0.0.4.0.0+0.1.0.0.0.0.4.0+0.1.0.0.0.0.4 11-13|0.1.0.0.0.0.3.0.1+0.1.0.0.0.0.3.0.0+0.1.0.0.0.0.3.0+0.1.0.0.0.0.3 8-10|0.1.0.0.0.0.2.0.1+0.1.0.0.0.0.2.0.0+0.1.0.0.0.0.2.0+0.1.0.0.0.0.2 5-7|0.1.0.0.0.0.1.0.1+0.1.0.0.0.0.1.0.0+0.1.0.0.0.0.1.0+0.1.0.0.0.0.1 2-4|0.1.0.0.0.0.0.0.1+0.1.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:38.413
(m / muscle-01 
      :ARG0 (c2 / citation) 
      :ARG1 (t / type 
            :mod (f / fib 
                  :ARG1-of (r / run-01 
                        :ARG0 (e / endurance 
                              :op7-of (a / and 
                                    :op1 (p4 / person 
                                          :name (n5 / name 
                                                :op1 "Wang" 
                                                :op2 "YX")) 
                                    :op2 (p3 / person 
                                          :name (n4 / name 
                                                :op1 "Zhang" 
                                                :op2 "CL")) 
                                    :op3 (p2 / person 
                                          :name (n3 / name 
                                                :op1 "Yu" 
                                                :op2 "RT")) 
                                    :op4 (t2 / thing 
                                          :name (n2 / name 
                                                :op1 (c / Cho) 
                                                :op2 (h / HK))) 
                                    :op5 (p / person 
                                          :name (n / name 
                                                :op1 "Nelson" 
                                                :op2 "MC")) 
                                    :op6 (r2 / regulation 
                                          :li (d / date-entity 
                                                :year 2004))))))))

# ::snt PLoS Biol 2 ( 10 ) : e294 .
# ::tok PLoS Biol 2 ( 10 ) : e294 .
# ::alignments 7-8|0 4-5|0.0 2-3|0.1 0-2|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T23:53:38.431
(e / e294 
      :op1 10 
      :quant (2 / 2 
            :mod-of (o / organization 
                  :name (n / name 
                        :op1 "PLoS" 
                        :op2 "Biol"))))

